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V 
Summary 
The current clinical choice for bone regeneration is autologous bone grafts 
from the iliac crest. The associated drawbacks, however, in terms of morbidity 
and low cell number following tissue harvest, have led to search for alternative 
stromal cell sources in conjunction with native tissue matrix components. For 
mineralised tissue engineering, alternative to mesenchymal bone marrow 
stromal cells (BMSCs), mesenchymal dental pulp stromal cells (DPSCs) have 
been proposed due to high colony formation and differentiation potential. 
Understanding which stromal population is exemplar for rapid and effective 
regeneration is paramount, and central to efficient bone regeneration is 
providing the optimal microenvironment to the characterised stem cells. 
 
This thesis compared clonal BMSCs that formed few and large colonies, with 
DPSCs that formed many small colonies. Comparison of clonal differentiation 
along adipogenesis, chondrogenesis, with particular attention on their capacity 
for osteogenic formation, showed BMSCs were multipotent, while DPSCs only 
displayed uni- and bi- potency (osteogenic inclusive). Neither VCAM1 nor 
MCAM mesenchymal marker expression related to differentiation capacity. 
 
Stromal clones exposed to whole-protein tissue matrix extracts from bone 
(BME) and tooth (TME), found in vitro mineralisation by BMSCs and DPSCs 
with TME, but mineralisation by DPSCs only with BME. BMSC and DPSC 
clones were also assessed on bone- and tooth- slabs to replicate in vivo injury 
of fracture and caries, respectively. BMSCs and DPSCs displayed proliferation 
and differentiation on tissue-slabs, but BMSCs did not attach to tooth-slab, 
which was probable of tissue differences in supportive extracellular proteins. 
 
In summary, results indicated BMSCs are more primitive stromal cells closely 
related to the mother stem cell, while DPSCs are more lineage committed and 
are suggestive of transit-amplifying cells; indicative of their in vivo roles, that 
is, bone is remodeled constantly and tooth responds to injury only. While much 
research is still required, DPSCs and their matrix-proteins potentially offer an 
easily accessible and viable alternative for craniofacial bone reconstruction. 
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Chapter 1 
Background Introduction 
 
Within the literature, the term stem cell is often used incorrectly for adult 
mesenchymal cells, which should be referred to as stromal cells (Horwitz et 
al., 2005) until they have been fully characterized by colony unit formation, 
surface marker expression, proliferation capacity, and differentiation potential 
(Dominici et al., 2006). Within the adult, mesenchymal stromal cells have two 
key characteristics of self-renewal and multi-differentiation potency, and serve 
to replace tissues during normal homeostasis or cells lost following injury 
(Hombach-Klonisch et al., 2008). Mesenchymal stromal cells are a vital tool in 
the fields of tissue engineering and regenerative medicine, as well as wound 
healing, and as such would enhance repair of craniofacial tissues and 
significantly benefit current clinical treatments for dental/periodontal disease, 
paradontopathies, malformations, trauma, and post cancer, which is lacking 
(Miura et al., 2006). The use of stromal cells in conjunction with an appropriate 
bio-scaffold is seen as the future for regenerative medicine and thus it is 
paramount to understand the intimate relationship that stromal cells share with 
their niche microenvironment.  
 
Mesenchymal bone marrow stromal cells (BMSCs) are the “gold standard” 
tissue source for regenerative medicine, against which other mesenchymal 
stromal cells are compared due to their colony formation, proliferation, and 
differentiation abilities (Prockop, 1997, Pittenger et al., 1999, Gronthos et al., 
2003). Bone marrow stromal cells can differentiate along multiple lineages that 
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typically include osteogenic, chondrogenic, and adipogenic, and in addition 
myelosupportive stroma, myogenic, and neurogenic lines. There are 
complications, however, associated with obtaining bone marrow stromal cells, 
such as pain and secondary-morbidity at collection site following the 
procedure, and a low harvest number of cells (Huang et al., 2009). As such, it 
is becoming increasingly apt to find an alternative tissue source, and 
understanding what stromal cell population is best suited to bring about rapid 
and effective regeneration of several related tissues is a major issue. Dental 
pulp stromal cells (DPSC) were first isolated and introduced as a potential 
source for tissue engineering by Gronthos et al., 2000. Mesenchymal DPSCs 
are proposed as a viable option due to their adherence to culture plastic, 
expression of mesenchymal markers, and ability to form multiple cell lineages 
in vivo and tissue like structures ex vivo (Gronthos et al., 2000, Gronthos et 
al., 2002), which satisfied the minimal criteria for mesenchymal stromal cells 
(Dominici et al., 2006) (see Adult Mesenchymal Stromal Cells). In addition, the 
growth factors and genes that influence osteogenesis were also evident in 
contributing to odontogenesis, which suggests that despite the distinct origins 
of these mesenchymal stromal cells (Komada et al., 2012), they share similar 
molecular pathways involved in proliferation and differentiation (Shi et al., 
2001). 
 
Extensive research has focused on growth factors to promote bone formation 
e.g. bone morphogenic proteins (BMPs), but costly supra-physiological levels 
are required for clinical use (Fan et al., 2013a). The extracellular matrix is 
hypothesised to regulate niche signalling by provision, storage and/or 
 3 
compartmentalisation of growth factors and cytokines that are indispensable 
for both cell proliferation and differentiation (Riquelme et al., 2008). The 
proteoglycans decorin and biglycan belong to the small-leucine rich protein 
(SLRP) family and play important roles in the development of osteoid. Biglycan 
and decorin are conjugated to dermatan sulphate or chondroitin sulphate 
glycosaminoglycans, with two and one glycosaminoglycan chains respectively 
(Mecham, 2001). During bone formation, dermatan sulphated biglycan was 
present during phases of proliferation and differentiation, and chondroitin 
sulphated biglycan was present at onset of mineralisation (Waddington et al., 
2003b). Within the tooth, dermatan sulphated decorin was associated with 
early matrix deposition and maturation, while chondroitin sulphated decorin 
presents during matrix mineralisation (Waddington et al., 2003a). Moreover 
biglycan was implicated as a coregulator of growth factors such as FGF2 (Hou 
et al., 2007) and TGFβ (Chen et al., 2002), which are important factors for 
progenitor proliferation and mineralisation. As such, we have specific interest 
in the influence of extracellular matrix proteins on stromal cell proliferation, and 
differentiation, with particular attention to osteogenic capacity. Here, in vitro 
bone formation of stromal cells within 2-Dimensional in vitro cultures to assess 
the role of extracellular matrix proteins in controlling stem cell behaviour, with 
a view to producing novel bioactive scaffolds. As in conjunction with the 
stromal cells, a bio-scaffold can act as a matrix where cells can adhere and 
reside by mimicking the native niche microenvironment, and importantly the 
matrix protein itself influences the behaviour of unspecialised and non-
differentiated stromal cells. 
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In this thesis, the focus was to compare the properties of bone marrow and 
dental pulp stromal cells. For each source, the proliferative capacity and gene 
expression will be characterised. The differentiation potential of clonal 
populations will be analysed along the lineages of adipocytes, chondrocytes, 
and osteocytes. Clonal populations will be observed in the presence of 
extracellular matrix proteins and within a 2-Dimensional culture tissue-slab 
model, to investigate the novel role and influence that extracellular matrix 
proteins have on stromal cell proliferation and osteogenic differentiation. Thus, 
the goal is to increase understanding of how the niche microenvironment 
controls stromal cell survival, proliferation, and differentiation, and whether the 
dental pulp can prove an alternative source for cell-based tissue engineering. 
 
Stem Cell Overview 
Within the literature, it is has been highlighted that the use of the terms ‘stem’ 
and ‘progenitor’ cells are often inter-changed and the rigorous definitions 
abandoned. Emphasis of such classification, underscores the need for 
repeated culture-assays to continuously assess cells for ‘stem’ and ‘progenitor’ 
criteria (Seaberg and van der Kooy, 2003), which may not be practically 
feasible. To this end, a simplistic definition of a stem cell (“mother”) would be 
having unlimited self-renewal capacity and multi-potent differentiation ability, 
and a progenitor cell (“progeny”) as having limited proliferation and potency 
i.e. restricted differentiation potential (Pittenger et al., 1999).  In addition, 
stromal cells are often termed progenitors, before they have been 
characterised and classified as stem cells. Stem cells are unique cells with two 
essential characteristics of self-renewal and potency. Self-renewal is the 
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generation of an identical daughter cell and occurs either by symmetric or 
asymmetric division. Symmetric division produces two identical daughter cells. 
Whereas asymmetric division produces one cell identical to the first and 
another, more differentiated daughter cell. As such, the self-renewal of stem 
cells can occur at a single cell or progeny population level to maintain the stem 
cell population (Spradling et al., 2001). Stem cell potency refers to the ability 
of stem cells to produce diverse cell types via differentiation, and as a result 
generate tissues and organs (Sell, 2004). In humans, there are four main 
classes of stem cell potency: ‘totipotent’ or ‘omnipotent’ cells differentiate into 
a range of cells that are present in all tissues, but are limited to blastomeres of 
the early-stage morula and consequently differentiation capacity is difficult to 
prove experimentally. ‘Pluripotent’ cells differentiate into a range of 
phenotypes across several tissues e.g. embryonic stem cells. ‘Multipotent’ 
cells differentiate into a range of phenotypes only within a specific tissue e.g. 
the haematopoietic system. ‘Oligopotent’ cells differentiate into a few 
descendent phenotypes e.g. lymphoid or myeloid cells. Finally, ‘unipotent’ cells 
only differentiate into its own closely related phenotype within a single tissue 
e.g. fibroblast cells (Knoepffler et al., 2007). 
 
Stem cells are present during development, but also throughout adulthood, 
reserved for when the body experiences damage and requires repair, or during 
normal cell replacement as part of homeostasis. There are three main classes 
of stem cell: germ stem cell (GSM), embryonic stem cell (ESC), and 
adult/somatic stem cell (ASC/SSC). As such, stem cells in the adult are 
referred to as progenitors, or an intermediate precursor, in order to refrain from 
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the more generic term or entity ‘stem cell’ that can imply pluripotent embryonic 
stem cells (Fuchs et al., 2004). As cells responsible for repair, this thesis will 
focus on adult stromal cell progenitors. Within many different organs of the 
body e.g. bone marrow, brain, and liver, stromal cells infrequently divide to 
generate transient-amplifying cells, which act to divide and rapidly expand cell 
numbers to produce more mature progeny (Reya et al., 2001). In adults, the 
hierarchical division and differentiation of stem cell progenitors permits 
amplification of mature cell numbers from a single progenitor (figure 1.1) and 
minimises possible DNA replication mutations in the genome of these long-
lived cells (Reya et al., 2001, Riquelme et al., 2008).  
 
Adult Mesenchymal Stromal Cells  
Adult progenitors are found in tissues of the bone marrow, the blood stream, 
cornea and retina, dental pulp, blood vessels, skeletal muscle, liver, skin, 
gastrointestinal tract, pancreas, spinal cord and brain (Sell, 2004), but this list 
is not an exhaustive one. Adult progenitors are self-renewing, clonogenic, are 
multipotent or pluripotent in nature, and show characteristics of plasticity, 
although it is unclear by which process this occurs e.g. de-differentiation, trans-
differentiation, epigenetic factors, and/or cell fusion. In addition, the use of 
adult progenitors for tissue regenerative medicine overcomes ethical and 
tumorigenic issues associated with embryonic stem cells, and immuno-
rejection problems by sourcing cells from the patient themselves (Hombach-
Klonisch et al., 2008). 
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Adult progenitors are cells known as mesenchymal stromal cells that have 
enormous therapeutic potential, which has generated considerable interest 
throughout the biomedical disciplines for use in tissue engineering medicine. 
Due to the varied tissue sources and different methodologies used for 
isolation, expansion, and characterisation of mesenchymal stem cells, it is 
sometimes difficult to directly compare and contrast studies in the field of stem 
cell science. To address this issue the International Society for Cellular 
Therapy (ISCT) reported “minimal criteria” to define mesenchymal stem cells 
because of inconsistent definitions used among investigators, which is crucial 
to ensure progress in human cell therapy (Dominici et al., 2006). From the 
report, the Mesenchymal and Tissue Stem Cell Committee of the ISCT 
proposed three criteria to define human mesenchymal stem cells used in 
laboratory-based investigations, and recognise that standards may need 
revision as new data arise. Briefly, the three criteria proposed are adherence 
to plastic, expression of specific surface antigens, and multipotent 
differentiation. Although it is recognised that recommendations may not apply 
in non-human systems, as other species antigen expression is not entirely 
characterised, the criteria are a standard on which mesenchymal stem cells 
should be based. The first criterion is that mesenchymal stem cells must be 
plastic-adherent when being maintained with standard culture conditions in 
tissue culture flasks. The adherence of mesenchymal stem cells to plastic is a 
well described property (Colter et al., 2000), and while they can be maintained 
without adherence using highly specific culture conditions (Baksh et al., 2003), 
these cells would need to demonstrate adherence to be considered as true 
mesenchymal stem cells. The second criterion states ≥95% of the 
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mesenchymal stem cell population should express specific surface antigens 
CD73 (an ecto 5’ nucleotidase), CD90 (Thy-1), and CD105 (endoglin), as 
measured using flow cytometry. There is recognition however, that there are a 
vast number of other mesenchymal markers. In addition, cells should lack 
expression or be ≤2% positive for haematopoietic antigens CD45 (pan-
leukocyte marker), CD34 (endothelial cells and primitive haematopoietic 
progenitors), CD14 or CD11b (both for monocytes and macrophages), CD79α 
or CD19 (B-cell markers) and HLA class II (human leukocyte antigen that can 
be expressed by mesenchymal stem cells when stimulated with IFNγ, 
interferon gamma). Only one out of two markers for macrophages and B-cells 
need to be tested. For the third and final criterion, mesenchymal stem cells 
must be capable of differentiating into osteoblasts, chondroblasts, and 
adipocytes, using in vitro differentiating conditions from standard published 
protocols or even commercially available kits. Osteoblast differentiation is 
demonstrated using alizarin red to detect calcium deposits, or von Kossa 
staining to quantify mineralisation. Chondroblast differentiation can be shown 
by alcian blue staining for glycoproteins or immunohistochemical detection of 
collagen type II. While Oil Red O staining for lipids can demonstrate adipocyte 
differentiation most readily. Abiding by the minimal set of criteria stated above 
allows for uniform characterisation of mesenchymal stromal cells and 
facilitation of more direct comparisons within the scientific literature (Dominici 
et al., 2006), that can lead to defining tissue sources are harbouring true stem 
cells for regenerative medicine. 
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Mesenchymal Bone Marrow Stromal Cells 
Mesenchymal stromal cells are found in many tissues throughout the adult 
body, and follows from early works by German pathologist Cohnheim, who 
studied wound repair in the 1860s. The initial discovery of clonogenic fibroblast 
precursors, CFU-F (Colony-Forming Unit-Fibroblastic), was in bone marrow, 
spleen and thymus of adult mice (Friedenstein et al., 1976), and were 
subsequently characterised in human bone marrow as fibroblast colony-
forming cells (Castro-Malaspina et al., 1980). These bone marrow CFU-F cells 
became later referred to as mesenchymal stem cells or marrow stromal cells 
(MSCs), in order to be distinguished as non-haematopoietic tissue stem cells 
(Prockop, 1997). Bone marrow mesenchymal stem cells are the most studied 
cells of mesenchymal origin, and are found in long bones along with 
haematopoietic stem cells, and endothelial stem cells. BMSCs are the “gold 
standard” for tissue engineering medicine and against which other 
mesenchymal stem cell populations are characterised (Pittenger et al., 1999, 
Gronthos et al., 2003). The repertoire of mitogenic factors required for bone 
marrow progenitor proliferation is not entirely known, but those known to be 
important are PDGF, EGF, FGF2, TGFβ, and IGF1 (Bianco et al., 2001). Bone 
is a large repository of many growth factors that provides a rich 
microenvironment for the cells contained within (Kamura et al., 2010). The 
extracellular matrix serves as a reservoir for growth factors by presenting 
extracellular binding molecules, as with FGF2 (Brunner et al., 1993). The 
turnover of bone involves numerous cytokines and chemokines that are 
released during remodelling as a means for osteoblast and osteoclast 
communication. In addition, the specialised microvasculature of the bone 
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marrow allows for ease of cells to pass in and out of blood (Bussard et al., 
2008). 
 
BMSCs have a great ability for ex vivo expansion up to approximately 40 
population doublings before senescence occurs, which is not a state of 
terminal differentiation because cells remain capable of osteogenic 
differentiation (Bruder et al., 1997). An array of cell surface markers have been 
observed for bone marrow progenitors, which include STRO-1 (bone marrow 
stromal cell and erythroid precursor marker), CD73, CD90, CD105, CD146 
(MCAM), Oct4 and Nanog (pluripotent stem cell markers). Bone marrow 
progenitors are absent for CD14, CD34, CD45, and HLA-DR. BMSCs were 
highlighted as a population of heterogeneous cells with different morphologies, 
and gene and protein expression profiles (Huang et al., 2009). Compared to 
heterogeneous cell populations, purified clonal populations are reported to 
only undergo proliferation of >20 population doublings in a small proportion of 
clones (Gronthos et al., 2003). The heterogeneity in morphology, function, and 
growth of bone marrow cells is evidence of the difficulty in identifying a 
phenotypic fingerprint of mesenchymal stromal cells (Bianco et al., 2001) and 
supports the notion of stromal hierarchy due to limited potential of some CFUs 
where others show multipotent differentiation (Owen and Friedenstein, 1988). 
Within the mesenchymal stem cell field, it is well known that bone marrow 
stromal cells can differentiate along multiple lineages that typically include 
osteogenic, chondrogenic and adipogenic, and in addition myelosupportive 
stroma, myogenic, and neurogenic lines. There are complications, however, 
associated with obtaining bone marrow stromal cells, such as pain and 
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secondary-morbidity at collection site following the procedure, and a low 
harvest number of cells, and as a result alternative sources of mesenchymal 
stem cells have been sought after (Huang et al., 2009). One such source that 
has attracted much attention is mesenchymal dental pulp stromal cells 
(DPSCs), which is discarded as biomedical waste following tooth extraction. 
Dental pulp stromal cells were first identified from human adult dental pulp and 
compared to bone marrow stromal cells in vitro and in vivo by Gronthos et al., 
2000. 
 
Mesenchymal Dental Pulp Stromal Cells 
Dental tissue is specialised and the mineralised matrices of enamel and dentin 
do not undergo continuous remodelling as does bone tissue. Bone remodels 
slowly throughout post-natal life, and may indicate that dental stromal cells 
have restricted differentiation potency compared to bone marrow stromal cells 
(Gronthos et al., 2000). Dentin is formed by odontoblasts that differentiate from 
the ectomesenchymal cells of the dental papilla that later becomes the pulp, 
following interaction with epithelial cells of the inner enamel organ, during a 
process known as dentinogenesis. Odontoblasts are of neural crest origin that 
are recognized morphologically as tall columnar cells with an eccentric nucleus 
and long processes that align at the outer edge and throughout the dentin. 
Odontoblasts produce an organic matrix that subsequently becomes 
mineralised (Ten Cate, 1994). The formation of enamel is by ameloblasts and 
is known as amelogenesis, which is induced by dentinogenesis. Ameloblasts 
are of ectodermal origin, which differentiate from the inner dental epithelium 
following elongation and polarization (Ten Cate, 1994) (figure 1.2). So dental 
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stromal cells are responsible for forming the special mineralised matrices that 
constitute the tooth (Gronthos et al., 2000). Although progenitors do not 
remodel the tooth, cells present in the adult pulpal tissue induce reparative 
dentin to form a loosely organised mineralised matrix to serve as a protective 
barrier for dental pulp following trauma from mechanical damage, chemicals 
or disease processes (Smith et al., 1995). The dental mesenchyme is referred 
to as ectomesenchyme due to its early developmental association with neural 
crest cells (Lumsden, 1988) that are a group of multipotent cells that derive 
from the ectoderm, which are collectively responsible for forming epidermal 
tissues and the nervous system during embryogenesis. As such, dental 
stromal cells are proposed to have greater potential for differentiating along a 
neural lineage compared to other mesenchymal stromal cells (Huang et al., 
2009). 
 
The clonogenic capacity of dental pulp stromal cells was first recognised by 
Gronthos et al., 2000 who found the colony-forming efficiency and proliferation 
rate of dental pulp was higher than whole-bone marrow progenitors. The report 
states, however, that colony forming efficiency of bone marrow progenitors 
devoid from haematopoietic cells was 10-fold higher than whole-bone marrow 
and thus is fairly equivalent to dental pulp progenitors, but they did not publish 
these data. In addition, the report finds the cell surface and protein marker 
phenotypes of dental pulp and bone marrow stromal cells was quite similar 
and indicated that both are heterogeneous cell populations. Some of the 
markers present were CD44, integrin β1, VCAM1, collagen types I and III, 
osteonectin, and FGF2, in all cell populations, while αSM actin, MCAM, Spp1 
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(osteopontin), and alkaline phosphatase were in a subset of the 
heterogeneous population. Exceptions were osteocalcin that was present in all 
dental pulp cells but only in a subset of bone marrow cells, and BSP that was 
not present in dental pulp but was present in a subset of cells in bone marrow. 
Absent markers included CD14, CD34, CD45, MYOD, neurofilament, 
collagen-II, and PPARγ (Gronthos et al., 2000), which comprised a set of 
minimal criteria markers for defining mesenchymal stromal cells (Dominici et 
al., 2006). In addition, odontoblast marker DSPP was absent in dental pulp 
stromal cells, which suggested they had an undifferentiated phenotype 
(Gronthos et al., 2000). Bone marrow stromal cells also demonstrated low level 
presence of dentin markers DSPP and DSP (Qin et al., 2002). In addition to 
dental pulp stromal cells (DPSC), other so-termed dental progenitors include 
stem cells from human exfoliated deciduous teeth (SHED) (Miura et al., 2003), 
periodontal ligament stem cells (PDLSCs) (Seo et al., 2004), stem cells from 
apical papilla (SCAP) (Sonoyama et al., 2006), and dental follicle progenitor 
cells (DFPCS) (Morsczeck et al., 2005). Similar to other post-natal stromal 
cells, these cell populations display mesenchymal stem cell properties, which 
include self-renewal and multi-lineage differentiation similar to that of bone 
marrow mesenchymal stromal cells (Huang et al., 2009). 
 
Bone Marrow and Dental Pulp Mesenchymal Stromal Cells Control 
Extracellular Matrix Production 
At in vitro level, a heterogeneous DPSC population can differentiate into 
osteocytes, chondrocytes, adipocytes, neurocytes, and myocytes, like that 
attributed to BMSCs (Huang et al., 2009). High-level alizarin red-positive 
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calcium nodules were reported to demonstrate osteoblast differentiation of 
heterogeneous DPSCs but deposits were sparse throughout a single 
mineralised layer, in contrast to BMSCs that formed calcified deposits within 
extensive sheets of adherent cells (Gronthos et al., 2000). Differentiation of 
DPSCs to adipocytes correlated with expression of the early adipogenic 
marker PPARγ2 and late adipogenic marker lipoprotein lipase, and DPSC-
derived neurocytes expressed neural precursor marker nestin and GFAP 
(Gronthos et al., 2002). Myogenic differentiation gave elongated myoblast-like 
phenotype but no multinucleate cells, and demonstrated presence of early 
myocyte marker MYOD1 and the late differentiation marker MHC (Zhang et 
al., 2006). Myogenic fusion was possible, however, when human dental pulp 
was co-cultured with a murine myocyte line, C2C12, to form myotubes (Laino 
et al., 2006). Differentiation of BMSCs along the chondrogenic lineage was 
seen by alcian blue staining of cells among an organised extracellular matrix 
containing collagen-II and many sulphated proteoglycans (Zhang et al., 2006). 
It must be noted, however, that there were occasions when DPSCs failed to 
differentiate into adipocytes, chondrocytes, and myoblasts (Zhang et al., 
2006). This failure was suggested to be due to the heterogeneous cell types 
that constituted the dental pulp, due to stem cell hierarchy, and also because 
in vitro culture systems do not offer an architectural tissue model to determine 
complete developmental potential and formation (Gronthos et al., 2000). 
 
When a human heterogeneous DPSC population was expanded ex vivo and 
transplanted in vivo with HA/TCP (hydroxyapatite/tricalcium phosphate) 
powder into immunocompromised mice, dentin and pulp-like structures 
 15 
formed. The dentin was akin to primary dentin, as opposed to the disorganised 
matrix that is characteristic of reparative dentin (Gronthos et al., 2000). The 
dentin structures comprised an ordered collagen matrix, predominantly 
collagen-I, perpendicular to a differentiated odontoblast-like layer of cells. 
Odontoblast-like cells extended cytoplasmic processes into a dentinal matrix 
that had an interface with a pulp-like tissue, which was infiltrate with blood 
vessels and nerve fibres, but they failed to produce active haematopoietic 
marrow and adipogenesis (Gronthos et al., 2000, Gronthos et al., 2002). In 
addition, the dentin laid down can thicken over time (Batouli et al., 2003). 
Corresponding BMSCs formed distinct lamellae bone on the HA/TCP 
conjugate surface with collagen fibres and differentiated osteoblasts aligning 
parallel to bone-forming surfaces, while differentiated osteocytes became 
entombed within bone matrix. In addition, the bone matrix surrounded 
interstitial tissue and was infiltrate with a sinusoid network that resembled a 
marrow-like organ, and unlike DPSCs, BMSCs showed areas of 
haematopoiesis and adipocyte accumulation (Gronthos et al., 2000, Gronthos 
et al., 2002).  The formation of these organ-like structures, however, are 
chimeric tissues formed by dynamic and interactive processes between both 
the transplanted progenitor cells and host microenvironment (Batouli et al., 
2003). 
 
Heterogeneous multi-colonies stromal cells derived from deciduous teeth were 
capable of ex vivo expansion and have achieved >140 population doublings 
(Miura et al., 2003), whereas BMSCs achieved 30-45 population doublings 
(Bruder et al., 1997), and they showed consistent capacity for proliferation and 
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regeneration of dentin in vivo (Gronthos et al., 2000). The majority of single 
cell derived colonies/clones, i.e. 80%, was reported to only proliferate up to 20 
population doublings. As such, only the approximate 20% of DPSCs that 
proliferated beyond 20 population doublings were able to be analysed for their 
in vivo developmental potential (Gronthos et al., 2002). The single-cell derived 
colonies that did proliferate beyond 20 population doublings were able to form 
ex vivo dentin-pulp like structures containing organised collagen fibres, similar 
to heterogeneous multi-colony derived DPSCs (Gronthos et al., 2000), but a 
third of single-cell clones only formed low to moderate amounts of dentin 
(Gronthos et al., 2002). This suggested DPSC have subset populations that 
differ in their ability for odontogenesis due to different proliferative capacities 
and developmental potentials, which was a property originally attributed to that 
of BMSCs (Owen and Friedenstein, 1988). 
 
Regarding other tooth-associated stromal cells, SHED proliferated faster than 
DPSCs and BMSCs (SHED>DPSC>BMSC) (Huang et al., 2009) and showed 
a capacity of >140 population doublings (Miura et al., 2003). SHED have also 
been termed immature DPSCs (IDPSCs) following findings that cells 
expressed embryonic and pluripotent markers Oct4 and Nanog, and were 
positive for stage-specific embryonic antigens SSEA-3 and -4, and tumour 
recognition antigens TRA-1-60 and TRA-1-81 (Kerkis et al., 2006). Both 
SHED/IDPSC showed capacity for osteogenic, chondrogenic, adipogenic, 
neurogenic, myogenic, and odontogenic differentiation (Miura et al., 2003, 
Kerkis et al., 2006). SHED was positive for a variety of neural markers, and 
formed aggregate and sphere-like clusters, which in conjunction with high 
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proliferative capacity was analogous to neural stem cells. In vivo studies show 
SHED formed DSPP-positive odontoblast-like cells in association with a 
dentin-like structure, but did not form a dentin-pulp like complex (Miura et al., 
2003). Stromal cells from deciduous teeth (SHED) and permanent teeth 
(DPSC) both demonstrated ability to differentiate into osteoblasts, 
chondrocytes and adipocytes (Govindasamy et al., 2010), which satisfied 
minimal mesenchymal stem cell requirements (Dominici et al., 2006). SHED 
exhibited greater capability to differentiate along osteogenic and adipogenic 
lineages and in addition were capable of forming odontoblasts and 
hepatocytes. Compared to DPSCs, the proliferation rate of SHED was higher 
and expression of pluripotent markers Oct4, SOX2 and Nanog was >2 fold 
higher, which suggested these cells are of more primitive origin. Conversely, 
DPSCs showed higher expression of neuroectoderm markers Pax6 and 
nestin, and higher neurosphere formation with better ability to form neuron-like 
cells expressing NF and GFAP. Both stromal cell types showed propensity for 
neuronal lineage, but SHED retained plasticity over the same amount of 
passages as DPSC, which lost plasticity and commited toward neuronal 
lineage (Govindasamy et al., 2010). As such, dental progenitors are 
mesenchymal stromal cells that share close origins with the neural crest, which 
probably relates to their higher neurogenic potency compared to bone marrow 
progenitors (Huang et al., 2009). 
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Gene Expression and Growth Factors of Mesenchymal Stromal Cells 
Influence Extracellular Matrix Production 
The gene expression profiles of DPSCs and BMSCs were similar for >4000 
genes, and among those encoded genes for collagen types III and V, non-
collagenous components of the extracellular matrix (osteopontin, osteonectin, 
matrix gla-protein, decorin, biglycan, and alkaline phosphatase) and cell 
adhesion molecules (VCAM1, CD44, integrins β1, αv2, αv, and β3). These 
similarly expressed gene marker molecules are functionally associated with 
initiating mineralisation and bone homeostasis, and also influence 
dentinogenesis (Shi et al., 2001). The gene expression profiles were an 
accurate representation of those proteins detected by immunohistochemical 
analyses of pulp and marrow progenitors (Gronthos et al., 2000), which 
included growth factors implicated as strong osteogenic promoters and in 
mineralised matrix formation (IGF1, PDGF, FGF2, TGFβ, BMP2, BMP4, and 
BMP7) (Shi et al., 2001). Shi et al., 2001 also reported human dental pulp and 
bone marrow progenitors expressed low levels of two CBFA1 isotypes, CBFA1 
type I and II, although it was unclear if the low levels represented that which 
was only expressed in a subset of the cell population. The transcription factor 
CBFA1 was a specific osteoblast regulatory molecule, but seemed to be an 
important factor for normal tooth development as CBFA1-null mice displayed 
arrested tooth development (D'Souza et al., 1999), in addition to lack of bone 
formation (Komori et al., 1997) and. Human CBFA1 gene mutations caused 
manifestation of cleidocranial dysplasia syndrome that was associated with 
skeletal abnormalities and delayed tooth development (Otto et al., 1997). 
Other transcription factors, MSX1 and MSX2, were expressed in dental pulp 
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and bone marrow progenitors at high and low levels respectively, and so the 
MSX gene family may act as regulators in odontogenesis and osteogenesis 
(Shi et al., 2001). Evidence of MSX regulation include phenotypic observations 
in MSX1-deficient mice and MSX1 human mutations of craniofacial 
abnormalities such as cleft palate and tooth development failure (Satokata and 
Maas, 1994), while MSX2-deficient mice showed delay in bone growth and 
ossification, concomitant with CBFA1 downregulation (Ducy, 2000). In 
addition, TGFβ signals controlled proliferation of chondrocytes and prevented 
premature cartilage/bone differentiation, and loss of TGFβ signals cause 
diminished MSX2 expression, but not MSX1. Specifically, the TGFβ2 isoform 
was suggested to mediate MSX2 expression that was critical for cranial 
development (Hosokawa et al., 2007). Of interest, enhanced expression of 
MSX2 prevented osteoblast differentiation and extracellular matrix 
mineralisation, and stimulated cells to harbour a state of proliferation (Dodig et 
al., 1999, Liu et al., 1999). Only a few genes were expressed differently 
between pulp and marrow progenitors, which included IGF2 and IGFBP7, 
while no genes were exclusively expressed by either cell population. The 
expression profiles between dental pulp and bone marrow functionally 
demonstrated that pulp progenitors have a higher proliferative capacity 
compared to marrow progenitors, due to increased expression of CDK6, a cell-
cycle specific kinase, and the mitogen IGF2 (Shi et al., 2001), which was 
supported by the ex vivo expansion capacity of >140 population doublings by 
SHED (Miura et al., 2003). Specifically, IGF2 may contribute to steady-state 
conditions of the tooth and dental pulp microenvironment by preventing dentin 
de-mineralisation (Finkelman, 1992). Conversely, IGFBP7 may contribute to 
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the lower proliferation rate of bone marrow progenitors (Shi et al., 2001), as 
the IGFBPs are implicated in the suppression of growth rate and cellular 
senescence (Kato, 2000). Even though there were genes expressed differently 
between dental pulp and bone marrow stromal cells, the majority were 
expressed similarly, which indicated similar molecular pathways involved in 
both tooth development and bone formation (Shi et al., 2001). The dissimilar 
pathways, however, of dentinogenesis and osteogenesis allowed for active 
haematopoiesis by bone marrow and not dental pulp progenitor transplants in 
vivo, likely due to elevated FGF2 and MMP-9 (Batouli et al., 2003). In addition, 
different gene profiles and molecular pathways exist between native 
osteoblasts and osteoblasts derived from human pulp stem cells (ODHPSC), 
which may explain the histological differences observed in the bone-like 
tissues formed (Carinci et al., 2008). 
 
Odontoblasts and osteoblasts both expressed several mineralised matrix 
proteins as stated above (Gronthos et al., 2000). The potent regulators 
involved in bone formation were implicated as promoters in development of 
odontoblasts e.g. TGFβ, BMP2 and BMP4 (Nakashima et al., 1994, Shiba et 
al., 1998). In addition, other growth factors that influenced osteoblast cells also 
regulated odontoblast precursor proliferation and differentiation, which 
included FGF2, PDGF, EGF, IGF1, TNFα and ILβ1 (Kettunen et al., 1998, 
Shiba et al., 1998, Onishi et al., 1999). Taken together, the biochemical 
pathways shared by dental pulp and bone marrow progenitors were very 
similar in the differentiation of pulp progenitors into odontoblasts and marrow 
progenitors into osteoblasts (Gronthos et al., 2000). Of note, dental pulp and 
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bone marrow progenitors originate from highly vascular tissues, and both 
expressed markers for smooth muscle and endothelium. Based on 
developmental biology, studies have suggested that several different stem cell 
types may originate from the developing blood vessels (Bianco and Cossu, 
1999), with evidence that bone progenitors have a close relationship to 
pericytes of outer surface vasculature (Doherty et al., 1998). Even though 
dental pulp and bone marrow progenitors shared similar cell surface and 
protein marker profiles, and regulatory factors, dental pulp differed significantly 
in its proliferation capacity and developmental potential in vitro, and upon 
transplantation in vivo their representative tissues distinctly mimicked their 
native microenvironments (Gronthos et al., 2000). 
 
Extracellular Matrix Components Control Stromal Cell Progenitors 
Connective tissue stroma and the associated extracellular matrix (ECM) 
organisation are vitally important to normal functioning of the human body, as 
evidenced by the array of pathologies known because of mutations within 
connective tissues. The ECM and its associated molecules are an integral 
component of a stem cell niche by way of creating a microenvironment and 
architecture that is favourable for survival and propagation of progenitors, in 
addition to acting as a substrate anchor. The ECM is hypothesised to regulate 
niche signalling by provision, storage and/or compartmentalisation of growth 
factors and cytokines that are indispensable for both cell proliferation and 
differentiation. In addition, other ECM components such as proteoglycans and 
collagen-I are thought to modulate growth factor and cytokine accessibility as 
well as other signalling molecules (Riquelme et al., 2008). Hence, the following 
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sections highlight the roles of those structural and/or signaling molecules of 
importance to stromal cell progenitors, with many in common between BMSCs 
and DPSCs. 
 
Small Leucine-Rich Proteoglycans 
The small leucine-rich proteoglycans (SLRPs) are relatively small and 
generally <150kDa including their glycosaminoglycan (GAG) chains, 
compared to other proteoglycans. SLRPs are a group of molecules with a 
similar structural motif known as the leucine-rich repeat (LRR). Other structural 
features include, a highly variable N-terminal domain that may have GAG 
chains attached or even sulphated tyrosine residues, a cluster of four-
cysteines, and a disulphide bond at the C-terminal (figure 1.3). They tend to 
have more leucine and other aliphatic-hydrophobic amino acids than most 
other proteins. The common features may allow similar functions of the SLRP, 
by binding the same molecules on the cell surface and in the extracellular 
matrix. The SLRP gene and protein structures, however, suggest the members 
have been structurally diverged for a long time (Neame and Kay, 2000). SLRPs 
interacted with a number of cytokines, which included TGFβ, BMP4, WISP1, 
von Willebrand factor, PDGF and TNFα, leading to the modulation of a diverse 
range of biological functions. SLRPs also engaged signalling receptors, which 
included TLRs, IGF1R, EGFR, LRP1, integrin α2β1, and c-Met. Thus, SLRPs 
can act as direct triggers for signal transduction, to modulate cell growth, 
proliferation, differentiation, survival, adhesion, and migration (Merline et al., 
2009). 
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Biglycan and decorin are both members of the SLRP family. The core protein 
of decorin is ~38kDa and has a single chondroitin or dermatan sulphate GAG 
chain at its N-terminus. Decorin has heterogeneous GAG chain sizes and as 
such, the secreted proteoglycan ranges in molecular weight between 100 and 
250kDa. The core protein of biglycan is 45kDa, and harbours two chondroitin 
or dermatan sulphate GAG chains at the N-terminus. The GAG chains are also 
heterogeneous and give a proteoglycan weight range between 200-350kDa 
(figure 1.4) (Mecham, 2001). 
 
Proteoglycans Regulate Cellular Behaviour 
Biglycan and decorin were highly expressed in bone, and displayed spatially 
restricted gene expression patterns and proteoglycan localisation (Bianco et 
al., 1990). Clinical conditions involving low biglycan levels caused short stature 
in Turner syndrome patients because they lack an X chromosome, whereas 
patients with high biglycan levels have increased limb length due to additional 
X chromosomes (Vetter et al., 1993, Ameye and Young, 2002). The 
importance of decorin and biglycan in vivo is clear from targeted deletion of 
the genes in mice (reviewed Ameye and Young, 2002). In single-deletion of 
biglycan, mice developed a phenotype of osteoporosis and failed to achieve a 
peak bone mass, causing significantly short femurs, due to low osteoblast 
numbers and low activity (Xu et al., 1998). Lack of biglycan in vitro, caused a 
rapid decrease of bone marrow progenitors with age due to a decrease in 
proliferation and an increase in apoptosis, and biglycan knock-out showed a 
decrease in response to exogenous TGFβ and synthesis of collagen-I. Taken 
together, these features contributed to the osteopenic phenotype observed in 
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vivo (Chen et al., 2002). In addition, altered phenotype in tooth mineralisation 
caused a broader predentine/dentine interface and dramatic enamel increase, 
which suggested biglycan normally exerts negative feedback (Goldberg et al., 
2003). The important relationship shared by stromal cell progenitors and their 
microenvironment was observed from the different histological characteristics 
between bone-like tissue formed by normal osteoblasts and osteoblasts 
derived from human pulp cells (ODHPSC). Although seemingly the same 
morphological cell, the different genetic profiles displayed between the two 
osteoblasts, and as a result most probably the proteins expressed, led to 
formation of different tissues (Carinci et al., 2008).  
 
The influence that the ECM component proteoglycans have on stromal cells is 
evident from the mineralisation processes involved in both bone and dentine. 
Such mineralised matrices typically harboured chondroitin sulphate 
substituted proteoglycans, whereas soft connective tissues e.g. skin and 
ligament contained dermatan sulphated glycosaminoglycans (Waddington et 
al., 2003b). Proteoglycans in their non-glycosylated forms have also been 
identified in human skin (Fleischmajer et al., 1991), human intervertebral disc 
(Johnstone et al., 1993), human cartilage (Johnstone et al., 1993, Theocharis 
et al., 2002), and predentine (Waddington et al., 2003a). It is, however, unclear 
if non-glycosylated proteoglycans are simply presence of the core-protein 
alone or because of degradation, hence these structurally different molecules 
may contribute alternative functions. In teeth, various proteoglycan pools are 
suggested to extend from predentine to dentine, which includes the 
predentine/dentine interface. Dermatan sulphate conjugated biglycan and 
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decorin were predominantly present in the predentine, while chondroitin 
sulphate conjugated proteoglycans dominated the predentine/dentine and was 
the only glycosaminoglycan present in dentine. Catabolism of biglycan and 
decorin within predentine suggested that glycosaminoglycan degradative 
products may contribute bioactivity, whereby dermatan sulphate may act to 
inhibit mineralisation, and conversely chondroitin sulphate could control and/or 
promote mineralisation (Waddington et al., 2003a) having the capacity to bind 
five-fold more calcium than dermatan sulphate (Embery et al., 1998). The role 
of glycosylated biglycan and decorin in the developing osteoid is becoming 
more apparent. Dermatan sulphated decorin was associated with early matrix 
deposition and maturation, while chondroitin sulphated decorin presented 
during matrix mineralisation. Dermatan sulphated biglycan was expressed 
during phases of proliferation, whereas chondroitin sulphated biglycan was 
expressed at onset of mineralisation (Waddington et al., 2003b). Biglycan 
bound active TGFβ but not as effectively as its non-glycosylated form, which 
had higher activity. This suggested conjugated glycosaminoglycans could 
hinder growth factor interaction with the core protein (Hildebrand et al., 1994). 
Recombinant forms of chondroitin sulphate conjugated decorin promoted 
collagen fibrillogenesis, as did the core protein itself, although there was a 
delay in initial fibril aggregation. Conversely, recombinant biglycan did not 
influence collagen fibrillogenesis. These recombinant proteoglycans also 
bound hydroxyapatite predominantly through glycosaminoglycan chains and 
inhibited crystal growth, with greater inhibition by core proteins alone. As such, 
both proteoglycans regulated mineralisation, whereby biglycan had a more 
prominent role due to higher hydroxyapatite affinity (Sugars et al., 2003). 
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Biglycan Regulates Cellular Proliferation and Differentiation 
Among the multitude of functions performed by SLRPs, they have a role in 
regulating cellular proliferation, but only a limited number of studies have 
addressed the specific role of biglycan in regulating proliferation. Up to now, 
TLR2 and TLR4 were identified as the signalling receptors of biglycan (Merline 
et al., 2009). Biglycan was suggested to favour proliferation during osteoblast 
development (Waddington et al., 2003b), and proliferation of vascular smooth 
muscle cells by CDK2- and p27- dependent pathways (Shimizu-Hirota et al., 
2004). Opposed to its proliferative capacity, biglycan also had anti-proliferative 
effects. In pancreatic cancer, biglycan induced G1 arrest, thereby inhibiting the 
proliferation of tumour cells. This inhibition was associated with upregulated 
CDK inhibitor p27, downregulated cyclin A and PCNA, and decreased Ras and 
ERK activation (Weber et al., 2001). Biglycan has been shown to inhibit 
proliferation of BMSCs, which can be abrogated by WISP1 (Inkson et al., 
2009). Interestingly, WISP1 rescued diminished osteogenic differentiation in 
the absence of biglycan. Biglycan also influenced cellular differentiation, and 
was shown to control osteoblast differentiation by modulating BMP4 (Chen et 
al., 2004b). Biglycan was a critical component in organising the niche of tendon 
stem/progenitor cells, and its absence affected tendon progenitor 
differentiation by modulating BMP signalling (Bi et al., 2007). Taken together, 
biglycan may regulate proliferation in a cell-specific manner via specific 
receptor and signalling pathways, or by an indirect and unidentified 
mechanism. Thus, more research is required to understand biglycan-mediated 
signalling, and its influence in cellular processes such as proliferation and 
differentiation (Merline et al., 2009). 
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Dermatan Sulphate Biological Activity 
Proteoglycans within bone and tooth harbour sulphated glycosaminoglycans. 
An interesting notion is that the glycosaminoglycan, dermatan sulphate, may 
have a specific cell signalling role and may be responsible for biological actions 
(Akita et al., 2008). As the core protein of biglycan, along with the 
glycosaminoglycan chains, influenced tissue remodelling and mineralisation in 
tooth (Waddington et al., 2003a) and bone (Waddington et al., 2003b). From 
the literature, more evidence is reported on decorin rather than biglycan. In 
matrix organisation, following chemical insult of mouse skin, decorin increased 
in molecular size by increasing dermatan sulphate rather than protein core size 
during post-inflammation. These dermatan sulphate filaments orientated in an 
orthogonal fashion to collagen fibrils and extended into enlarged interfibrillar 
gaps between collagen fibrils, which indicated the important role of dermatan 
sulphate in extracellular matrix organisation in wound healing (Kuwaba et al., 
2001). Proteoglycans such as biglycan are identified as coregulators in FGF 
signalling (Hou et al., 2007). Studies show that in vitro proteoglycans from 
wound fluid bound to multiple components within the cellular microenvironment 
and were functionally active during wound healing processes. Among present 
proteoglycans was decorin, and a large proportion of glycosaminoglycans was 
dermatan sulphate that bound FGF2 (Turnbull et al., 1992), which supports to 
FGF2 mediated cell proliferation via FGFR1 (Penc et al., 1998). In addition, 
FGF2 was the major factor released via ERK signalling pathways upon 
damage of articular cartilage by cutting or enzymatic degradation, which 
supports an extracellular sequestered store (Couchman et al., 1984), 
influencing tissue remodelling (Vincent et al., 2002) by preferentially activating 
 28 
FGFR1 (reviewed Ellman et al., 2008). As well as a functional role in wound 
healing, the dermatan sulphate molecule itself may have a role in reparative 
processes as opposed to deleterious effects during inflammation. Dermatan 
sulphate, unlike heparin sulphate and chondroitin sulphates A and C, rapidly 
activated NF-κB (nuclear factor kappa B), and induced surface and soluble 
ICAM1 (intercellular adhesion molecule 1) following direct cell activation at 
physiological wound concentrations in vitro and in vivo. The aforementioned 
activation and induction, however, did not involve TNFα or IL1 that normally 
contribute to pro-inflammation, but was facilitated by other unknown autocrine 
factors. This suggested a beneficial upshot considering NF-κB has a variety of 
advantageous biological functions, which include ICAM1 cascade and 
transmigration of leukocytes that defend against infection at sites of injury. It 
has been speculated, however, that dermatan sulphate may contribute 
towards dermal disease processes that induce ICAM1 (Penc et al., 1999), as 
well as other pathological diseases (reviewed Malavaki et al., 2008). Hence, 
dermatan sulphate is an important glycosaminoglycan that needs further 
elucidation to its role in proliferation and differentiation of mesenchymal 
progenitors. 
 
Transforming Growth Factor β Superfamily and Bone Morphogenic 
Proteins 
TGFβ is a superfamily that includes at least thirty-four members, which 
constitute growth and differentiation factors (Dimitriou et al., 2005). The BMPs 
belong to the TGFβ superfamily and strongly influence osteoprogenitor 
differentiation, although osteogenesis does occur in BMP-deficient mice 
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(Deschaseaux et al., 2009). The BMPs modulate bone formation, whereby 
positive osteogenesis was regulated by BMP2, BMP6, BMP7, and BMP9, and 
activity was inhibited by BMP3. Signalling by BMP/TGFβ was transduced 
through type I and II serine/threonine kinase receptors (Chen et al., 2004a). 
The ligand-receptor complexes acted through the transcriptional modulator 
SMAD proteins (Wan and Cao, 2005). SMADs were critical mediators for 
TGFβ signalling, but BMP2 could activate pathways that are Smad-
independent. Such pathways included MAPK that had distinct regulatory roles 
in alkaline phosphatase and osteocalcin (Lai and Cheng, 2002). Following 
injury of articular cartilage BMP2 was upregulated, and SMAD1 and SMAD5 
underwent phosphorylation, which may possibly have a reparative role 
(Dell'Accio et al., 2006). 
 
Fibroblast Growth Factor Polypeptide Family 
The FGF gene family includes twenty-three members that bind variously to the 
seven FGF tyrosine kinase receptors, the FGFRs (Su et al., 2008), and are 
well known for their roles in embryogenesis and angiogenesis (Kim et al., 
1993), and wound healing (Shirakihara et al., 2011). The FGF polypeptide 
family play critical roles in the regulation of endochondral and 
intramembranous ossification. FGFR1 was expressed by hypertrophic 
chondrocytes, and signalling had stage-specific effects on the maturation of 
osteoblasts. FGFR1 acted by stimulating osteoprogenitor differentiation, or 
arresting differentiated osteoblast maturation (Jacob et al., 2006). In 
osteoblasts, FGF -2, -9 and -18 are thought to bind FGFR1. FGF -9 and -18 
expression was seen in the perichondrium/periosteum, and were thought to 
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predominantly influence embryonic skeletogenesis (Huang et al., 2007). At 
post-natal stages, FGF2 was expressed by periosteal cells and osteoblasts, 
and mesenchymal stromal cells from FGF2-null mice failed to mineralise in 
vitro (Montero et al., 2000). The addition of FGF2 to bone marrow progenitors 
improved their proliferation potential and maintained their differentiation 
potential (Delorme et al., 2009). Signalling via FGF2/FGFR and its effects on 
migration and proliferation of cells such as vascular endothelia has been 
apparent for some time (Yoshida et al., 1996). The downstream signalling 
pathways involved in such processes, however, are not well known. One 
activated pathway of migration signalling was the PI3K family, found in corneal 
endothelial cells (Lee and Kay, 2003), and bone and soft tissue tumour cells 
(Kamura et al., 2010). In this case, PI3K was motile specific and did not involve 
its other pathways in stimulating proliferation and survival. During the migration 
of such cells, the PI3K pathway reorganised the actin cytoskeleton that altered 
cell morphology and allowed motility (Kamura et al., 2010). FGF2 was also 
known to stimulate epithelial to mesenchymal transition, which was important 
during development, wound healing and tissue repair (Shirakihara et al., 
2011), and was implicated in tumour metastasis (Lee and Kay, 2003). FGFR2 
was expressed by reserve chondrocytes and was down-regulated in 
proliferating chondrocytes. FGFR2 splice variants were tissue-specific, and 
mesenchymal FGFR2C forms were activated by FGF -2, -4, -6, -8, and -9. 
FGFR3 and its physiological ligand FGF18, regulated proliferating chondrocyte 
growth and differentiation, and bone density and cortical thickness in 
differentiated osteoblasts (Ornitz, 2005). 
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Platelet Derived Growth Factor Signalling 
PDGF is an extracellular factor that has three biologically active isoforms, 
composed of polypeptide chains PDGF-A and PDGF-B. PDGF-BB inhibits 
osteogenic differentiation, which decreases mRNA levels and activity of 
alkaline phosphates. PDGF binding occurs through dimerisation of two 
receptors (αPDGFR and βPDGFR), which formed three distinct patterns (αα, 
αβ, and ββ) (Arvidson et al., 2011). Mesenchymal stromal cells expressed both 
forms of receptor. The nature of signalling in these cells was not clear, but 
PDGF signalling was important in various cell functions e.g. cell growth and 
division. Depleting the βPDGFR gene in mesenchymal bone marrow stromal 
cells decreased mitogenic activity and migration, but enhanced osteogenic 
differentiation, as shown by increased alkaline phosphatase activity, 
osteocalcin, BMP2, RUNX2 and osterix (Tokunaga et al., 2008). Although 
pharmacological inhibition of PDGFR decreased PDGF-BB-induced 
proliferation in mesenchymal stromal cells, but had no influence on osteoblast 
differentiation (Kumar et al., 2010).  
 
Insulin-like Growth Factor Signalling 
The IGF family has two secreted forms of growth factor, IGF1 and IGF2, which 
bind the two receptors, IGF1R and IGF2R. IGF stimulated osteoblasts and 
bone matrix deposition, which favoured collagen and non-collagenous protein 
synthesis. Osteoblasts expressed both IGF forms and showed similar 
biological activities, but IGF1 was more potent (Giustina et al., 2008). IGF1 
appeared to correlate with bone mesenchymal stromal cell recruitment and 
proliferation at implant sites, while IGF2 correlated with differentiation and 
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mineralisation (Prisell et al., 1993). Studies using animal models showed that 
IGF was essential for normal formation, growth, and maintenance of bone 
(Arvidson et al., 2011). 
 
Wnt Signalling Pathway 
Wnts (wingless) are a large family of secreted proteins that bind membrane-
spanning frizzled (FZD) receptors, and are involved in many cellular 
processes, such as cell growth, differentiation, function, and death. Wnts 
signal through canonical and non-canonical pathways. The canonical pathway 
involves complexes of Wnt proteins, FZD, and low-density receptors, LRP5 or 
LRP6 (Arvidson et al., 2011). Much evidence indicated the canonical pathway 
was critical in bone formation and expression of osteoblast specific markers 
(Westendorf et al., 2004, Jackson et al., 2005). Binding of Wnt proteins to 
FZD/LRP5/6 complexes inhibited GSK3 (glycogen synthase kinase 3) activity 
that blocked phosphorylation of β-catenin and prevented its ubiquitin-
degradation, which led to nuclear translocation and interaction with T-cell 
factor/lymphoid enhancer family of transcription factors (Fujita and Janz, 
2007). β-catenin appears to be required for directing bipotential osteochondro-
progenitors toward a specific lineage. Whereby β-catenin/T-cell factor 1 
complex enhanced expression and activity of osteogenic promoter RUNX2, 
and low β-catenin levels caused mesenchymal stromal cells to be directed 
along chondrogenesis (Day et al., 2005). 
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Epidermal Growth Factor 
EGF receptors, ErbB1-4, activate intrinsic kinases that are widely expressed 
by many cell types, which include epithelial and mesenchymal lineages. EGF 
receptors have five genetically distinct ligands, which include EGF, TGFα 
(transforming growth factor α), amphiregulin, HB-EGF (heparin-binding EGF), 
and other virally encoded factors. The EGF receptors have pleiotropic cell 
responses, which include cell proliferation, differentiation, and migration, as 
well as homeostatic functions (Wells, 1999). EGF is a prototypical mitogen 
shown to enhance BMSC motility and proliferation in human (Krampera et al., 
2005), but not rat (Tamama et al., 2006). EGF has also been shown to 
enhance osteogenic differentiation, whereas PDGF did not (Kratchmarova et 
al., 2005). To the contrary, other reports show EGF alone does not induce 
differentiation, or alter osteogenic, adipogenic, and chondrogenic 
differentiation processes (Tamama et al., 2006). These contradictions are 
possibly due to the different actions of soluble and tethered forms of EGF 
(Tamama et al., 2010). 
 
β1 Integrins 
Integrins are the receptors providing structural links between a cells 
cytoskeleton and the ECM, which allows for oriented division of the cell. 
Integrins also assist growth factor receptors by enhancing signal transduction 
in such processes as cell proliferation, apoptotic protection and motility 
(Kuwada and Li, 2000, Comoglio et al., 2003, Riquelme et al., 2008). In 
addition, with integrins being most likely responsible for spatial positioning 
within a stem cell niche, integrins may well influence downstream cellular 
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signals and play a key role in niche maintenance (Riquelme et al., 2008). The 
importance of integrins as cell adhesion receptors during development and 
matrix organisation is well described (Barczyk et al., 2010). Primitive cells were 
specifically isolated by their high expression of surface β1 integrins (Jones et 
al., 1995, Gandarillas and Watt, 1997, Zhu et al., 1999). This was via rapid 
focal adhesion to the extracellular matrix (ECM) protein fibronectin, as 
opposed to transit amplifying cells, which express lower levels of β1 integrins 
(Adams and Watt, 1991, Jones and Watt, 1993). The terminal differentiation of 
keratinocytes has been shown to be associated with a decrease in the 
fibronectin-specific α5β1 integrin receptor and precedes a loss in fibronectin-
adhesion (Adams and Watt, 1990, Hotchin et al., 1995). Furthermore, 
interaction of fibronectin with α5β1 integrin has the ability to suspend terminal 
differentiation (Watt et al., 1993). In addition, when fibronectin was present 
within the matrix, decorin and biglycan were shown to regulate specific gene 
signals that possibly contribute to remodelling of tissues in such processes as 
morphogenesis and wound healing, as well as disease states (Huttenlocher et 
al., 1996). 
 
Gene Markers of Mesenchymal Stem Cells 
In addition to the markers for “minimal criteria” in defining mesenchymal stem 
cells, research is uncovering other markers that identify BMSCs and DPSCs. 
As Shi et al., (2001) report, however, the gene expression profiles of DPSCs 
and BMSCs are similar for >4000 genes. Added to this, is the heterogeneity of 
both progenitor cell types, which can make it difficult to distinguish between 
them. Nevertheless there were two differentially expressed gene markers, 
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IGF-2 and IGFBP-7, between each progenitor source that plays an important 
role for mesenchymal stromal cells (Shi et al., 2001). 
FGFR1 (CD331) was important for bone development and osteoblast 
maturation (Jacob et al., 2006).  In addition, FGFR1 was important in 
orchestrating epithelial-mesenchymal transition (EMT) and mesoderm 
morphogenesis, which involved cell migration and patterning, by controlling 
Snai1 expression (Ciruna and Rossant, 2001). The importance of FGFR1 and 
Snail1 during development was illustrated in their absence, by craniofacial 
abnormalities e.g. cleft palate. FGFR1 was implicated in human congenital 
defects (Carinci et al., 2007), and animal models (Trokovic et al., 2003). Snai1 
was implicated in murine craniofacial defects (Murray et al., 2007). 
Interestingly, FGF2 is a main activator of FGFR1, and was suggested to have 
a regulatory role in the expression of decorin and biglycan (Bodo et al., 1999). 
Snai1 was also involved in EMT, and important in differentiation of embryonic 
epithelia to mesenchymal cells. Interestingly, Snai1 was induced by TGFβ2, 
and mediated endogenous EMT (Kokudo et al., 2008). 
The adhesion molecules MCAM (CD146) and VCAM1 (CD106) were both 
present in BMSCs (Halfon et al., 2011) and DPSCs (Gronthos et al., 2000). 
MCAM is a vascular/endothelial lineage marker (Filshie et al., 1998), and 
dental pulp and bone marrow progenitors originate from highly vascular 
tissues. This marker is of interest as studies have suggested that several 
different stem cell types may originate from the developing blood vessels 
(Bianco and Cossu, 1999), and could localise the stem cell niche within these 
tissues. VCAM1 is critical in MSC mediated immunosupression, which is a vital 
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component for translation therapy to be used in a clinical setting (Ren et al., 
2010). 
 RUNX2 (Cbf1a) is a key transcription in osteoblast differentiation, and is a 
member of the RUNX transcription factor family, which were abundantly 
expressed in calcified cartilage and bone (Lian et al., 2004). In addition, 
RUNX2 was suggested to be involved in dental development, influencing cell 
growth and differentiation (Xuan et al., 2010). RUNX2 is a transcription factor 
for Spp1 (Osteopontin) (Nakashima et al., 2002), which was suggested to be 
important for cell anchoring (Reinholt et al., 1990). Osteopontin was expressed 
by BMSCs and DPSCs (Gronthos et al., 2000), and in bone osteopontin was 
reported to be an important factor in osteoblast differentiation and 
development during bone remodelling (Sodek et al., 1995). 
Embryonic markers Nanog and SOX2 will be investigated by gene expression, 
as an indication of pluripotency of the DPSCs and BMSCs. Nanog was 
important in the self-renewal of ESC (Loh et al., 2006), and SOX2 generated 
inducible pluripotent stem cells (Takahashi et al., 2007). These embryonic 
markers were reported to be expressed by BMSCs and DPSCs (Janebodin et 
al., 2011). Lastly, mesenchymal stromal cells should be negative for CD14, 
CD34, and PTPRC (CD45), which are markers for monocytes/macrophage, 
haematopoietic, and leukocyte lineages, respectively (NIH Stem Cell 
Guidelines). 
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Research Aims 
An increasing amount of literature on mesenchymal stromal cells, from in vitro 
and in vivo studies, is shedding light on dental pulp as a potential alternative 
cell source for use in tissue regenerative medicine. The vast majority of reports 
on both dental pulp and bone marrow stromal cells, however, uses multi-
colony stromal cell progenitors as opposed to single-cell derived clones. This 
thesis seeks to better understand the potential of dental pulp stromal cells, and 
the continued use of bone marrow stromal cells for tissue engineering, and to 
investigate the influence of extracellular matrix proteins on stromal cell 
proliferation and mineralisation. The aims are: 
 
I. Characterise primitive bone marrow and dental pulp mesenchymal 
stromal cells, from fibronectin-adherence assay, by comparing colony-
formation and proliferation capacity of isolated clonal colonies, and 
quantify stem cell marker expression of clones during culture 
expansion. 
II. Examine differentiation capacity of characterised mesenchymal stromal 
cell clones along adipogenic, chondrogenic, and osteogenic lineages. 
III. Observe influence of whole bone- and tooth- extracellular matrix protein 
extracts on proliferation and osteoinduction of selected mesenchymal 
stromal cell clones. 
IV. Investigate proliferation and differentiation of selected mesenchymal 
stromal cell clones on bone and tooth tissue-slabs, to assimilate fracture 
and caries, respectively. 
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Figure 1.1: Hierarchy of stem cell differentiation showing possible relationship 
to large and small colonies. Stem cells are able to self-renew and replace 
themselves, or differentiate to give rise to committed progenitors. These 
progenitors proliferate and give rise to more differentiated transit amplifying 
(TA) cells, which rapidly proliferate and finally differentiate to produce a large 
number of terminally differentiated functional cells with no capacity for 
proliferation. It is postulated that large colonies are initiated by putative 
stem/progenitor cells and the small colonies are initiated by putative TA cells. 
Taken directly from (Chan et al., 2004). 
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Figure 1.2: Schematic of developing tooth involving odontoblasts and 
ameloblasts. Odontoblasts differentiate from ectomesenchymal cells of the 
dental papilla, which later becomes the pulp, following interaction with inner 
enamel organ epithelial cells. Odontoblasts are of neural crest origin and form 
dentin during a process known as dentinogenesis, which is the tissue layer 
below enamel. Odontoblasts are tall columnar cells with an eccentric nucleus 
and long processes that aligns with dentin. Ameloblasts are of ectodermal 
origin and form enamel during amelogenesis, which is induced by 
dentinogenesis. Ameloblasts differentiate from the inner dental epithelium 
following elongation and polarization (Ten Cate, 1994). EOE, enamel organ 
epithelia layer; DP, dental papilla. Adapted from (Nagano et al., 2003). 
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Figure 1.3: A generic structure representing small leucine-rich proteoglycans 
(SLRPs). SLRPs all possess features which include: an N-terminal domain, 
followed by a 4-cysteine-cluster region that harbours a 3 amino acid group 
Cys-X-Cys. Following the cysteine-cluster region, are a variable number of 
leucine-rich repeats, which has a disulphide bond at its C-terminal. In addition, 
osteoadherin has a C-terminal extension. Sourced from (Neame and Kay, 
2000). 
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Figure 1.4: Domain maps of decorin and biglycan from the small leucine-rich 
proteoglycan family. The core protein of decorin is ~38kDa with a single 
chondroitin or dermatan sulphate glycosaminoglycan (GAG) chain at its N-
terminus. Decorin GAG chains are heterogeneous and the molecular weight 
ranges between 100 and 250kDa. The core protein of biglycan is 45kDa, with 
two chondroitin or dermatan sulphate GAG chains at the N-terminus. Biglycan 
GAG chains are also heterogeneous and range between 200-350kDa. CS, 
chondroitin sulphate; DS, dermatan sulphate. Adapted from (Mecham, 2001). 
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Chapter 2 
Materials and Methods 
 
2.1 Primary Bone Marrow and Dental Pulp Cell Culture  
All animals were handled and sacrificed in accordance with Code of Practice 
for the Humane Killing of Animals Under Schedule 1 to the Animals (Scientific 
Procedures) Act 1986. Upper and lower incisors, and femoral bones, were 
dissected from 21-28 day old male Wistar rats. The incisors and bones were 
collected in αMEM (with ribonucleasides and deoxyribonucleosides; 
Invitrogen) with 10% antibiotic-antimycotic (1x103 units/mL penicillin G, 
1mg/mL streptomycin sulfate, and 2.5µg/mL amphotericin B; Sigma-Aldrich, 
Inc). Dental pulp was extirpated, chopped by hand on a glass slide using a 
scalpel, and digested with 4mg/mL collagenase/dispase (Roche) for 45 
minutes at 37oC. Digested pulp was filtered through a 70µm nylon cell strainer 
(BD Falcon) with 9mL αMEM with 1% antibiotic-antimycotic (working medium) 
and centrifuged at 1800rpm for 5 minutes. The cell pellet was suspended in 
1mL of working medium and the number of viable cells counted using Trypan 
Blue solution (Sigma-Aldrich, Inc). 
Bone marrow was prepared using a Histopaque-1077 (Sigma-Aldrich, Inc) 
medium to facilitate isolation and recovery of the mononuclear cell layer 
containing progenitor cells. Marrow was collected in 1mL working medium by 
opening and brushing the bones with a disposable 2mm micro-applicator brush 
(MICROBRUSH® International). Marrow was suspended in working medium 
with an equal volume to the pellet, and centrifuged at 1800rpm for 5 minutes. 
Histopaque was allowed to come to room temperature and the marrow with 
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working medium was layered onto an equal volume of histopaque, and 
centrifuged at 1800rpm in a swing-bucket for 30 minutes at room temperature. 
The mononuclear layer of cells (second from the top) was then recovered and 
counted as above. 
Fibronectin plates were prepared at 10µg/mL (fibronectin from human plasma; 
Sigma-Aldrich, Inc) reconstituted in PBS (phosphate buffered saline, with 1mM 
calcium and 1mM magnesium), and used with 1ml fibronectin/PBS (Ca2+ and 
Mg2+) per well in 6-well plates. The recovered pulp and marrow cells were 
seeded at 4000 cells/cm2 in 1mL culture medium into each well of coated 
plates, immediately after removing fibronectin/PBS solution. Cells were then 
incubated at 37oC for 20 minutes to select for the fibronectin adherent, α5/β1 
integrin-positive primitive cell populations. After 20 minutes incubation, non-
adherent cells were aspirated and unattached cells were rid with several PBS 
washes. A volume of 2mL fresh culture medium was added and plates were 
incubated. Culture medium consisted of αMEM supplemented with 20% Fetal 
Bovine Serum (FBS) (EU Approved, South American origin, Invitrogen), 1% 
antibiotic-antimycotic, and 100μM L-ascorbic acid 2-phosphate (both Sigma-
Aldrich, Inc). Culture medium was changed every two days. Cells were 
incubated at 37oC in a 5% CO2 atmosphere. All tissue culture plastic 
consumables were SARSTEDT or Greiner Bio-One, unless specified. 
Mycoplasma testing was routinely conducted every two weeks and if found 
positive cells were treated with 10µg/mL Ciprofloxin antibiotic (Claris 
Lifescience UK Ltd) for 2 weeks until tested negative. If infection persisted cells 
underwent BM Cyclin treatment (Roche) for 2 weeks, after which cells were 
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either cultured as normal if mycoplasma negative, or disposed of if 
mycoplasma positive. 
 
2.2 Colony-Forming Efficiency and Population Doubling Level 
Within each well the numbers of clonal colonies (>32 cells) were counted on 
days 3, 6, 10 and 12, and considered as a proportion of the total number of 
cells at 24 hours, to calculate the colony forming efficiency (CFE) (Dowthwaite 
et al., 2004). All cells and colonies attached in each well were counted 
manually by viewing in a serpentine configuration using an Olympus CK2 
inverted microscope with stage. On day 12, the number of cells in each 
individual colony was counted, and then isolated using a cloning ring, and 
treated with a proteolytic and collagenolytic enzyme StemPro® Accutase® 
(Invitrogen) as follows. The 6-well plate was washed with PBS, each individual 
colony was isolated using a cloning ring with petroleum jelly smeared around 
the lower rim, and incubated at room temperature with 150µL StemPro® 
Accutase® for 5 minutes. Alternatively, dental pulp clones were positively 
“picked” to ensure isolation of large or close proximity colonies. Cells were 
recovered and plated into a well of a 96-well plate and culture expanded. When 
approximately 80% confluent, cells were passaged with StemPro® Accutase® 
(Invitrogen), counted using 0.4% trypan blue solution (Sigma-Aldrich, Inc) to 
calculate passage cell number, and the population doubling level (PDL) as a 
proportion to original number of cells within the colony at isolation 
(PDL=(log10(24 hour cell count)-(total cell number reseeded))/log10(2)). 
Passaged cells were reseeded at the density 4x103 cells/cm2. All dental pulp 
clones (except DP 2.7) were culture expanded by doubling surface area alone 
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for the first four passages, after which culture expansion proceeded in the 
normal way of seeding at 4x103 cells/cm2. Cells were continually propagated 
and underwent cryopreservation using 1:10 dimethyl sulphoxide (DMSO) 
(Invitrogen)/FBS when sufficient cells were gained. Cryopreserved cells were 
decreased to -80oC in isopropanol before transferring to liquid nitrogen for 
storage until required for future use. 
 
2.3 Mycoplasma Testing for Polymerase Chain Reaction 
Mycoplasma testing used the VenorGeM Mycoplasma Detection Kit for 
Conventional PCR standard protocol (Cambio, manufactured by Minerva 
Biolabs). Briefly, 100µL of culture medium supernatant was used from cell 
cultures at approximately 80% confluency. The sample was incubated at 95oC 
for 5 minutes, centrifuged to pellet cellular debris, and 2µL of culture medium 
supernatant used for PCR in a final volume of 25µL containing kit master-mix. 
Cycling conditions used for PCR was one cycle at 94oC for 2 minutes, and 
thirty-nine cycles at 94oC for 30 seconds, 55oC for 30 seconds, and 72oC for 
30 seconds. Products were separated using 2% agarose/ethidium bromide 
gels and captured using UV light. Bands are seen at 191bp for negative 
sample, and 270bp for positive sample. Negative control used RNA free water, 
and positive control used DNA template. 
 
2.4 β-Galactosidase Stain for Cell Senescence 
Cell senescence was measured as a percentage of β-Galactosidase staining 
using the manufacturer protocol for Senescence Cells Histochemical Staining 
kit (Sigma-Aldrich, Inc). Briefly, cells seeded at 4x103 cells/cm2 were cultured 
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for 48 hours in culture medium, and the β-Galactosidase stain was used 
overnight without CO2 at 37oC. The number of positive cells out of 100 was 
counted from at least four random fields of view, to give an average 
percentage. 
 
2.5 Reverse Transcription and End-Point Polymerase Chain Reaction for 
Colony Clones 
Total RNA was extracted from 1.15x103 cells seeded at 4x103 cells/cm2 grown 
to 90% confluence, at the time-points shown in table 2.1. The extraction used 
RNeasy Mini Kit and QIAshredder (Qiagen) as per manufacturer protocols. 
Quantity and purity of RNA was determined by 260/280nm absorbance. Firstly, 
500ng of total RNA was denatured with 1µL random primer, added to 
nuclease-free water for a final volume of 15µL, and run at 70oC for 5 minutes. 
The reverse-transcription (RT) negative control did not contain sample RNA. 
Secondly, cDNA was transcribed by adding the 15µL of denatured RNA to an 
RT reaction mix to produce a final volume of 25µL sample cDNA. Each sample 
RT reaction mix contained: 5µL 5x MMLV Reaction buffer, 1.25µL 10mM 
dNTPs, 0.6µL RNasin, 1µL MMLV enzyme, and 2.15µL nuclease-free water, 
for a total volume of 10µL. The RT 25µL final volume was run at 37oC for 1 
hour. The polymerase chain reaction (PCR) reagents used for each 24µL 
reaction contained: 5µL 5x buffer, 0.5µL 10mM dNTPs, 2µL 3µM primers 
(forward and reverse), 1µL 25mM magnesium chloride, 0.25µL Taq 
polymerase, and 13.25µL nuclease-free water. To the 24µL PCR reaction mix, 
1µL cDNA was added for a final volume of 25µL. The PCR negative control 
did not contain sample cDNA. All reagents used were Promega. Thermo cycler 
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(G-Storm, Gene Technologies Ltd., Software V3.3.0.0) conditions used were: 
heated lid at 110oC, 95oC for 5 minutes, and thirty-five cycles of 95oC for 1 
minute, primer specific annealing temperature for 1 minute, and 72oC for 1 
minute, and a final cycle of 72oC for 10 minutes. Primer sequences were 
designed using online internet National Centre for Biotechnology Information 
(NCBI) Primer-BLAST software unless specified, see table 2.2. The control 
reference gene used was β-actin. Products were separated using 1% or 2% 
agarose/ethidium bromide (Promega) or Safeview DNA Stain (NBS 
biologicals) gels, and captured using UV light. 
 
2.6 Quantitative-Polymerase Chain Reaction of Colony Clones 
Total RNA was extracted and cDNA synthesised as for end-point PCR. cDNA 
was diluted 1:10 with nuclease-free water. For each reaction the qPCR 
reagents used were 2µL 3µM primers (forward and reverse), 5µL diluted cDNA 
sample, 10µL Precision MasterMix pre-mixed with SYBR green (Primer Design 
Ltd), and  1µL RNA-free water, for a final volume of 20µL. All samples were 
triplicated in Bright White 96-well plates (Primer Design Ltd). Real-time 
quantitative-PCR runs were conducted on ABI Prism 7000 Sequencing 
Detection System and ABI Prism 7000 SDS Software V1.0. Reaction 
conditions were one cycle of 95oC for 10 minutes, and forty cycles of 95oC for 
15 seconds, 55oC for 30 seconds and 72oC for 30 seconds. Primer sequences 
were designed by OligoArchitect Primer and Probe Design Solutions (Sigma-
Aldrich, Inc) unless specified, see tables 2.3, 2.4, and 2.5. The control 
reference gene used was β-actin. Products were separated and captured as 
for end-point PCR to confirm product band. Statistical analyses were 
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conducted using one-way ANOVA with Tukey test and statistical package 
GraphPad InStat v3.06. Statistical values were defined as * = P<0.05 
(significant), ** = P<0.01 (very significant), *** = P<0.001 (extremely 
significant). 
 
2.7 Mesenchymal Stromal Cell Differentiation 
Assessment of MSC differentiation potential was investigated for three 
lineages: adipocytes, chondrocytes, and osteoblasts. Differentiation potential 
was investigated for three clonal populations from both tissue sources: bone 
marrow and dental pulp. These same three clonal populations from both tissue 
sources at mid PDL (see table 2.1) underwent analysis hereon in. 
 
2.7.1 Adipogenic Differentiation Media 
For adipogenesis cells were seeded at 10x103/cm2 and fed with 10% serum 
culture medium (see 2.1 Primary Bone Marrow and Dental Pulp Cell Culture) 
until virtually 100% confluent (NB cells need to be tightly packed). 
Differentiation media consisted of two treatments referred to as induction and 
maintenance. Adipogenic induction medium consisted of 1µM dexamethasone 
(Sigma-Aldrich, Inc) dissolved in ethanol (Genta Medical, UK), 0.5mM 3-
isobutyl-1-methylxanthine (IBMX) in dissolved dimethyl sulfoxide (DMSO) 
(both Sigma-Aldrich, Inc), 10µg/mL dissolved insulin (Sigma-Aldrich, Inc) 
dissolved in hydrochloric acid (HCl) (Fisher Scientific), and 100µM 
indomethacin (Sigma-Aldrich, Inc) dissolved in methanol (Fisher Scientific). 
Adipogenic maintenance medium contained 10µg/mL insulin dissolved in HCl 
only. At 100% confluency (day 1), adipogenic differentiation was started for a 
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total 21 days. Media change schedule as follows: induction (days 1 and 4), 
maintenance (day 7), induction (days 9 and 12), maintenance (day 15), and 
induction (day 17). Photographs were taken on days 1, 7, 15, and 21, and 
finally specimens were processed on day 21. Media stock solutions were 
vortexed to give a precipitate-free solution and 0.22µm filter sterilised before 
storing at -20oC until use. Adipogenic components were thawed, mixed, and 
added to 10% serum culture medium (final concentrations stated above), and 
vortexed for thorough dissolution immediately before each change. Control 
was 10% serum culture medium alone, and was fed alongside adipogenesis 
treatment. Cells were cultured using 32mm #1 glass round cover slips (VWR 
International Ltd) in 3x9.6cm2 wells for total RNA extraction, and 13mm #1 
glass round cover slips (VWR International Ltd) in 2cm2 wells for neutral lipid 
staining. 
 
2.7.2 Adipogenic Differentiation Marker Expression Analysis 
Total RNA was extracted from 28.8x105 cells seeded at 10x103 cells/cm2 after 
21 days in culture, for adipogenic expression detection using quantitative PCR, 
see markers in table 2.4 (see 2.6 Quantitative-Polymerase Chain Reaction of 
Colony Clones). Total RNA was analysed from three samples: before 
differentiation at mid PDL (see table 2.1), and 21-day non-adipogenic and 
adipogenic differentiation media (see 2.7.1 Adipogenic Differentiation Media). 
 
2.7.3 Adipogenic Differentiation Neutral Lipid Detection 
Two culture groups were set up for neutral lipid analysis: 21-day non-
adipogenic medium and 21-day adipogenic differentiation medium. Cells were 
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fixed and probed using HCS LipidTOXTM Green neutral lipid stain as per 
manufacturers protocol (Invitrogen). Briefly, cells were washed twice with PBS, 
fixed with 4% PFA for 10 minutes at room temperature, washed thrice with 
PBS, and stained with LipidTOXTM diluted 1:200 in PBS for 30 minutes. Lastly, 
glass cover slips were counter-stained with DAPI Vectashield Hard-Set 
Mounting Medium (Vector Labs) and inverted onto SuperFrost microscope 
slides (Thermo Scientific Gerhard Menzel). Nuclear DAPI and green-lipid 
fluorescence was observed at 373nm/456nm and 490nm/520nm wavelengths, 
respectively, using Olympus Provis AX70 microscope with Nikon ACT-1 v.2.63 
software. 
 
2.7.4 Chondrogenic Differentiation Media 
Chondrogenesis was assessed using StemMACS ChondroDiff Media as per 
manufacturers protocol (Miltenyi Biotech Ltd.). To the ChondroDiff Media 1% 
antibiotic-antimycotic (Sigma-Aldrich, Inc) was added. Working aliquot 
volumes were stored at -20oC, and thawed immediately before use. Cells were 
seeded at 2.5x105 with either 1mL non-chondrogenic 10% serum culture 
medium (see 2.1 Primary Bone Marrow and Dental Pulp Cell Culture) or 1mL 
ChondroDiff Media, in 15mL polypropylene tubes with loosely capped lids for 
air circulation. A minimum two tubes for each specimen with non-chondrogenic 
and chondrogenic media was set up. Tubes were centrifuged at 150g for 5 
minutes at room temperature before and after each media change. Media was 
changed every three days and formed pellets were collected for processing on 
day 24. An additional two tubes for both media were set up for RNA extraction, 
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however, neither RNeasy Mini Kit with QIAshredder (Qiagen) nor TRI 
Reagent® (Sigma-Aldrich, Inc) could recover total RNA for PCR. 
 
2.7.5 Chondrogenic Differentiation Pellet Tissue Histology 
Following 24 days, formed pellets were washed with PBS and transferred to a 
universal tube containing 20mL 3.7% formalin/PBS fixative for a minimum 24 
hours with gentle agitation. After fixing, pellets were transferred to tissue paper 
and dabbed with haematoxylin for easy identification, wrapped up within the 
tissue paper by folding edges several times and put in embedding cassettes 
for automatic processing (Leica ASP300S). This automation dehydrated 
samples through 90%, 95%, and 100% ethanol concentrations, washed by 
xylene immersion, and soaked in molten paraffin wax. Specimens were then 
manually embedded in paraffin wax (Leica EG1150H) and stored in darkness 
at room temperature until use. Paraffin embedded samples were microtomed 
(Leica SM2400), and 5µm sections collected on SuperFrost poly-L-lysine 
coated microscope slides (Thermo Scientific Gerhard Menzel) and incubated 
overnight in a drying oven at 60oC (BINDER). Mounted sections were stored 
in a sealed dark box until use. 
 
2.7.6 Chondrogenic Differentiation Immunohistological Analysis 
Chondrogenic pellet sections (see 2.7.5 Chondrogenic Differentiation Pellet 
Tissue Histology) underwent haematoxylin and eosin (H&E) staining for 
nuclear and cytoplasmic components for extracellular matrix observation, 
which was conducted by automation (Shandon Linistain). A series of xylene, 
graded ethanol and water submersions, deparaffinised and rehydrated 
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samples. Samples were then stained with haematoxylin, and Scott’s tap water, 
and washed with 1% acid alcohol. Lastly samples were stained with eosin, 
dehydrated in ethanol, and washed in xylene. Sections were fixed and sealed 
with cover slips using DPX mounting medium (CellPath, UK). 
In addition, chondrogenic pellet sections were examined for collagen type II. 
Tissue sections were deparaffinised with xylene for 10 minutes, rehydrated in 
a series of 90%, 70%, 60%, and 40% ethanol for 5 minutes each, and washed 
with TBS (tris buffered saline) for 5 minutes. Endogenous peroxidase was 
quenched with 1% v/v H2O2 (30% weight in H2O; Sigma-Aldrich, Inc) in 
methanol for 40 minutes, and washed in TBS for 5 minutes. Sections were 
enzymatically treated with 1mg/mL pepsin peptidase (porcine gastric mucosa; 
Sigma-Aldrich, Inc), 0.1M AcOH and 0.5M NaCl in TBS (pH 2-3) at 37oC for 1 
hour, washed in TBS for 5 minutes (enzyme deactivation), followed by 
treatment with 1mg/mL type I-S hyaluronidase (bovine testes; Sigma-Aldrich, 
Inc) in TBS at 37oC for 1 hour, and another wash in TBS for 5 minutes. Sections 
were blocked in 1% BSA fraction V (Fisher Scientific Bioreagent) in TBS for 30 
minutes and incubated in 2µg/mL primary antibody collagen type II (mouse 
CIIC1 supernatant; Developmental Studies Hybridoma Bank) in 1% BSA/TBS, 
overnight at 4oC. Isotype control used 2µg/mL normal mouse IgG (sc-2025; 
Santa Cruz Biotechnology, Inc), and antibody exclusion control was 1% 
BSA/TBS only. Next day, sections were washed three times in TBS for 5 
minutes, incubated with 4µg/mL secondary antibody goat anti-mouse IgG-
HRP (SC-2005; Santa Cruz Biotechnology, Inc) for 1 hour at room 
temperature, and washed three times in TBS for 5 minutes for a final time. 
Peroxidase substrate was developed by 30 minutes incubation with 2mg/mL 
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AEC (3-Amino-9-ethylcarbazole; Sigma-Aldrich, Inc) in DMF (N,N-
Dimethylformamide; Sigma-Aldrich, Inc), with 10mL 10x imidazole buffer 
solution (1M NaCl, 0.2M citric acid.xH2O, and 1M imidazole ACS reagent; all 
Sigma-Aldrich, Inc), plus 80mL ddH2O, activated by addition of 20µL H2O2 
(30% weight; Sigma-Aldrich, Inc). Sections were mounted using 10% v/v 
glycerol/TBS (Sigma-Aldrich, Inc), overlaid with 22x22mm #1 glass square 
cover slips (VWR International Ltd), and sealed with varnish. All images were 
captured using Olympus Provis AX70 microscope with Nikon ACT-1 v.2.63 
software. 
 
2.7.7 Osteogenic Differentiation Media 
For osteogenesis, cells were seeded at 4x103/cm2 and fed with 10% serum 
culture medium (see 2.1 Primary Bone Marrow and Dental Pulp Cell Culture) 
for 5 days. On day 5, osteogenic differentiation medium was started for 21 
days. Media was changed every two days, and specimens were collected on 
day 23 for analysis. Osteogenic medium consisted of 10µM dexamethasone 
(Sigma-Aldrich, Inc) and 10mM β-glycerophosphate, 0.22µm sterile filtered, in 
10% serum culture medium. Non-osteogenic used 10% serum culture medium 
alone. Cells were cultured using 32mm #1 glass round cover slips (VWR 
International Ltd) in 3x9.6cm2 wells for total RNA extraction, and 13mm #1 
glass round cover slips (VWR International Ltd) in 2cm2 wells for protein 
imuunocytochemistry and alizarin red staining. 
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2.7.8 Osteogenic Differentiation Marker Expression Analysis 
Total RNA was extracted from 1.15x105 cells seeded at 4x103 cells/cm2 after 
23 days in culture, for osteogenic expression detection using end-point product 
and quantitative PCR, in table 2.5 (see 2.5 Reverse Transcription and End-
Point Polymerase Chain Reaction for Colony Clones and 2.6 Quantitative-
Polymerase Chain Reaction of Colony Clones). Total RNA was analysed from 
three samples: before differentiation at mid PDL (see table 3.1), and 23-day 
non-osteogenic and osteogenic differentiation medium (see 2.7.7 Osteogenic 
Differentiation Media). 
 
2.7.9 Osteogenic Differentiation Alizarin Red Staining 
To assess mineralisation of cultured cells, alizarin red S (Sigma-Aldrich, Inc) 
was used to stain calcium ion deposits within the extracellular matrix. Samples 
were washed twice with PBS, exposed to 2% w/v alizarin red S/ddH2O (pH 
4.2, 0.5% ammonium hydroxide) for 4 minutes at room temperature with gentle 
agitation, and washed thrice with ddH2O or until wash solution was clear of 
red. Samples were allowed to air dry before acquiring images using Nikon 
Eclipse TS100 with a Canon P1234 camera. 
 
2.7.10 Osteogenic Differentiation Immunocytochemistry 
Cells were washed twice with PBS, fixed in ethanol for 30 minutes, and blocked 
with 1% BSA/TBS solution for 30 minutes at room temperature. Osteopontin 
primary goat polyclonal IgG antibody (P-18) (sc-10593; Santa Cruz 
Biotechnology, Inc) was incubated using 4µg/mL in 1% BSA/TBS for 1 hour at 
room temperature. Isotype control used 4µg/mL normal goat IgG (sc-2028; 
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Santa Cruz Biotechnology, Inc), and antibody exclusion control was 1% 
BSA/TBS only. Cells were washed twice with TBS for 5 minutes, and incubated 
with 4µg/mL secondary antibody rabbit anti-goat IgG-FITC (sc-2777; Santa 
Cruz Biotechnology, Inc) in 1% BSA/TBS for 1 hour at room temperature, and 
lastly washed thrice in TBS for 5 minutes. Glass cover slips were counter-
stained with DAPI Vectashield Hard-Set Mounting Medium (Vector Labs) and 
inverted onto SuperFrost microscope slides (Thermo Scientific Gerhard 
Menzel). Nuclear DAPI and green-lipid fluorescence was observed at 
373nm/456nm and 490nm/520nm wavelengths respectively, using Olympus 
Provis AX70 microscope with Nikon ACT-1 v.2.63 software. 
 
2.8 Mineralised Tissue-Slab Preparation and Culture 
Male Wistar rats, 21-28 days old, were dissected for long-bones from femur, 
tibia, and fibula, and for tooth lower and upper incisors. Extracted bones and 
teeth were rid of all external soft tissues, had ends sawed to leave tissue-shaft 
chamber and were sectioned longitudinally using an IsoMet® low speed saw 
with a wafering blade 15HC (BUEHLER). Sections were cut two or three times 
to produce tissue-slabs of 4-5mm length. The internal chamber of tissue-slabs 
were cleaned of connective-tissues with a disposable 2mm micro-applicator 
brush (MICROBRUSH® International) and PBS, and placed in 10% antibiotic-
antimycotic (Sigma-Aldrich, Inc) in PBS on ice for use immediately, or at -80oC 
for storage. Within an ABS Class 2 Cabinet (Bioquell UK Ltd), tissue slabs 
were dabbed dry and placed into a 96-well plate (SARSTEDT) with adhesive 
carbon tape (Agar Scientific), and immediately seeded with cells at 16x103 
cells/cm2 in culture medium. Following two days incubation, cell-seeded 
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tissue-slabs were washed thrice with ddH2O for 10 minutes, and fixed with 
2.5% glutaraldehyde (25% EM grade; Agar Scientific) overnight at 4oC. Fixed 
cell-seeded tissue-slabs were then taken for antibody detection or scanning 
electron microscopy (SEM) analysis. Control tissue-slabs had no cells seeded 
with culture medium. 
 
2.9 Mineralised Tissue-Slab Antigen Detection 
Following fixation of cell-seeded tissue-slabs in 2.5% glutaraldehyde (25% EM 
grade; Agar Scientific) overnight at 4oC, endogenous peroxidase was 
quenched with 1% v/v H2O2 (30% weight in H2O; Sigma-Aldrich, Inc) in TBS 
for 30 minutes. Slabs were washed twice with TBS and a third time for 5 
minutes, before permeabilising with 0.1% Trition-X 100 (Sigma-Aldrich, Inc) in 
TBS for 15 minutes. Slabs were blocked with 1% BSA/TBS solution for 30 
minutes at room temperature, before incubating with proliferating cell nuclear 
antigen (FL-261) primary rabbit polyclonal IgG antibody (sc-7907; Santa Cruz 
Biotechnology, Inc) at 4µg/mL in 1% BSA/TBS for 1 hour at room temperature. 
Isotype control used 4µg/mL Rabbit (DA1E) mAb IgG XP® (#3900; Cell 
Signaling Technology, Inc), and antibody exclusion control was 1% BSA/TBS 
only. Slabs were washed twice with TBS for 5 minutes, and incubated with 
80ng/mL secondary goat anti-rabbit IgG-HRP antibody (sc-2004; Santa Cruz 
Biotechnology, Inc) in 1% BSA/TBS for 1 hour at room temperature. Slabs 
were washed thrice in TBS for 5 minutes, and lastly incubated with TMB 
(3,3',5,5'-Tetramethylbenzidine; eBioscience, Inc) for 13  minutes, and washed 
twice with TBS for 5 minutes. Images were immediately captured using Zeiss 
Axiovert 200M microscope with Improvision® OpenLab™ v4.0.3 software. 
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2.10 Mineralised Tissue-Slab Scanning Electron Microscopy 
Following fixation in 2.5% glutaraldehyde (25% EM grade; Agar Scientific) 
overnight at 4oC, cell-seeded tissue-slabs were washed thrice with ddH2O for 
10 minutes, and dehydrated in ethanol for 10 minutes each concentration: 
30%, 50%, 70%, 80%, 90%, and 95%. The final concentration of 100% ethanol 
was thrice for 20 minutes. Lastly, samples were exposed to 50% 
hexamethyldisilazane (HMDS) (Fisher Scientific) in ethanol for 10 minutes, 
and 100% HMDS twice for 15 minutes and a third time for evaporation 
overnight. Tissue-slab samples were affixed to 1.2mm aluminium stubs with 
adhesive carbon tape (both Agar Scientific), gold sputter-coated for 1 minute 
20 seconds (15nm/minute at 30mA with 3cm spacing) in an argon gas 
chamber at 3mb (Edwards Sputter Coater S150B), and viewed under SEM 
(Hitachi 4800 S, Hitachi High-Technologies Pte Ltd., Singapore). 
 
2.11 Mineralised Tissue Whole-Protein Extraction and Dialysis 
Rat bone and tooth tissues were prepared as in section 2.8 Mineralised Tissue-
Slab Preparation and Culture, up to point of culture. Next, prepared tissues 
were separately snap-frozen in liquid nitrogen and powdered with a 
Freezer/Mill® 6750 (SPEX CertiPrep) for 1 minute at rate 10. Powdered tissue 
was immediately collected with 10-20mL of 4oC-cold 10% tri-sodium 
ethylenediaminetetraacetic acid (EDTA) buffer in ddH2O with 10mM NaOH 
(both Fisher Scientific) (pH 7.45, AcOH), and put into 33mm width cellulose 
membrane dialysis tubing (>12kDa cut-off) (Sigma-Aldrich, Inc). Tubing 
contents was dialysed for 5 days in 10% EDTA buffer with 10mM NaOH, and 
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3 days in protease inhibitor solution (0.5mM iodoacetic acid, 0.5mM 
benzamidine, and 0.1mM N-ethylmaleimide) at 4oC with magnetic stirrer for 
continuous agitation. Dialysed contents was spun at 1600rpm for 30 minutes 
at 4oC to rid non-soluble proteins, supernatant collected in fresh tubing and 
dialysed a final time in ddH2O for a day. Dialysed supernatant was 
subsequently lyophilised (Edwards Freeze Dryer Modulyo), and referred to as 
bone matrix extract (BME) and tooth matrix extract (TME). 
 
2.12 Bicinchoninic Acid Protein Assay 
Lyophilised protein was suspended in 1-2mL TBS until completely dissolved 
and kept on ice. Protein concentration was analysed using BCA Protein Assay 
Kit as per manufacturer protocol (Pierce® Thermo Scientific). Briefly, 25 µL of 
each protein sample was added to 200µL working reagent alongside BSA 
standards (20-2000µg/mL) in triplicates and mixed thoroughly on plate shaker 
for 30 seconds. The plate was incubated at 37oC for 30 minutes, brought to 
room temperature, and colorimetric absorbance read at 562nm using 
SPECTROstar Omega plate reader v3 and MARS data analysis software 
v2.41 (BMG LABTECH). Absorbencies were blank corrected and averaged, 
and protein concentration calculated using standard curve and polynomial 
(order 4) equation with Microsoft® Excel® 2013 package. 
 
2.13 Metabolism Assay with Thiazolyl Blue Tetrazolium Bromide 
Cells were seeded in 10% culture medium (with or without protein) at 
2.8x103/cm2, 5.7x103/cm2, 11.4x103/cm2, 17.1x103/cm2, or 22.8x103/cm2, in 
triplicate wells of a 96-well plate (SARSTEDT) for 1, 2, 3, 5, or 7 days period 
 59 
of time, before addition of 5mg/mL MTT (Sigma-Aldrich, Inc) in fresh 10% 
medium for 5 hours. Next, MTT and medium solution was removed and 
replaced with dimethylsulfoxide (DMSO) for 30 minutes, and colorimetric 
absorbance was read at 570nm using SPECTROstar Omega plate reader v3 
and MARS data analysis software v2.41 (BMG LABTECH). Blank served as 
MTT in medium without cells. Absorbencies were blank corrected and 
averaged to plot metabolism over culture time-period. Statistical analyses were 
conducted using two-way ANOVA and Instat3 statistical package v3.06. 
 
2.14 Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis 
BME and TME protein samples were run in duplicate for Coomassie Brilliant 
Blue R (Sigma-Aldrich, Inc) and Silver Stain Kit analyses. An amount of 10µg 
protein sample was lyophilised (Edwards Freeze Dryer Modulyo), mixed with 
15µL Laemmli sample buffer (62.5mM Tris-HCl (pH 6.8), 2% SDS, 10% 
glycerol, 0.5% bromophenol blue, 2.5% β-mercaptoethanol (14.3M)), vortexed 
for 30 seconds, and centrifuged for 2 minutes at 2.5g, 4oC. Protein samples 
(10µg) were boiled for 5 minutes and centrifuged again. Protein samples were 
run on 1mm precast polyacrylamide gels (4-15% Mini-PROTEAN® TGX™; 
Bio-Rad Laboratories, Inc), at 200V for 40 minutes, alongside Kaleidoscope™ 
Prestained Standard (Bio-Rad Laboratories, Inc). Gel lanes containing 
standard and protein samples were isolated with a scalpel and subsequently 
stained. 
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2.15 Coomassie Brilliant Blue R Protein Staining 
Protein sample SDS-PAGE gels were immediately stained using 20% v/v 
Coomassie Brilliant Blue R (0.25% w/v in 50% v/v methanol; Sigma-Aldrich, 
Inc), 35% v/v methanol and 10% AcOH v/v for 30 minutes at room temperature. 
The gel was de-stained using 5% v/v methanol and 7.5 v/v AcOH for 30 
minutes and further overnight at room temperature, with constant agitation. 
Gels were finally washed with ddH2O to rid all excess coomassie and images 
were captured using a 3-Megapixel digital camera. 
 
2.16 Protein Silver Stain Kit 
A Silver Stain was conducted to detect proteins <100ng, as per manufacturer 
instructions (Thermo Fisher Scientific, Inc). Briefly, protein sample SDS-PAGE 
gels were fixed overnight with 50% v/v ethanol and 5% v/v AcOH at room 
temperature. Gels were washed with ultrapure water (Nanopure Diamond™, 
Barnstead) five times, each for 20 minutes with agitation. Gels were incubated 
with Silver working solution for 30 minutes, rinsed in ddH2O for 20 seconds, 
incubated in Reducer working solution for 5 minutes, rinsed in ddH2O for 5 
seconds, and lastly incubated in Stabiliser working solution for 40 minutes. 
Images were captured using a 3-Megapixel digital camera. 
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Table 2.1: RNA extraction time-points for gene marker expression detection. Tissue: 
BM, bone marrow; DP, dental pulp; and individual specimen identity. Clone: specific 
clone name. PDL, population doubling level. Day: in vitro culture time. Stage: E, earliest; 
M, mid; L, late; LR, later. 
 
Tissue Clone Passage PDL Day Stage 
BM i 1.4 8 12 35 E 
  11 16 47 M 
  19 32 82 L 
  23 42 96 LR 
BM i 2.6 7 8 40 E 
  16 17 87 M 
  23 30 102 L 
  31 41 125 LR 
BM ii 3.1 10 11 71 E 
  15 18 89 M 
  25 33 116 L 
  30 41 128 LR 
DP i 2.7 13 11 128 E 
  20 20 161 M 
  26 33 179 L 
  31 44 191 LR 
DP iii E11 9 10 151 E 
  12 19 172 M 
  17 32 205 L 
  21 41 224 LR 
DP iv F2 7 10 62 E 
  11 16 85 M 
  18 31 111 L 
  23 42 129 LR 
  
Table 2.2: End-point PCR primer sequences, annealing temperature, and cycle number for gene marker expression detection during culture 
expansion. Special annealing temperature for SOX2: 94oC for 10 minutes, forty cycles of 98oC for 10 seconds, 55oC for 30 seconds and 72oC for 1 
minute, and lastly 72oC for 7 minutes. 
Official 
Symbol 
Official Full Name Synonym Primer Sequence Annealing 
Temperature 
oC 
Product 
Length 
bp 
Designer 
Actb Actin, beta β-Actin F: 5’- TGAAGATCAAGATCATTGCTCCTCC-3’ 
R: 5’- CTAGAAGCATTTGCGGTGGACGATG-3’ 
55/62 108 Sigma-Aldrich, Inc 
Ptprc Protein tyrosine phosphatase, 
receptor type, C 
CD45 F: 5’- CTCACCACACTCACGGCTGCTCCCAGCG-3’ 
R: 5’- GCAGGGCCATTTCGTTGCACCCTCCCAA-3’ 
62 887-1010 Author 
Fgfr1 Fibroblast growth factor 
receptor 1 
CD331 F: 5’- GCCAACAAGACCGTGGCCCTGGGCAGCA-3’ 
R: 5’- TCGGCCAACACCACCTGCCCGAAGCAGC-3’ 
62 701 Author 
Mcam Melanoma cell adhesion 
molecule 
CD146 F: 5’- GCAGCGCCACGGGTGTGCCAGGAGAGG-3’ 
R: 5’- CCCCACTGTGGTGCTTCTGGGCGGGCT-3’ 
62 900 Lee CP 
(Cardiff University) 
Msx2 Msh homeobox 2 MSX2 F: 5’- CTTACAGAAACCCAGGTCAAA-3’ 
R: 5’- AGCACAGGTCTATGGAAGG-3’ 
62 200 Sigma-Aldrich, Inc 
Nanog Nanog homeobox Nanog F: 5’- GGGGATTCCTCGCCGATGCCTGCCGTT-3’ 
R: 5’- GGGATACTCCACCGGCGCTGAGCCCTT-3’ 
55 477 Lee CP 
(Cardiff University) 
Snai1 Snail family zinc finger 1 Snail F: 5’- GCGAGCTGCAGGACGCGTGTGTGGAGT-3’ 
R: 5’- CGGCAAAGGCACGGTTGCAGTGGGAGC-3’ 
62 597 Lee CP 
(Cardiff University) 
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Sox2 SRY (sex determining region 
Y)-box 2 
SOX2 F: 5’- CAGCATGTCCTACTCGCAGCA -3’ 
R: 5’- GGAACTGGCCTCGGACTTGA -3’ 
Special 82 (Nozaki and 
Ohura, 2011) 
Vcam1 Vascular cell adhesion 
molecule 1 
CD106 F: 5’- TCCACACTGACGCTGAGCCCTGTGGGTG-3’ 
R: 5’- CTCCGGCATCCTGCAGCTGTGCCTTGCG-3’ 
62 898 Author 
Nt5e 5' nucleotidase, ecto CD73 F: 5’- TCCCGCGGCTGCTACGGCACCCAAGTG-3’ 
R: 5’- ACCTTGGTGAAGAGCCGGGCCACGCCG-3’ 
62 204 Alraies A 
(Cardiff University) 
Thy1 Thy-1 cell surface antigen CD90 F: 5’- CCTGACCCGAGAGAAGAA-3’ 
R: 5’- TGAAGTTGGCTAGAGTAAGGA-3’ 
55 125 Sigma-Aldrich, Inc 
Eng Endoglin CD105 F: 5’- CGGTCTCCAGCTGCGGTGGTGGGCTCC -3’ 
R: 5’- CACTGCCACCACGGGCTCCCGCTTGCT-3’ 
62 896 Lee CP 
(Cardiff University) 
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Table 2.3: qPCR primer sequences for quantification of gene marker expression during culture expansion. 
 
Official 
Symbol 
Official Full Name Synonym Primer Sequence Annealing 
Temperature 
oC 
Product 
Length 
bp 
Designer 
Actb Actin, beta β-Actin F: 5’-TGAAGATCAAGATCATTGCTCCTCC-3’ 
R: 5’-CTAGAAGCATTTGCGGTGGACGATG-3’ 
55 108 Sigma-Aldrich, 
Inc 
Mcam Melanoma cell adhesion molecule CD146 F: 5’-TTCACAAGGAGAGGCAGATA-3’ 
R: 5’-TTGCTCTTACACAGGAACATC-3’ 
55 163 Sigma-Aldrich, 
Inc 
Msx2 Msh homeobox 2 MSX2 F: 5’-CTTACAGAAACCCAGGTCAAA-3’ 
R: 5’-AGCACAGGTCTATGGAAGG-3’ 
55 200 Sigma-Aldrich, 
Inc 
Vcam1 Vascular cell adhesion molecule 1 CD106 F: 5’-GAGACTTGAAATGCCTGTGAA-3’ 
R: 5’-CAATCTGAGCGAGCGTTT-3’ 
55 128 Sigma-Aldrich, 
Inc 
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Table 2.4: Adipogenic qPCR primer sequences for quantification of gene marker expression. 
 
Official 
Symbol 
Official Full Name Synonym Primer Sequence Annealing 
Temperature 
oC 
Product 
Length 
bp 
Designer 
Actb Actin, beta β-Actin F: 5’-TGAAGATCAAGATCATTGCTCCTCC-3’ 
R: 5’-CTAGAAGCATTTGCGGTGGACGATG-3’ 
55 108 Sigma-Aldrich, 
Inc 
Adipoq Adiponectin, C1Q and collagen 
domain containing 
Adiponectin F: 5’-GAATCATTATGACGGCAGCAC-3’ 
R: 5’-CTTGGAGCCAGACTTGGTCTC-3’ 
55 224 (Ding et al., 
2013) 
Cebpa CCAAT/enhancer binding protein 
(C/EBP), alpha 
C/EBPα F: 5’-GGGAGAACTCTAACTCCCCCAT-3’ 
R: 5’-CTCTGGAGGTGGCTGCTCATC-3’ 
55 82 Unknown 
Cfd Complement factor D Adipsin F: 5’-CCGATGTCCTGCAGCAACT-3’ 
R: 5’-GTCCCTGCGGTTGCTCTCT-3’ 
55 119 (Searfoss et al., 
2003) 
Fabp4 Fatty acid binding protein 4, 
adipocyte 
FABP4 F: 5’-GGAATTCGATGAAATCACCCC-3’ 
R: 5’-TGGTCGACTTTCCATCCCACT-3’ 
55 104 (Georgiou et al., 
2012) 
Lpl Lipoprotein lipase LPL F: 5’-AGGTCAGAGCCAAGAGAAGCA-3’ 
R: 5’-GGAGTAGGTTTTATTTGTGGCG-3’ 
55 215 (Li et al., 2012) 
Pparg Peroxisome proliferator-activated 
receptor gamma 
PPARγ F: 5’-GGAAGCCCTTTGGTGACTTTATGG-3’ 
R: 5’-GCAGCAGGTTGTCTTGGATGTC-3’ 
55 174 (Ji et al., 2009) 
6
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Table 2.5: Osteogenic end-point detection and quantitative PCR primer sequences for gene marker expression. 
 
Official 
Symbol 
Official Full Name Synonym Primer Sequence Annealing 
Temperature 
oC 
Product 
Length 
bp 
Designer 
Actb Actin, beta β-Actin F: 5’-TGAAGATCAAGATCATTGCTCCTCC-3’ 
R: 5’-CTAGAAGCATTTGCGGTGGACGATG-3’ 
55 108 Sigma-Aldrich, 
Inc 
Bglap Bone gamma-
carboxyglutamate (gla) protein 
Osteocalcin F: 5’-AAGCCCAGCGACTCTGAGTCT-3’ 
R: 5’-CCGGAGTCTATTCACCACCTTACT-3’ 
55 75 (Korkalainen et 
al., 2009) 
Ibsp Integrin-binding sialoprotein BSP F: 5’-CAGAAAGAGCAGCACGGTTG-3’ 
R: 5’-CCTCGTAGCCTTCATAGCCA-3’ 
55 173 (Li et al., 2012) 
Runx2 Runt-related transcription 
factor 2 
Cbfa1 F: 5’-GCCACCTTCACTTACACCCC-3’ 
R: 5’-CGCTGACGAAGTACCATAGTAGAG-3’ 
55 (end-point) 171 (Li et al., 2012) 
Sp7 Sp7 transcription factor Osterix F: 5’-GCTTTTCTGTGGCAAGAGGTTC-3’ 
R: 5’-CTGATGTTTGCTCAAGTGGTCG-3’ 
55 (end-point) 136 (Georgiou et al., 
2012) 
Sparc Secreted protein, acidic, 
cysteines-rich 
Osteonectin F: 5’-CCTGTGGAGCTGCTGGCCCGAGACTTTG -3’ 
R: 5’-CAGTGGGGCCAGCTCCGTGTGGGACAGGTA-3’ 
55 132 (Suzuki et al., 
2002) 
Spp1 Secreted phosphoprotein 1 Osteopontin F: 5’-TCCAAGGAGTATAAGCAGAGGGCCA-3’ 
R: 5’-CTCTTAGGGTCTAGGACTAGCTTGT-3’ 
55 200 (Kawashima et 
al., 1999) 
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Chapter 3 
Characterisation of Bone Marrow and Dental Pulp Mesenchymal 
Stromal Cell Clones 
 
3.1 Introduction 
Over the past few decades there has been increasing focus upon autologous 
adult mesenchymal progenitor stromal cells for use in tissue engineering and 
regenerative medicine, from sources such as bone marrow (Pittenger et al., 
1999), dental pulp (Zhang et al., 2006), adipose tissue (Zuk et al., 2002), 
cartilage (Peng et al., 2008), muscle (Jackson et al., 2011) and umbilical cord 
blood (Zhang et al., 2011), due to their multi-potent differentiation ability along 
adipogenic, chondrogenic and osteogenic lineages. Since their isolation from 
bone marrow stroma (Friedenstein et al., 1976), bone marrow stromal cell 
(BMSC) progenitors have become the “gold” standard source for tissue 
engineering applications, and comparison of other mesenchymal sources 
(Prockop, 1997). Owing to morbidity associated with their collection and low 
cell-harvest, however, alternative sources have been sought (Huang et al., 
2009). Dental pulp stromal cell (DPSC) progenitors are a proposed alternative 
source of mesenchymal progenitors due to their self-renewing capacity, 
displayed high clonogenicity and proliferation, and similar immuno-phenotype 
compared to BMSCs (Gronthos et al., 2000). In addition, DPSCs displayed 
capacity for multi-lineage differentiation potential (Gronthos et al., 2002). The 
focus, in this chapter, is to assess how the standard BMSC and alternative 
DPSC tissue sources compare, and how they can contribute to bone-tissue 
regeneration, specifically for the orofacial region due to congenital abnormality 
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and following trauma or tumor resection, which is an unmet clinical need (as 
reviewed (Mao and Prockop, 2012)). 
 
As with BMSCs (Gronthos et al., 2003), DPSC colonies can be isolated and 
propagated at a clonal level, albeit limitedly. DPSCs displayed heterogeneity 
in their proliferative abilities, with 80% having displayed less than 20 population 
doublings, and only a limited number of clones successfully propagated to 
more than twenty population doublings for characterisation; of which only 67% 
were capable of abundant ectopic dentin formation (Gronthos et al., 2002). 
Bone marrow tissue is also heterogeneous in nature, with high proliferation 
and multipotential differentiation displayed by an unidentifiable phenotype-
subset of BMSC progenitor clones, while other clones are lineage restricted 
(Satomura et al., 2000). Likewise, BMSCs displayed less than 20 population 
doublings in 83% of clones, and 54% of which form mineralised bone tissue 
(Gronthos et al., 2003). Such clonogenic features, could identify a “pure” 
population of mesenchymal stromal cell progenitors and lead to 
characterisation, by way of a favorable “fingerprint”, which thus far remains 
elusive (Bianco et al., 2001). Such heterogeneity amongst stromal cell clones 
highlights the hierarchical nature of stem cells and progenitors, in adult somatic 
tissues: within this model, clones that form large colonies are closely related 
to the mother stem cell and could be considered as multipotent progenitor 
cells, and clones that form smaller colonies are further-down the stem cell 
hierarchy and could be considered as lineage-restricted transit-amplifying (TA) 
cells (Chan et al., 2004) (see Chapter 1, figure 1.1). Clonal analysis is 
paramount, due to mesenchymal stromal cell (MSC) population heterogeneity 
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that suggests only 20-30% of the total cell population is truly multipotent, with 
the remaining population representing bi- or uni- potential, which are non-
distinguishable by morphology or MSC marker expression (Abdallah and 
Kassem, 2012). Further, heterogeneous MSC populations from the bone 
marrow and dental pulp displayed very similar immuno-phenotypes (Huang et 
al., 2009) and only a few differentially expressed genes out of 4000 (Shi et al., 
2001), which underlines need for analysis of tissue sources at a clonal level. 
 
Isolation of MSC clones, for the majority, is accomplished by plastic 
adherence, as defined by the minimal criteria of mesenchymal stem cells 
(Dominici et al., 2006). Alternative techniques, however, use isolation on the 
basis of cell-surface markers, but showed cells with similar capabilities 
(Gronthos et al., 2003). Within this thesis, fibronectin adherence was used to 
select for stem cells progenitors expressing the α5/β1 integrin receptor 
(Dowthwaite et al., 2004), which were highly clonogenic and proliferative, 
compared to lower-expression by transit-amplifying cells (Jones and Watt, 
1993). This has led to successful isolation of clones at a high efficiency, 
following protocol optimisation, and lends reliability of such a technique for 
analysis of clones from homogeneous tissue sources. 
 
This research chapter focus and aims are to compare the stem cell 
characteristics of BMSCs against DPSCs using clonal populations, rather than 
whole tissue, so as to better characterise and phenotype these progenitor 
tissue sources: analysing clonogenicity by colony forming efficiency (CFE), 
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proliferation by population doubling level (PDL), and cell-surface marker 
phenotype by observing and quantifying specific marker expression. 
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3.2 Materials and Methods 
Bone marrow and dental pulp stromal cell clones were isolated from 21-28 day 
old male Wistar rats, using fibronectin adherence (see 2.1 Primary Bone 
Marrow and Dental Pulp Cell Culture). The colony forming efficiency (CFE) 
was analysed by counting colonies up to 12 days in vitro and calculated as a 
proportion of the original cell number seeded. The CFE was analysed using 
three set parameters, based on seeding density and serum concentration: 
4000 cells/cm2 in 10% serum, 2000 cells/cm2 in 20% serum, and 4000 
cells/cm2 in 20% serum. Successfully isolated clones were culture expanded 
in vitro to observe proliferation potential (see 2.2 Colony-Forming Efficiency 
and Population Doubling Level). Three progenitor clones from each tissue 
source were further analysed and characterised. Following culture expansion, 
up to approximately 40 population doublings, the six progenitor clones had 
their in vitro growth curve replicative ability analysed, by culturing and 
expanding progenitors a second time, following cryopreservation. During 
culture expansion total RNA was isolated at defined time-points (see table 2.1), 
to assess presence and maintenance of stem cells markers using end-point 
PCR and quantitative PCR (see sections 2.5 Reverse Transcription and End-
Point Polymerase Chain Reaction for Colony Clones, and 2.6 Quantitative-
Polymerase Chain Reaction of Colony Clones). In addition, cell senescence 
was monitored during culture by blue β-Galactosidase staining (see 2.4 β-
Galactosidase Stain for Cell Senescence). 
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3.3 Results 
3.3.1 Progenitor Colonies from Bone Marrow and Tissues Dental Pulp  
Single-cell progenitor colonies (>32 cells) formed successfully on fibronectin 
for both tissues sources. Figure 3.1 shows typical morphological appearance 
of clonal colonies from dental pulp and bone marrow, 12 days post-seeding. 
Progenitors from both tissue types appeared healthy with haloed edges. Cells 
had a rounded appearance at the centre of the colony and a more flattened 
and spread shape at the border where the colony was expanding. Bone 
marrow formed larger cell-compact colonies harbouring higher cell numbers 
compared to dental pulp. On average, by day 12 post-isolation and seeding, 
bone marrow formed colonies with an average 3.3x103 cells, whereas dental 
pulp formed colonies <1.5x103 cells. Based on the total number of cells seeded 
and fibronectin-formed colonies at day 12, the percentage of progenitor cells 
from each source was calculated as <0.0001% and <0.001% for bone marrow 
and dental pulp (n=3), respectively. 
  
 
 
 
A B 
Figure 3.1:  Representative phase micrographs of high-density colony for dental pulp (A) and bone marrow (B) mesenchymal 
progenitors 12 days post-seeding. Morphological appearance of progenitors appeared healthy with haloed edges. Cells had a 
rounded appearance at the centre of the colony, and a more flattened and spread-shape at the border where the colony was 
expanding. 
7
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3.3.2 Colony-Forming Efficiency of Bone Marrow and Dental Pulp 
Progenitors 
The overall average colony forming efficiency (CFE) of dental pulp progenitors 
was twelve times greater than bone marrow progenitors over the twelve-day 
culture period (figure 3.2). At the three seeding densities and serum 
concentrations set, dental pulp formed higher colony numbers compared to 
bone marrow. Optimal colony formation occurred when cells were seeded at 
4000 cells/cm2 in 20% serum. At 4000 cells/cm2 in 10% serum the bone 
marrow failed to form any colonies. Using the optimal seeding density and 
serum concentration, the CFE of dental pulp and bone marrow, was 
0.088±0.033 and 0.007±0.006 at day 12 (n=3), respectively (figure 3.2). 
The statistical analysis of CFE for bone marrow and dental pulp tissue during 
twelve-day in vitro culture following isolations is detailed in figure 3.3 (see 
legend). No significant differences existed between bone marrow for all cell 
seeding density and serum concentration parameters set. Only by day 10, did 
the CFE of dental pulp progenitors become significantly higher than bone 
marrow progenitors (P<0.05), which became extremely significant by day 12 
(P<0.001). Likewise, only by and after 10 days culture was a significant 
difference (P<0.05) between dental pulp progenitor parameters evident, which 
became extremely significant by day 12 (P<0.001) (figure 3.3). As such, a 12 
day culture period is required to achieve maximum CFE. 
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Figure 3.2: The colony forming efficiency (CFE) of bone marrow and dental pulp tissue isolations during twelve-day in vitro 
culture. Dental pulp progenitors formed more colonies compared to bone marrow progenitors and the overall average CFE of 
dental pulp was thirteen times greater than bone marrow across twelve-days culture for each parameter set: 4x103 cells/cm2 in 
10% serum, 2x103 and 4x103 cells/cm2 in 20% serum. For bone marrow seeded at 4000 cells/cm2 in 10% serum, colonies failed 
to form. The optimal CFE occurred at 4000 cells/cm2 in 20% serum. Statistical analysis in figure 3.3. 7
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Figure 3.3: Statistical analysis of colony forming efficiency of bone marrow and dental pulp tissue isolations during twelve-day 
in vitro culture. By day 12, the CFE of dental pulp progenitors seeded at 4x103 cells/cm2 in 20% serum, was significantly 
(P<0.001) higher than bone marrow progenitors at 3, 6, 10 and 12 days seeded at 2x103 cells/cm2 and 4x103 cells/cm2 in 20% 
serum. In addition, by day 12, the CFE of dental pulp progenitors seeded at 4x103 cells/cm2 in 20% serum, was significantly 
(P<0.05) higher than dental pulp progenitors at all seeding and serum concentrations on days 3 and 6, and significantly 
(P<0.001) higher than 4x103 cells/cm2 in 10% serum and 2x103 cells/cm2 in 20% serum on days 10 and 12. * = P<0.05, ** = 
P<0.01, *** = P<0.001. na, no colonies. 7
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3.3.3 Population Doubling of Bone Marrow and Dental Pulp Progenitor 
Clones 
Once isolated the bone marrow and dental pulp clones were culture expanded 
and population doubling levels (PDLs) were recorded (figure 3.4 and 3.5). The 
isolation of bone marrow clones was initially more successful than dental pulp, 
with ~54% of bone marrow clones successfully propagated, as opposed to 
<10% of dental pulp clones. Each growth line represents a progenitor clone 
and each symbol a passage point, with a total eight BMSC clones isolated, 
and a total ten DPSC clones. Whereas DPSCs had a higher colony forming 
efficiency, the population doubling level of DPSC clones was on average 1.5 
times slower than BMSCs. In addition, the population doubling levels of 
DPSCs was more variable compared to BMSCs. The fastest proliferating clone 
for bone marrow was progenitor BM 1.4 that reached PDL 42 by 96 days, and 
the slowest was BM 1.2 that reached PDL 36 by 174 days, with clones 
achieving PDL 40 within an approximate 84 day range (figure 3.4). For DPSCs, 
the fastest proliferating clone was DP A4 that reached PDL 41 by 114 days, 
and the slowest was DP C5 that reached PDL 41 by 245 days, with all clones 
achieving PDL 40 within an approximate 131 day range (figure 3.5). To note, 
isolated clonal BMSCs are capable of up to 61 PDLs in 149 days (figure 3.6). 
An additional two clones, BM 2.1 and BM 2.6, were allowed to propagate 
further before cryopreservation, and achieved PDL 65 in 189 days and PDL 
54 in 145 days, respectively. Speculatively, if allowed to propagate, all other 
isolated clones would have probably reached this higher PDL, as none showed 
signs of decreased PDL or senescence (figure 3.7). Most clones, however, 
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were halted in culture upon achieving a PDL of 40, as progenitors of primitive 
age was desirable to use for analysis herein. 
All clones appeared to go through a period of plateau between days 40 and 
163, but following this period, clones continued to increase their population 
doubling level. During culture, clones remained healthy (figure 3.7A), however, 
for clones that displayed an intermittent plateau of PDL <0.5 a week, a β-
galactosidase stain (figure 3.7B) was conducted and levels were determined 
as <2% of the total population. Lack of staining excluded the possibility of 
senescence, particularly as population doubling levels proceeded to increase 
following plateau (figures 3.4 and 3.5). 
Once a minimum of 1.3x106 cells was achieved, each progenitor clone was 
cryopreserved for later use. Following highlight of such an intriguing feature of 
plateau growth patterns, the reproducibility of progenitor proliferation profiles 
was analysed. Three clones from each tissue source were chosen and were 
additionally propagated to establish a second proliferation curve, for 
comparison to the initial PDL growth curve. The progenitor clones (within this 
thesis these six clones were analysed herein, see table 2.1), were thawed 
following cryopreservation. Progenitor clones from bone marrow (figure 3.8) 
and dental pulp (figure 3.9) displayed remarkably similar proliferation curves 
following cryopreservation compared to their original proliferation curve 
following isolation. Progenitor clone DP F2, produced a virtually identical 
second PDL growth curve as for the initial PDL profile. While, the second PDL 
for progenitor clones BM 1.4, BM 3.1, and DP E11, produced a strikingly similar 
growth curve that mirrored the initial PDL achieved, albeit at a somewhat lower 
rate. Interestingly, the second PDL growth profile for progenitor clone DP 2.7, 
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followed an almost identical growth profile from the beginning of the second 
PDL curve at day 132 until day 155, after which point the second PDL curve 
proceeded as other clones at a mirrored lower rate. For progenitor clone BM 
2.6, however, the second PDL overtook the initial PDL growth profile following 
intersection at day 97, and thereafter proceeded at a rate above the original, 
reaching PDL 40 by 136 days compared to PDL 39 by 145 days for the initial 
PDL. Nevertheless, over the 66 day period, the second growth curves 
reproduced, only deviated by 15% from the initial PDL growth profile. In 
essence, for every clone from each tissue source, both PDL growth profiles 
were very similar and lends support to culture conditions’ reproducibility and 
efficiency for cell maintenance, following generation of sufficient cell numbers 
for cryopreservation.  
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A B 
Figure 3.7: Representative micrographs of a typical progenitor clone (A) and after β-galactosidase staining (B). β-galactosidase 
staining was weak and <2% of progenitor populations. This excluded cell senescence during population doubling plateau in 
clones, which displayed a PDL of <0.5 per week (see figures 3.4 and 3.5). β-galactosidase was seen as blue staining within 
cells (arrows in B). 
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Figure 3.8: Progenitor clones BM 1.4, BM 2.6, and BM 3.1 during in vitro culture expansion displayed strikingly similar 
proliferation curves following cryopreservation for 20 months, 12 months, and 1 month, respectively. The two PDL profiles shown 
are: following isolation and continual primary culture up to ~40 PDLs (blue), and the same clone having been cryopreserved, 
thawed, and re-seeded in standard culture conditions (red). BM 1.4, first PDL was 42 in 96 days and second PDL was 42 in 
101 days, cultured from day 35. BM 2.6, first PDL was 40 in 136 days and second PDL was 41 in 148 days, cultured from day 
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Figure 3.8: Progenitor clones DP 2.7, DP E11, and DP F2 during in vitro culture expansion displayed strikingly similar 
proliferation curves following cryopreservation for 5 months, 18 days, and 10 days, respectively. The two PDL profiles shown 
are: following isolation and continual primary culture up to ~40 PDLs (blue), and the same clone having been cryopreserved, 
thawed, and re-seeded in standard culture conditions (red). DP 2.7, first PDL was 42 in 189 days and second PDL was 42 in 
192 days, cultured from day 128. DP E11, first PDL was 42 in 224 days and second PDL was 40 in 224 days, cultured from day 
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3.3.4 Culture Expansion Morphology 
Micrographs of all six progenitor clones was qualitatively assessed visually, 
during in vitro culture at earliest, mid, late, and later PDL time points (see table 
2.1). For bone marrow and dental pulp progenitors, representative 
micrographs showed that at the four defined time-points, during the period of 
forty PDLs in culture, the morphological appearance of clones remained 
unchanged. Progenitor clones maintained their individual cell-pattern, with 
clearly distinguished nuclei, cell bodies and borders. Bone marrow progenitor 
clones had a characteristic cobble-stone appearance and were similar to each 
other (figure 3.14). Dental pulp progenitor clones DP 2.7 and DP E11, had a 
more stellate characteristic, while DP F2 displayed a rather dendritic 
appearance (figure 3.15). 
 
  
Figure 3.14: Representative micrographs of bone marrow clone progenitors during in vitro culture at earliest, mid, late, and later 
PDL time points. For the period of forty PDLs in culture, the morphological appearance of clones remained unchanged with 
clearly distinguished nuclei, cell bodies and borders (see main text for details). Scale bar, 100µm. 87
 
  
Figure 3.15: Representative micrographs of dental pulp clone progenitors during in vitro culture at earliest, mid, late, and later 
PDL time points. For the period of forty PDLs in culture, the morphological appearance of clones remained unchanged with 
clearly distinguished nuclei, cell bodies and borders (see main text for details). Scale bar, 100µm. 88
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3.3.5 End-point PCR Gene Expression Levels of Bone Marrow and Dental 
Pulp Progenitor Clones 
During culture-expansion, for the three clones from each tissue source, total 
RNA was extracted and end-point PCR conducted to establish gene marker 
expression, at four defined population doubling levels (see table 2.1). Due to 
limitations, end-point PCR was used as a product absence/presence 
technique to establish gene marker expression before proceeding with 
quantitative-PCR. The reference gene used was β-actin for 35 cycles, 
following amplification cycle increments to identify the geometric exponential 
phase (very specific reaction efficiency), as a rationale to decrease band-
intensity variability and increase band precision (figure 3.16, yellow box). End-
point PCR revealed that β-actin reference gene remained consistent during in 
vitro culture expansion over 40 population doubling levels, and absence of 
hematopoietic marker, PTPRC (CD45) (figure 3.16). 
For defined mesenchymal stem cells, the minimal criteria triplicate markers 
CD73, CD90 and CD105, were present in all clonal progenitors over their 
culture period. FGFR1 and MSX2 markers, appeared to be consistently 
expressed during culture. Likewise, Snai1 and Nanog, was expressed by all 
progenitors from both tissue sources during culture. VCAM1 and MCAM 
markers displayed the most variability over the four defined PDLs, as-well-as 
different intensities between tissue sources, and between clones from the 
same tissue source. For example, clones BM 3.1, DP E11, and DP F2, showed 
no band for VCAM1. A second example marker, MCAM, was absent for clone 
DP F2, and displayed different intensities at the four PDLs for clones DP 2.7 
and DP E11, while all three bone marrow clones appeared consistent. The 
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only marker that seemed the exception between tissue sources was SOX2, 
with all three bone marrow progenitor clones showing a band, which was 
absent in all three dental pulp progenitor clones. 
 
  
Figure 3.16: Collated end-point PCR of gene marker expression for bone marrow and dental pulp progenitor clones at defined 
in vitro PDLs. Reference marker β-actin was consistently expressed throughout culture and haematopoietic marker CD45 was 
negative. Minimal-defined MSC triplicate markers CD73, CD90, and CD105 were consistently expressed. Other markers varied 
in banding intensity e.g. VCAM1 and MCAM, and as such qPCR analysis was subsequently conducted (see figures 3.18-3.19). 
For β-actin, a band first appeared at cycle 35 (yellow box), which indicated geometric phase of PCR (increased band intensity 
precision). Earliest PDL, 7-12; Mid PDL, 16-20; Late PDL, 30-33; and Later PDL, 41-44 (see table 2.1). Spleen positive control. 91
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3.3.6 qPCR Gene Expression Levels of Bone Marrow and Dental Pulp 
Progenitor Clones 
Within this chapter, for each progenitor clone, the gene expression levels were 
quantified by consistently setting the same Ct (cross threshold) value within 
the geometric phase for the β-actin reference gene, against which genes of 
interest were compared as a percentage. In addition, only those genes with a 
dissociation curve peak at a single melting temperature was considered as 
specific expression for analysis. Using relative quantification, bar graphs 
represented gene expression levels as a percentage of reference gene β-actin 
Ct value, which acted as a reliable and specific control. A cDNA dilution assay 
was conducted that proved reliability of β-actin, due to overlapping and 
proportional Ct values, and decreased cDNA band intensities (see figures 
3.17A and 3.17B). 
qPCR was analysed for the three bone marrow (figure 3.18) and three dental 
pulp (figure 3.19) progenitor clones, at population doubling levels shown in 
table 2.1. Expression of MCAM for all clones, was either extremely low or not 
present during culture expansion e.g. for BM 3.1 earliest and later PDLs MCAM 
was not detected. VCAM1 was expressed in two bone marrow clones and one 
dental pulp clone, and each gave a completely different expression pattern. 
The overall trend for MSX2, was decreased expression with in vitro culture. 
For BM 1.4 VCAM1, culture expansion to later PDL led to a significant increase 
in expression compared to earliest PDL (P<0.05) and late PDL (P<0.01). 
Culture expansion led to a significant (P<0.001) decrease in MSX2 expression 
at both late and later PDLs compared to earliest and mid PDLs. The third 
marker expression, MCAM, decreased expression at later PDL significantly 
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compared to mid PDL (P<0.05) and later PDL (P<0.01). For BM 2.6, VCAM1 
expression had a significant (P<0.001) increase at mid and late PDLs 
compared to earliest PDL, while continued culture expansion led to a 
significant (P<0.001) decrease at later PDL. MSX2 expression had a 
significant (P<0.001) decrease from earliest PDL compared to all other PDLs, 
while later PDL was expressed at a significantly (P<0.001) higher level 
compared to mid and late PDLs. MCAM marker expression had no significant 
changes due to extremely low expression levels. BM 3.1 expression of MSX2 
had an extremely significant (P<0.001) decrease in a time-dependent manner, 
from earliest PDL compared to all other PDLs. In addition, all MSX2 PDLs had 
a statistically significant (P<0.05) decrease compared to the previous PDL. 
MCAM marker expression had no significant changes due to extremely low 
expression levels, and VCAM1 was not expressed. For DP 2.7, VCAM1 
expression had a significant (P<0.001) decrease from earliest PDL compared 
to mid, late, and later PDLs. During culture expansion MSX2 expression had 
a significant (P<0.001) increase at mid PDL compared to earliest PDL, and 
compared to mid PDL, MSX2 expression significantly decreased at late PDL 
(P<0.05) and later PDL (P<0.01). MCAM marker expression had no significant 
changes due to extremely low expression levels. For DP E11, MSX2 
expression had a significant (P<0.05) decrease from earliest to mid PDL, while 
late and later PDLs displayed a non-significant increase in expression. VCAM1 
was not expressed and MCAM marker expression had no significant changes 
due to extremely low expression levels. For DP F2, MSX2 expression had a 
significant (P<0.05) increase from earliest to mid PDL, and compared to mid 
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PDL, MSX2 expression significantly decreased at late PDL (P<0.05) and later 
PDL (P<0.01). Again VCAM1 was not expressed, and neither was MCAM. 
For bone marrow progenitors, the fastest proliferating clone BM 1.4 (PDL 42 
in 96 days), expressed the highest level of MSX2 up to 4%. Clones BM 2.6 
(PDL 40 in 136 days) and BM 3.1 (PDL 42 in 128 days) had similar proliferation 
rates, but BM 2.6 MSX2 was expressed three and a half times greater than 
BM 3.1. Likewise for dental pulp progenitors, the fastest proliferating clone DP 
F2 (PDL 42 in 129 days), expressed the highest level of MSX2 up to 24%. The 
next fastest proliferating clone DP 2.7 (PDL 42 in 128 days), expressed MSX2 
up to 0.5%, and the slowest proliferating clone, of all dental pulp clones, DP 
E11 (PDL 42 in 224 days) expressed MSX2 up to 14%. Thus, each individual 
clone displayed a unique profile, with clones from the same tissue source and 
between the two tissue sources having distinct marker expressions. 
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Figure 3.17A: Reference gene β-actin cDNA dilution assay. qPCR was 
amplified at 55oC for 40 cycles, with cDNA diluted ten fold from 1:10 to 
1:1x105, for earliest, mid, late, and later PDLs. Raw Ct values overlapped 
and increased proportionally with dilution at each time-point, which 
indicated that age and dilution were not limiting factors. The RT and 
qPCR cDNA controls showed no expression. At 1:1x105 diluted cDNA 
(>30 Ct), no expression was observed. β-actin reference gene proved 
reliable. See gel products below. 
Figure 3.17B: Reference gene β-actin cDNA dilution assay products 
agarose gel. As cDNA dilution increased, the band intensity decreased. 
qPCR was amplified at 55oC for 40 cycles, with cDNA diluted ten fold 
from 1:10 to 1:1x105, for earliest (top lanes 2-6), mid (top lanes 7-11), late 
(top lanes 12-16), and later (bottom lanes 2-6) PDLs. Diluted RT sample 
(bottom lanes 7-11) showed no bands. The working dilution chosen for 
analyses was 1:10. β-actin product, 108bp. 
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Figure 3.18: Bone marrow progenitor clones expression levels of MSC 
gene markers during in vitro culture expansion. VCAM1 and MSX2 gave 
unique expression profiles for each clone. VCAM1 had up- and down- 
regulation in BM 1.4 and BM 2.6, but was not expressed in BM 3.1. MSX2 
gave a general trend of decreased expression with in vitro culture. MCAM 
marker expression was extremely low and only had significance in BM 
1.4. Mean±SD. * = P<0.05, ** = P<0.01, *** = P<0.001. PDL, population 
doubling level (see table 2.1). (-) indicates not expressed. 
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Figure 3.19: Dental progenitor clones expression levels of MSC gene 
markers during in vitro culture expansion. VCAM1 and MSX2 gave 
unique expression profiles for each clone. From earliest PDL, VCAM1 
was downregulated in DP 2.7 significantly. MSX2 gave a general trend of 
decreased expression with in vitro culture. MCAM marker expression had 
no significant changes due to negligible expression levels. VCAM1 was 
not expressed by DP E11 and DP F2, and MCAM not by DP F2. 
Mean±SD. * = P<0.05, ** = P<0.01, *** = P<0.001. PDL, population 
doubling level (see table 2.1). (-) is not expressed. 
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SX  CAM 
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3.4 Discussion  
This chapter presents the first comprehensive and rigorous comparison of 
proliferative ability and quantification of MSC gene expression profiles, for 
progenitor clones from bone marrow and dental pulp tissue sources. Dental 
pulp progenitors formed fibronectin-adherent colonies at a rate on average 
twelve times greater than bone marrow. The bone marrow progenitors, 
however, proliferated approximately 1.5 times faster than dental pulp 
progenitors, and showed less variation in proliferation. Such findings shed light 
onto the cells that are contained within each tissue and highlights the stem cell 
hierarchy. Further analysis, revealed unique gene expression profiles of 
mesenchymal stem cell markers by each clone from both tissue sources, and 
elucidated that quantified MSC marker profiles are not able to identify a 
suitable and ideal progenitor clone for tissue engineering. These data lead the 
way to setting and defining culture conditions of progenitor clones for use in 
regenerative medicine. 
 
Neural crest cells contribute to the origins of dental pulp (Lumsden, 1988, Chai 
et al., 2000), and bone marrow progenitor cells (Komada et al., 2012), which 
possibly have a neuro-ectodermal relationship (Pierret et al., 2006). 
Quantitative analyses suggested that colony-forming units of dental pulp 
originate from neural crest cells entirely, whereas bone marrow composed 
57% neural crest-derived cells (Komada et al., 2012). Here, bone marrow 
progenitors formed colonies twice the size of dental pulp progenitors, and had 
a higher and less variable PDL capacity. As such, it appears that dental pulp 
are lineage-restricted stromal cells referred to as TA cells, which couples 
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proliferation and maturation (Potten and Loeffler, 1990). It has been proposed, 
large highly proliferative cell-dense colonies that are few in number, derive 
from the mother stem cell and closely-related progenitor cells, similar to 
BMSCs that displayed high proliferation and low CFE. While small colonies 
that are higher in number, derive from lineage-mature TA cells, which are 
committed to differentiate following a finite division number (see Chapter 1, 
figure 1.1) (Chan et al., 2004), similar to DPSCs that displayed a high CFE and 
lower more variable proliferation. This was akin to fibroblastic large colonies 
that possessed a high proliferation capacity compared to slow-replicating cells 
that formed small colonies (Smith et al., 1978). As such, the progenitors 
appeared to mimic their native microenvironment tissue source functions. For 
example, in vivo, resident dormant dental pulp stromal cells are proposed to 
only respond to trauma or damage (Smith et al., 1995) and so rarely divide or 
replace within the tissue, if at all. Whereas, bone marrow progenitors are 
constantly replenished from the stem cell population, due to continual bone -
turnover and -remodeling during life-span (Parfitt, 1984). 
 
Due to the heterogeneous nature of human cell populations, the vital 
recognition for examining the replicative behavior of single-cell clones, has 
long been suggested (Smith et al., 1978). The CFE of DPSCs was significantly 
greater than BMSCs, as reported by others for human (Gronthos et al., 2000) 
and rat (Alge et al., 2010), with a twelve fold difference. One reason for CFE 
differences between tissues, could be isolation and seeding of other mono-
nucleate cells within the bone marrow Histopaque preparation e.g. 
haematopoietic stem cells (HSCs), monocytes, and leukocytes. Conversely, 
 100 
Gronthos et al. (2000) state that from their unpublished observations, 
hematopoietic-free and collagenase-treated bone marrow increased the CFE 
by 10-fold to a similar level as dental pulp. Isolation and successful propagation 
of BMSCs was ~54%, which was similar to that reported using more technical 
methods on the basis of cell sorting (Gronthos et al., 2003), and BMSCs 
formed colonies twice the size as dental pulp. Such differences in colony size, 
was likely a contributing factor for the initial success in expanding and 
propagating BMSC colonies, compared to DPSCs with <10% propagated. 
Similarly, others report <20% of dental pulp clones successfully propagated 
during in vitro culture (Gronthos et al., 2002, Gronthos et al., 2003). Here, only 
two clones, DP 2.7 and DP E11, were isolated and initially propagated using a 
seeding density of 4000 cells/cm2 in 20% serum. Hence, an alternative method 
of doubling surface area was adopted for DPSC clones (Breyer et al., 2006, 
Janebodin et al., 2011) by expanding in a single well of sequential 96-, 48-, 
24-, 12-, and 6- well plates. After which point, clones were seeded at the 
normal 4x103 cells/cm2 density, having achieved sufficient cells numbers. This 
increased the success of propagated clones to ~50%, a level similar to bone 
marrow. Thus, while the fibronectin technique is simplistic, the cloning 
efficiency was very effective and has good basis to use by preferentially 
binding more primitive progenitor cells  (Jones et al., 1995, Gandarillas and 
Watt, 1997, Zhu et al., 1999), rather than lineage-mature TA cells (Adams and 
Watt, 1991, Jones and Watt, 1993). In addition, the binding of fibronectin to 
α5β1 integrin, inhibits terminal differentiation (Watt et al., 1993).  
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For the first time, these results demonstrated proliferation of clonal progenitors 
from bone marrow and dental pulp tissues over an extended period, and 
provided high through-put techniques for successful isolation and propagation 
of approximately 50% of clonal progenitors up to 40 PDLs for both tissues. 
Reports state colony clones were difficult to obtain (d'Aquino et al., 2007), and 
80% of clones propagated less than 20 PDLs for DPSCs (Gronthos et al., 
2002) and BMSCs (Gronthos et al., 2003). Discrepancies are likely due to 
different employed protocols for progenitor isolation and propagation e.g. 
enzymatic dissociation (Gronthos et al., 2000), tissue explants (Lizier et al., 
2012), extremely high-density (1x106 cells/cm2) (Kern et al., 2006), and age 
(Stenderup et al., 2003). While others observe no significant differences in 
cloning efficiency of human bone marrow progenitors from different aged 
donors (Oreffo et al., 1998, Muraglia et al., 2000). The proliferative ability of 
BMSC progenitors was less variable and on average 1.5 times greater 
compared to DPSC progenitors. This is opposed to a report using donor-
matched heterogeneous populations from rat bone marrow and dental pulp, 
which showed DPSC doubling time was significantly less and 1.5 times faster 
than BMSC (Alge et al., 2010). This observation, however, used a single rat 
and simple cell-count over three days at passage 3, unlike the extensive 
analysis with multiple animals here. Bone marrow clones proliferated a 
minimum 40 PDLs and up to 61 PDLs by passage 45, which was twice that of 
other literature reports for heterogeneous populations of <4-32 PDLs between 
7-24 passages, irrespective of specimen age (Bruder et al., 1997, Duggal and 
Brinchmann, 2011, Zhang et al., 2011, Zou et al., 2012, Jin et al., 2013). In 
relation to time, heterogeneous BMSC populations that did reach 40 PDLs 
 102 
required >200 days (Shibata et al., 2007) and up to 300-400 days in vitro 
culture (Stenderup et al., 2003), which was over twice as long as the slowest 
BMSC clone to reach 40 PDLs here. Concerning DPSCs, there are literature 
reports on the high clonogenic and proliferative nature of human molar DPSCs, 
but these were calculated from colony counts of BrdUrd incorporation over a 
twenty-four-hour period (Gronthos et al., 2000), and cell dilution assays over a 
three week period (Laino et al., 2006, d'Aquino et al., 2007), which was not a 
comparison to the culture period up to 248 days here. There are no reports 
that present long-term propagation data of heterogeneous populations to 
determine population doubling, as rigorously demonstrated here, despite 
claims of DPSC culture up to seven months with no senescence (Laino et al., 
2005, Laino et al., 2006). In addition, other reports stated heterogeneous molar 
DPSC progenitor populations achieved a PDL of 20-30 (Gronthos et al., 2002), 
and PDL of ~120 (Miura et al., 2003), but they did not explain isolation or 
calculation protocols, which highlights the lack of protocol precedent within the 
literature for culture of progenitor cells. Stem cells from human exfoliated 
deciduous teeth (SHED), are reported to be maintained for only fifteen 
passages (Lizier et al., 2012), and goes some way to elucidating the 
proliferation ability of tooth stem cells, yet was half the passage number that 
DPSC clones achieved here. Of note, inter-species differences must be 
considered, as heterogeneous populations of mouse and rat bone marrow 
progenitors were capable of 120 PDLs within ~325 days and 100 PDLs in ~350 
days, respectively, and single-cell populations, can expand for 120 and 80 
PDLs, respectively (Jiang et al., 2002). In addition, cryopreservation of bone 
marrow progenitors, up to 20 months, and dental pulp progenitors, up to 5 
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months, displayed minimal effect on progenitor clones due to their reproducible 
proliferation growth curves (Bruder et al., 1997) in αMEM supplemented 
medium (Lizier et al., 2012), which lends support to reliability of the clones’ 
growth profiles and highlights heterogeneity within total cell populations. 
 
Within the literature, reports state hallmarked cellular senescence upon halted 
proliferation, which included: mitotic cessation, stressed morphology, >50% 
positive β-galactosidase, marked up-regulation of senescent proteins (p53, 
p21, and p16), and eventual apoptosis (Bruder et al., 1997, Jin et al., 2013). 
Here, clones did not senesce and showed no signs of stressed morphology or 
high β-galactosidase over 40 PDLs. Others, however, state that cell division 
potential primarily determines in vitro life-span (Dell'Orco et al., 1974), with a 
PDL rate of <0.5 per week defined as senescent (Stephens et al., 2003), and 
as such clones here during plateau-phase would be classed senescent, which 
was not the case. Hence, the importance of studying progenitor cells at a 
single-cell clone level, to isolate the potentially distinct clonal phenotypes that 
contribute the 20-30% multipotent progenitors, within a heterogeneous 
population (Abdallah and Kassem, 2012). The majority of clones had a unique 
plateau phase before linear growth, as seen elsewhere in rodent cell-sourced 
dental pulp progenitors (Waddington et al., 2009), and during early passage, 
up to P10 (Martin-Piedra et al., 2013). Similarly here, it was following the initial 
ten passages that the majority of clones increased their cell numbers 
substantially, up to 65 PDLs, which surpasses the somatic-cell proliferative 
limitation of 50 PDLs (Hayflick, 1989). An important consideration, however, is 
that upon reaching a plateau phase, progenitor cells are widely regarded as 
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senescent, with reports basing senescence on population doubling alone 
(Zhang et al., 2011) and when it is analysed with an additional parameter e.g. 
senescence marker, explanation is still lacking due to maintenance of 
telomeres (Franco et al., 2001). Thus, the scientific community could be over-
looking cell populations. A hypothesis for this plateau-phase, is that while an 
isolated colony by definition is a single-cell derived clone (Dowthwaite et al., 
2004), the stem cell hierarchy involves mother and progenitor stem cells, 
including more lineage restricted TA cells following further cell-divisions (Chan 
et al., 2004). Mother stem and daughter progenitor cells undergo a few 
divisions (initial PDL growth phase), to produce TA cells that are eventually 
rendered terminal and do not contribute to the progenitor-population (plateau 
phase). With no contribution from TA cells, mother stem cell and daughter 
progenitor cells adapt to culture conditions and may become engaged in 
continuous mitotic events (linear-like growth phase) to produce mass 
progenitor cell-numbers. Similarly ascribed during stromal bone marrow in vitro 
culture (Mets and Verdonk, 1981, Bruder et al., 1997), based on the terminal 
differentiation theory (Martin et al., 1974).  
 
End-point PCR identified possible genes that were differentially expressed e.g. 
noticeably for VCAM1 and MCAM, which were then analysed via qPCR (see 
below). Interestingly, SOX2 was the only gene expressed by BMSC 
progenitors and not by DPSCs. Lack of expression may go some way to 
supporting the view that DPSCs are from a more mature and committed TA 
cells, compared to a more primitive bone marrow progenitor, as SOX2 is a 
critical transcription factor that regulated stem cell pluripotency (Takahashi et 
 105 
al., 2007). Overall, expression of MSC markers was much like that previously 
shown by immuno-phenotype (Gronthos et al., 2000) and microarray analysis, 
which showed >4000 genes similarly expressed between bone marrow and 
dental pulp progenitors (Shi et al., 2001). As such, gene expression 
characteristics of these tissue sources was extremely similar, and isolation of 
preferential clones by phenotype for tissue engineering, is as yet unidentifiable 
(Abdallah and Kassem, 2012). Similarly, clonal quantification of such gene 
expression, was lacking within the literature, and is reported for the first time 
within this chapter.  
The qPCR data revealed clearly distinguishable and unique profile 
“fingerprints” for each MSC clone at four defined PDLs, from both bone marrow 
and dental pulp tissue sources. VCAM1 was expressed by half of the clones, 
and likewise with MCAM, a clear expression pattern was only evident from 
qPCR compared to end-point PCR. The adhesion markers, MCAM (CD146) 
and VCAM1 (CD106), are two of the most reported MSC-phenotypes for bone 
marrow and dental pulp progenitors (Gronthos et al., 2000). Still, much is 
unknown concerning attributes of these markers to MSC progenitors. Clones 
DP 2.7 and DP E11 had negligible MCAM expression and DP F2 did not 
express MCAM, and showed 12-fold greater CFE than bone marrow. Yet, a 
report stated that MSC progenitors negative for MCAM did not form colonies, 
and that MCAM-positive progenitors contributed 96% of colonies formed (Shi 
and Gronthos, 2003). In addition, MCAM has been implicated to identify a 
progenitor perivascular niche due to localisation with blood vessel walls (Shi 
and Gronthos, 2003). As such, the clones isolated here could have identified 
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another niche within the mileu of bone marrow and dental tissues, of which 
there are a few proposed (Sloan and Waddington, 2009). 
The close relationship of VCAM1-positive MSCs with endothelium also lends 
support to a possible resident niche of MSCs being peri-vascular (Ruster et 
al., 2006). With VCAM1 suggested to be involved in cell trafficking between 
bone marrow and vasculature (Jacobsen et al., 1996). In addition, a major 
advantage of VCAM1-positive MSCs is that they modulate immune 
suppression and response, in part due to inhibition of T-cell proliferation by 
BMSCs (Di Nicola et al., 2002) and monocyte proliferation by DPSCs (Wada 
et al., 2009). Here, BM 2.6 expressed the highest VCAM1, which altered during 
culture expansion. Similarly, VCAM1 was majorly expressed by BMSCs and 
down-regulated during culture (Qian et al., 2012), which could be due to in vivo 
environment priming before extraction and isolation (Shimizu et al., 1990). As 
such, expression of VCAM1 by MSCs appears to be sensitive to the 
microenvironment in which it finds itself. In addition, the progeny of higher 
proliferative clones, over 20 PDLs, have a VCAM1-positive characteristic 
(Gronthos et al., 2003), but BM 2.6 only achieved an average-mean 
proliferation rate. 
MSX2 may act as a regulator in odontogenesis and osteogenesis (Shi et al., 
2001), as enhanced MSX2 expression stimulated cell proliferation (Liu et al., 
1999). End-point PCR showed MSX2 was consistent, but qPCR displayed 
MSX2 decrease during culture expansion, and yet proliferation rate was at its 
highest during later PDL. As such, expression of homeobox factor MSX2 may 
act to promote and facilitate proliferation of progenitors, when required during 
in vitro culture. Similarly as VCAM1, MSX2 expression appeared dependent 
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on microenvironment cues, and thus MSC marker quantification will probably 
not highlight an “ideal” progenitor for tissue engineering that is highly 
proliferative and multipotent (see next  chapter). 
 
In summary, bone marrow and dental pulp tissues can be acknowledged as 
heterogeneous populations, as displayed by unique growth profiles of single-
cell derived colony clones. Isolating single colony clones on the basis of their 
β1 integrin receptor expression by fibronectin-adherence provided a reliable 
technique for progenitor cell isolation, with high colony formation and 
proliferation. While others report that isolated clones have limited proliferation 
capacity, with 80% of clones with a PDL of <20 (Gronthos et al., 2002), bone 
marrow clones here displayed higher proliferation rates and less variable 
growth patterns compared to dental pulp clones. Such shorter culture time 
combined with generation of sufficient population cell numbers, is beneficial 
for clinical applications (Jin et al., 2013). In addition, continued propagation 
following plateau, led to linear-like growth phase, and underlined that 
progenitor populations could be being overlooked by the scientific community. 
As such, rigorous and combined methodology is lacking in the literature for 
successful isolation of clonal populations from bone marrow and dental pulp 
tissues. From phenotypic MSC gene expression, the SOX2 marker appeared 
beneficial in highlighting preferential clones for isolation. To better understand 
the cell-phenotypes of these tissues, more research is required at a single-cell 
clone level if they are to be successfully applied within translational medicine.  
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Chapter 4 
Differentiation Capacity of Bone Marrow and Dental Pulp Mesenchymal 
Stromal Cell Clones 
 
4.1 Introduction 
A critical criterion in the characterisation and utilisation of MSCs in tissue 
engineering is the multi-differentiation potential. The whole cell population of 
bone marrow and dental pulp tissues are relatively heterogeneous, and clonal 
analysis suggested only 20-30% of the total cell population was truly 
multipotent and the remaining population represents bi- or uni- potential, 
despite the identical expression of MSC markers (Abdallah and Kassem, 
2012). Tri-differentiation capacity of MSC heterogeneous populations along 
adipogenic, chondrogenic, and osteogenic lineages was reported in human 
bone marrow (Pittenger et al., 1999, Zhang et al., 2011), rodent dental pulp 
(Janebodin et al., 2011) and human dental pulp (Zhang et al., 2006). While 
BMSC clones have proved pluripotent in their differentiation ability (Jiang et 
al., 2002), individual DPSC clones have thus far not been reported multipotent 
(Gronthos et al., 2000, Gronthos et al., 2002). 
 
Human bone marrow sheds light on the nature of the whole cell population, as 
analysis on clonal populations revealed their tri-potent capacity, with all clones 
being osteogenic, and simultaneously being 80% adipogenic, and 30% 
chondrogenic (Pittenger et al., 1999). Individual multipotent colony clones 
reported by Pittenger et al., (1999) are opposed to the notion of bone marrow 
tissue harboring several committed progenitor cell-types each forming bone, 
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cartilage, and adipose tissues (Dennis and Caplan, 1996a). The study of clonal 
and heterogeneous populations is important for regenerative medicine, to best 
understand tissue and cell source efficacy for mineralised clinical applications, 
such as bone repair and tooth caries (Dennis and Caplan, 1996b). Elsewhere, 
17% of primary human BMSC clones are reported tri-potent, with 80% as 
chondro-osteogenic, and 3% as osteogenic only, with no other uni- or bi-potent 
combination clones observed, which may indicate a hierarchical differentiation 
pathway, with tri-potent cells considered early progenitor MSCs that 
sequentially lose lineage potential to render osteogenic progenitors only 
(Muraglia et al., 2000). Others have attempted to isolate a preferential 
progenitor population for differentiation based on STRO-1+/VCAM1+ cells, 
however, tri-lineage capacity was limited to clones at 20 PDLs, with clones >25 
PDLs displaying differentiation inability (Gronthos et al., 2003). No reports, 
however, compare tri-lineage differentiation of clonal populations from bone 
marrow and dental pulp simultaneously, and within this chapter is the first 
presentation of such data. 
 
Within this research chapter, the focus and aims are to simultaneously assess 
adipo-chondro-osteogenic differentiation capacity of three BMSC and three 
DPSC clonal populations (characterised in Chapter 3), and relate ability to their 
potential stem cell hierarchy, in order to compare efficacy of bone marrow and 
an alternative dental pulp progenitor source for use in tissue engineering 
applications. Differentiation capacity was analysed by in vitro assays with 
tissue-specific staining and quantitative gene-expression markers.
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4.2 Materials and Methods 
The differentiation potential of three clonal populations from bone marrow and 
dental pulp at mid PDL (see table 2.1) was investigated, each for three 
lineages: adipocytes, chondrocytes, and osteoblasts. Briefly, each clone for 
adipogenesis was seeded at 10x103/cm2 until >95% confluent and exposed to 
dexamethasone, 3-isobutyl-1-methylxanthine (IBMX), insulin, and 
indomethacin for 21 days (see 2.7.1 Adipogenic Differentiation Media). On day 
21, total RNA was extracted for adipose-specific gene expression analysis 
(table 2.4) by qPCR (see 2.7.2 Adipogenic Differentiation Marker Expression 
Analysis), and presence of neutral lipids was assessed using LipidTOXTM stain 
(2.7.3 Adipogenic Differentiation Neutral Lipid Detection). For chondrogenesis, 
2.5x105 clonal cells were exposed to StemMACS ChondroDiff Media (Miltenyi 
Biotech Ltd.) as per manufacturer protocol for 24 days (see 2.7.4 
Chondrogenic Differentiation Media). Formed pellets were sectioned by 
microtomy (see 2.7.5 Chondrogenic Differentiation Pellet Tissue Histology) 
and assessed for: haematoxylin and eosin staining, and collagen II synthesis 
by immunolocalisation (mouse CIIC1) (see 2.7.6 Chondrogenic Differentiation 
Immunohistological Analysis). For osteogenesis, clones were seeded at 
4x103/cm2 for 5 days and exposed to dexamethasone and β-glycerophosphate 
(see 2.7.7 Osteogenic Differentiation Media) for 23 days. On day 23, total RNA 
was extracted and analysed for osteogenic-specific gene expression (table 
2.5) by qPCR (see 2.6  Quantitative-Polymerase Chain Reaction of Colony 
Clones), and in addition was assessed for calcium deposition by alizarin red 
stain (see 2.7.9 Osteogenic Differentiation Alizarin Red Staining), and 
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osteopontin (P-18) protein production by immunolocalisation (see 2.7.10 
Osteogenic Differentiation Immunocytochemistry). 
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4.3 Results  
4.3.1 Adipogenic Differentiation of Characterised Progenitor Clones  
Adipogenesis was successful in all three bone marrow clones (figures 4.1) and 
DP 2.7 clone, but not in DP E11 and DP F2 clones (figure 4.2). Adipocytes 
were seen to form intra-cellular lipid vesicles, which was confirmed by 
presence of neutral lipids using LipidTOXTM fluorescent stain (figure 4.3), but 
was absent in non-adipogenic dental pulp clones. An adipocyte morphology of 
intracellular lipid vesicles was apparent for all adipogenic clones by day 7, and 
adipocytes increased in number and size by day 21 with concomitant increase 
in lipid vesicle size. BM 1.4 adipocytes observed very small lipid vesicles, some 
of which increased considerably by day 21 to large lipid vesicles. BM 2.6 
adipocytes had small to medium size lipid vesicles and increased uniformly in 
adipocyte number by day 21. BM 3.1 adipocytes had small lipid vesicles, which 
increased substantially over 21 days to extremely large lipid vesicles. Although 
BM 1.4 had several larger lipid vesicles by day 21, they were not as numerous 
as BM 3.1. For DP 2.7, a single adipocyte with a few very small lipid vesicles 
was observed on day 7, which increased to a few adipocytes with medium size 
lipid vesicles by day 21. Morphology of all clones in non-adipogenic medium 
remained unchanged over the 21 days and only observed more compact cells 
due to proliferation (figures 4.1 and 4.2) compared to start of differentiation 
media (not shown). 
For the three bone marrow clones, qPCR analysis revealed significant up-
regulation in five of six adipogenic markers (figure 4.4). Mature adipogenic 
genes, FABP4 and LPL, were most markedly upregulated in bone marrow 
clones, up to 200% and 100% of reference gene expression, respectively. For 
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BM 1.4 and BM 3.1, adipsin, adiponectin, and FABP4 were only expressed in 
21 day adipogenic treatment, with CEBPα and LPL showing a significant 
(P<0.001) increase in expression compared to 0- and 21- day non-adipogenic 
medium controls. BM 2.6 had expression only in 21 day adipogenic treatment, 
for adipsin, adioponectin, FABP4, and LPL. CEBPα and PPARγ did not 
significantly change, however, the expression pattern for 21 day treatment was 
of increase compared to 0- and 21- day non-adipogenic. 
DP 2.7 showed significant upregulation in two adipogenic markers, but less 
than 20% (figure 4.5). Adipogenic treatment led to a significant (P<0.001) 
increase of CEBPα compared to 0- and 21- day non-adipogenic medium. LPL 
had a significant (P<0.001) increase compared to 0-day non-adipogenic 
medium, however, 21 day non-adipogenic medium and adipogenic treatment 
showed no difference in expression between them. PPARγ was only 
expressed in 21 day adipogenic treatment. DP E11 and DP F2 clones did not 
form adipocytes and qPCR showed no discernible pattern in adipogenic gene 
expression. The reliable marker LPL, showed no upregulation. For DP E11, 
PPARγ was only present in 21 day adipogenic treatment, and DP F2 showed 
significant (P<0.001) differences in transcription factor CEBPα, but were less 
than 4% (figure 4.5). Adipsin, adiponectin and FABP4 were not expressed for 
all three dental pulp clones. 
 
 
  
 
Figure 4.1: Adipogenic differentiation of progenitor clones BM 1.4, BM 2.6, and BM 3.1, over 21 days at mid PDL. Adipogenesis 
was observed from 7 days with formation of lipid vesicles in treatment. Up to 21 days, lipid vesicles increased considerably in 
number and size. Morphology of non-adipogenic medium remained unchanged by day 21. Scale bar, 50µm (20x objective). 
1
1
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Figure 4.2: Adipogenic differentiation of progenitor clones DP 2.7, DP E11, and DP F2, over 21 days at mid PDL. In DP 2.7 
adipogenic treatment, a single adipocyte with a few very small lipid vesicles was observed on day 7, which increased to a few 
adipocytes with medium size lipid vesicles by day 21. DP E11 and F2 formed no adipocytic lipid vesicles. Morphology of non-
adipogenic medium remained unchanged by day 21. Scale bar 50µm (20x objective). 11
5
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Figure 4.3: Adipogenesis of progenitor clones BM 1.4, BM 2.6, BM 3.1, 
and DP 2.7, on day 21 at mid PDL. Green fluorescence indicated 
presence of neutral lipid vesicles in adipogenic treatment only. Non-
adipogenic medium had no lipid vesicles. DAPI nuclei stain (blue). Scale 
bar, 100µm (40x objective). 
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Figure 4.4: Bone marrow progenitor clones expression levels of adipose-
related genes following in vitro adipogenic differentiation for 21 days. The 
three BM clones expressed all six adipogenic genes analysed. At 21 days 
adipogenic treatment, FABP4 and LPL were most markedly upregulated 
up to 200% and 100%, respectively. Mean±SD. *** = P<0.001. (+) 
indicates expression in adipogenic treatment only. 
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Figure 4.5: Dental pulp progenitor clones expression levels of adipose-
related genes following in vitro adipogenic differentiation for 21 days. 
Only a maximum of three genes were expressed out of six adipogenic 
genes analysed. Only DP 2.7 adipogenic treatment formed adipocytes 
and correspondingly increased adipogenic gene expression. DP E11 and 
DP F2 failed to form adipocytes. Mean±SD. *** = P<0.001. (+) indicates 
expression in adipogenic treatment only; (-) indicates not expressed. 
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4.3.2 Chondrogenic Differentiation of Characterised Progenitor Clones  
Chondrogenic pellets were formed by all bone marrow clones (figure 4.6) and 
DP F2 only, while DP 2.7 and DP E11 did not form spherical pellets but disk-
like tissues that were not recoverable (figure 4.7). Chondrogenesis was 
evident in all bone marrow clones, with haematoxylin and eosin staining 
revealing cell-devoid areas where extracellular matrix had been produced in 
chondrogenic treatment but not in non-chondrogenic medium (figure 4.8). The 
higher cell numbers in treatment than non-chondrogenic are likely responsible 
for the production of extracellular matrix. Chondrogenic matrix was confirmed 
by cartilage marker collagen type II, which was abundant in clones BM 2.6 and 
BM 3.1 treatment, but equally present in BM 1.4 non-chondrogenic and 
chondrogenic treatment (figure 4.9). The chondrogenic pellet of DP F2 
contained mostly cells with some matrix formation visible at its centre (figure 
4.8), and collagen type II staining was minimal (figure 4.10). Isotype and 
antibody exclusion controls were negative for collagen II. 
Chondrogenic differentiation was assessed on two separate occasions, and 
the least chondrogenic clones, BM 1.4 and DP F2, failed to form pellets on one 
of these occasions. Due to the diminutive pellets formed no RNA could be 
recovered for PCR analysis. 
 
  
 
Figure 4.6: Photographs of bone marrow progenitor clones following 24 days culture in non-chondrogenic and chondrogenic 
treatment media. All clones for both non-chondrogenic and chondrogenic media formed pellets, which are encircled red. Scale 
bar (light blue), 1cm. 
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Figure 4.7: Photographs of dental pulp progenitor clones following 24 days culture in non-chondrogenic and chondrogenic 
treatment media. Formed pellets are encircled red, and chondrogenic treatment that formed a tissue-like disk only with no 
spherical pellet are encircled yellow. Scale bar (light blue), 1cm. 12
1
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Figure 4.8: Bone marrow and dental pulp progenitor clones on day 24 
chondrogenic differentiation in vitro, at mid PDL. Haematoxylin and eosin 
(H & E) staining showed a higher number of cells in chondrogenic 
treatment than non-chondrogenic medium, and chondrogenic treatment 
produced areas of extracellular matrix (white arrow-head) devoid of cells. 
  
Figure 4.9: Bone marrow progenitor clones on day 24 chondrogenic differentiation in vitro, at mid PDL. Production of collagen 
II (Col2) was seen as brown staining (black arrow-head) in all chondrogenic (Chondro) treatment, and also in non-chondrogenic 
(Non-Ch) medium for BM 1.4 (black arrow). Isotype (IgG) and exclusion (Ex) antibody controls were negative. Scale bar, 100µm. 
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Figure 4.10: Progenitor clone DP F2 on day 24 chondrogenic differentiation in vitro, at mid PDL. The non-chondrogenic (Non-
Ch) medium pellet was extremely large and approximately four times the size of the chondrogenic (Chondro) treatment pellet. 
Production of collagen II (Col2) was minimal in chondrogenic treatment, brown staining (black arrow-head). No collagen II was 
visible in non-chondrogenic. Isotype (IgG) and exclusion (Ex) antibody controls were negative. Scale bar, 100µm. 
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4.3.3 Osteogenic Differentiation of Characterised Progenitor Clones 
Osteogenesis was evident in all clones from bone marrow and dental pulp. 
The morphology majorly differed between tissues, whereby bone marrow 
clones formed spherical nodules and dental pulp formed a more diffuse 
extracellular matrix. Calcification of these laid-down matrices was confirmed 
by intense alizarin red staining (figures 4.11 and 4.12). qPCR analysis showed 
all bone marrow clones and DP 2.7 clone significantly (P<0.001) increased 
their osteopontin expression, while all other markers showed no discernible 
pattern (figures 4.13 and 4.14). Upregulation of osteopontin was confirmed by 
immuolocalisation (figures 4.15 and 4.16). While mature markers BSP and 
osteocalcin were expressed by DP E11 and DP F2, which showed the most 
diffuse and intense alizarin red stain, 23 day treatment was not significantly 
upregulated compared to 23 day non-osteogenic control. Transcription factors 
RUNX2 was detected in all bone marrow and dental pulp clones at all time-
points, while osterix was only detected in dental pulp clones at all time-points. 
For BM 1.4, levels of bone-related gene expression at 23 day osteogenic 
treatment had a significant (P<0.001) decrease in osteonectin and increase in 
osteopontin, compared to 0- and 23- day non-osteogenic medium. For BM 2.6, 
osteopontin significantly (P<0.001) increased at 23 day osteogenic treatment 
compared to 0- and 23- day non-osteogenic medium. For BM 3.1, osteopontin 
significantly (P<0.001) increased between each time-point and group, and 
osteonectin was significantly (P<0.001) higher at 23 day non-osteogenic 
medium compared to 0 day non-osteogenic and 23 day osteogenic media but 
showed no discernible pattern. 
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DP 2.7 had a significant (P<0.001) increase in osteonectin at 23 day non-
osteogenic medium and 23 day osteogenic treatment compared to 0 day non-
osteogenic, and increase in osteopontin at 23 day osteogenic treatment 
compared to 0- and 23- day non-osteogenic medium. For DP E11, BSP at 23 
day non-osteogenic and 23 day osteogenic treatment led to a significant 
(P<0.001) increase compared to 0 day non-osteogenic. Osteopontin was 
significantly (P<0.001) lower at 23 day non-osteogenic medium compared to 0 
day non-osteogenic and 23 day osteogenic media, but as with osteocalcin and 
osteonectin there was no discernible expression pattern. For DP F2, BSP was 
significantly (P<0.001) higher at 23 day non-osteogenic medium compared to 
0 day non-osteogenic and 23 day osteogenic media, osteocalcin was 
significantly (P<0.001) higher at 0 day non-osteogenic medium compared to 
23 day non-osteogenic and osteogenic media, and osteonectin was 
significantly (P<0.001) different between each time-point and group, however, 
there was no discernible gene expression patterns. 
 
 
 
 
  
Figure 4.11: At mid PDL, osteogenic differentiation of progenitor clones BM 1.4, BM 2.6, and BM 3.1, on day 23 promoted 
medium, large, and extremely large dense spherical nodules respectively (arrows). Alizarin red stained calcium deposits within 
the extracellular matrix of osteogenic treatment (arrow-head). Morphology of non-osteogenic medium for all clones remained 
unchanged with no alizarin red staining. Scale bars: 4x and 20x objectives. 
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Figure 4.12: Osteogenic differentiation of progenitor clones DP 2.7, DP E11, and DP F2, on day 23 at mid PDL, promoted dark 
and dense accumulates (arrows). Alizarin red stained diffuse calcium deposits within the extracellular matrix of osteogenic 
treatment (arrow-head). Morphology of non-osteogenic medium for all clones remained unchanged with no alizarin red staining. 
Scale bars: 4x and 20x objectives. 
1
2
8
 
 129 
 
 
 
  
 
0
100
200
300
400
BSP Osteocalcin Osteonectin Osteopontin
P
er
ce
n
ta
g
e 
o
f 
β
-A
ct
in
Day 0 23 day Non-Osteogenic 23 day Osteogenic Treatment
0
100
200
300
400
BSP Osteocalcin Osteonectin Osteopontin
P
er
ce
n
ta
g
e 
o
f 
β
-A
ct
in
Day 0 23 day Non-Osteogenic 23 day Osteogenic Treatment
0
100
200
300
400
BSP Osteocalcin Osteonectin Osteopontin
P
er
ce
n
ta
g
e 
o
f 
β
-A
ct
in
Day 0 23 day Non-Osteogenic 23 day Osteogenic Treatment
Figure 4.13: Progenitor clones BM 1.4, BM 2.6, and BM 3.1, expression 
levels of bone-related genes following in vitro osteogenic differentiation for 
23 days. Osteogenic treatment lead to a significant increase in osteopontin 
for all bone marrow clones. Osteonectin showed a significant decrease for 
BM 1.4 only, with no discernible pattern for BM 2.6 and BM 3.1. Transcription 
factor RUNX (Ru) was present all at three time-points but osterix (Ox) was 
absent (end-point PCR inset). R = RT and P = PCR internal controls. 
Mean±SD. *** = P<0.001. (-) indicates not expressed. 
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Figure 4.14: Progenitor clones DP 2.7, DP E11, and DP F2, expression 
levels of bone-related genes following in vitro osteogenic differentiation for 
23 days. Osteogenic treatment lead to a significant increase in osteonectin 
and osteopontin for DP 2.7. DP E11 and DP F2 showed no osteogenic-
treatment related gene expression patterns. Transcription factors RUNX 
(Ru) and osterix (Ox) were present all at three time-points (end-point PCR 
inset). R = RT and P = PCR internal controls. Mean±SD. *** = P<0.001. 
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Figure 4.15: Osteogenic differentiation of progenitor clones BM 1.4, BM 2.6, 
and BM 3.1, on day 23 at mid PDL. Osteopontin (OPN) production in 
osteogenic (Osteo) treatment (white arrow) was confirmed by green-FITC, 
as indicated by upregulated gene expression using qPCR. No osteopontin 
expression was seen in non-osteogenic (Non-Osteo) medium. Isotype (IgG) 
and exclusion (Ex) antibody controls were negative. Equal exposure time 
for each clone. DAPI nuclei stain (blue). Scale bar 100µm (20x objective). 
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Figure 4.16: Osteogenic differentiation of progenitor clones DP 2.7, DP 
E11, and DP F2, on day 23 at mid PDL. Osteopontin (OPN) production in 
osteogenic (Osteo) treatment (white arrow) was confirmed by green-FITC, 
as indicated by upregulated gene expression using qPCR. No osteopontin 
expression was seen in non-osteogenic (Non-Osteo) medium. Isotype (IgG) 
and exclusion (Ex) antibody controls were negative. Equal exposure time 
for each clone. DAPI nuclei stain (blue). Scale bar 100µm (20x objective). 
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4.4 Discussion 
As a continuation of the previous chapter, this chapter pioneered to 
simultaneously compare the multi-differentiation potential of clones from bone 
marrow and dental pulp tissues, in order to comprehensively characterise 
clonal variations of MSCs. All three bone marrow clones were capable of tri-
lineage differentiation i.e. adipogeneis, chondrogenesis, and osteogensis. 
Whereas, dental pulp clones where uni- or bi- potent, which highlighted clonal 
variation. Bone marrow clones formed: adipocytes with the largest lipid 
vesicles and highest adipogenic-genes expression levels, chondrogenic 
spherical pellets with extensive extracellular matrix and collagen II production, 
and calcified extracellular nodules with the highest osteopontin expression 
change. Dental pulp clone DP 2.7 was bi-potent (adipogenic and osteogenic), 
DP E11 was uni-potent (osteogenic), and DP F2 was bi-potent (chondrogenic 
and osteogenic). Dental pulp clones, however, formed the most diffuse alizarin 
red calcified extracellular matrix, and was likely due to lineage restriction, as 
underlined in chapter 3 clonal characterisation, whereby DPSCs are lower 
hierarchy TA cells and more committed compared to BMSCs that are closely 
related to the mother stem cell. In addition, in conjunction with the previous 
chapter findings, the SOX2 marker appeared beneficial in the differentiation 
capacity of BMSCs. 
 
The findings of this chapter lends support to the previous observations of the 
clones, whereby bone marrow clones are true stem cell progenitors and dental 
pulp stromal cells are more committed transit-amplifying (TA) cells. These 
results highlight that stem cells exist within a hierarchy (see Chapter 1, figure 
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1.1) (Chan et al., 2004), and that differentiation capacity was lost along the 
hierarchy to generate uni-potent osteogenic precursors (Muraglia et al., 2000). 
Dental pulp clones formed the most diffuse calcium extracellular matrix, which 
may represent precursors with osteogenic potential (Kuznetsov et al., 1997) 
due to mineralisation ability. Much debate surrounds the use of tissue clones 
vs. heterogeneous populations and none more so than concerning 
differentiation, in part due to reported limited proliferative ability of BMSC 
progenitor clones (Gronthos et al., 2003); with less than a third of the total cell 
population thought to be truly multipotent (Abdallah and Kassem, 2012). 
Dental pulp heterogeneous populations are reported to have greater multi-
potent differentiation capacity compared to clones for odontoblasts, 
chondrocytes, adipocytes, neurons, and smooth muscles (Janebodin et al., 
2011), which is opposed to bone marrow clones that display pluripotency 
(Jiang et al., 2002) and a high frequency for tri-potent differentiation (Muraglia 
et al., 2000). Lack of differentiation capacity lends support to limited potency 
of DPSC clones and possibly low numbers within the tissue, and hence for 
dental pulp sourced MSCs, a mixed heterogeneous cell population was likely 
required for multipotency. 
 
Variation in differentiation capacity of human bone marrow clones has been 
reported, with all clones undergoing osteogenesis, 80% undergoing 
adipogenesis, and 30% undergoing chondrogenesis (Pittenger et al., 1999). In 
addition, limited bi-potency in human bone marrow clones has been reported 
for chondro-osteo but not for adipo-osteo (Muraglia et al., 2000), as seen here 
in DP F2 and DP 2.7, respectively. Interestingly, decreased bone formation 
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associated with age, was suggested to be due to lower cell numbers rather 
than decreased proliferative capacity or loss of function (Stenderup et al., 
2003). Similarly, lack of multipotent differentiation capacity by DPSC clones 
could be due to proposed different progenitor populations, which were isolated 
based on neural crest marker low affinity nerve growth factor receptor 
(LANGFR) and β1 integrin expression (Sloan and Waddington, 2009), 
although both show propensity for adipogenic, chondrogenic, and osteogenic 
lineages (Waddington et al., 2009). 
 
Adipocytes are derived from multipotent MSCs (Rosen and MacDougald, 
2006). While all adipogenic clones formed multiple small lipid vacuoles 
characteristic of brown immature adipose tissue, BM 3.1 displayed large 
singular lipid vesicle sizes up to 25µm that engorged the adipocyte, which is 
characteristic of mature white adipose tissue (Saely et al., 2012). In addition, 
BM 1.4 and BM 2.6 displayed enlarging lipid droplets during adipogenic culture 
indicating maturing adipocytes that may have developed to white tissue as BM 
3.1 if allowed to differentiate longer in culture. All droplets in DP 2.7 were 
<10µm and characteristic of immature brown adipose (Silva et al., 2014). The 
most marked upregulation during adipogenesis was seen by metabolic 
markers FABP4, a vital protein for solubilisation of fatty acids, their transport 
and storage (Marr et al., 2006), and LPL that hydrolyses triglyceride 
lipoproteins to form free fatty acids (Eckel, 1989). FABP4 upregulation was 
largest in BM 3.1 clones, and could be associated with formation of largest 
vesicles (unreported). There was no significant upregulation in transcription 
factor PPARγ, which could be due to its known early expression following 
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adipogenic induction (Ayala-Sumuano et al., 2008). Transcription factor 
CEBPα played a pivotal role in terminal adipogenic differentiation and halting 
proliferation (Freytag and Geddes, 1992), and was significantly upregulated in 
clones BM 1.4, BM 3.1, DP 2.7, and DP F2, however, DP F2 did not form 
adipocytes. Adipsin is a serine protease indicated in lipid metabolism (Cook et 
al., 1987, Miner et al., 2001) and adiponectin is an adipocytokine thought to be 
involved in insulin sensitisation (Okada-Iwabu et al., 2013). Both 
aforementioned markers were only expressed in adipogenic treatment culture 
for bone marrow clones and supports these truly multipotent MSCs as having 
committed fully to adipocytes, as displayed in mature white adipose (Ronti et 
al., 2006). 
 
Chondrogenesis was successful in all BMSC clones and only DP F2 clone, as 
displayed by haematoxylin and eosin pellet morphology, and collagen type II 
expression. Collagen type II is classical of cartilage matrix (Oesser and Seifert, 
2003) and the most reliable marker of chondrocytes (Lefebvre et al., 1997). 
Cartilage was the tissue type least formed by MSCs (Pittenger et al., 1999), 
which highlighted multipotency of BMSCs and confounds their true primitive 
stem cell hierarchy. While RNA was un-obtainable for gene expression 
comparison, elsewhere immunocytochemical analysis reports that un-
stimulated DPSC and BMSC clones are negative for collagen type II (Gronthos 
et al., 2000). 
 
Progenitors from the mesenchymal lineage are responsible for forming 
osteoblasts that once fully mature undergo either apoptosis, or proceed as 
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quiescent bone-lining cells, or entombed osteocytes (Delany and Hankenson, 
2009). Osteogenic transcription factors RUNX2 and osterix are master 
regulators of osteogenic commitment, and RUNX2 was detected in all BMSC 
and DPSC clones for both non-osteogenic and osteogenic treatment cultures, 
as reported elsewhere (Gronthos et al., 2003). Expression level of RUNX2 was 
consistent during osteoblast differentiation (Mizuno and Kuboki, 2001), and 
knock-out arrested osteoblast differentiation (Ducy, 2000). The presence of 
RUNX2 was likely an indicator of a cells ability to undergo osteogenesis. 
Osterix is downstream of RUNX2 and specifically expressed by osteoblasts, 
and was essential for commitment of pre-osteoblasts to mature osteoblasts 
(Iohara et al., 2009, Zhang, 2012), which supports the notion of lineage-
restricted DPSCs as BMSCs did not express osterix. Concerning bone-
associated markers, osteopontin was present in osteoprogenitors indicating 
progenitor differentiation and was upregulated during matrix maturation (Lian 
and Stein, 1995), which was prior to BSP and subsequently osteocalcin (Liu et 
al., 1994) that bind hydroxyapatite and nucleates crystal formation (Ogata, 
2008). Osteopontin is a phosphorylated glycoprotein expressed by osteoblasts 
restricted to endosteal and periosteal bone surfaces, and had a role in 
mineralised bone formation (Chen et al., 1993, Nilsson et al., 2005). 
Conversely, osteopontin was present on cells and involved in other processes 
such as cell adhesion, migration, and survival (Sodek et al., 2000). Here, 
osteopontin was significantly upregulated in all BMSC clones and DP 2.7, and 
likely indicated these clones were more primitive and non-committed, 
compared to DP E11 and DP F2 that expressed twice as much osteopontin 
with no significant upregulation and yet the most diffuse extracellular matrix 
 138 
calcium deposition, which potentially indicated their lineage-commitment. BSP 
was reported to be expressed in pre-osteoblasts through to mineralisation 
stage, whereas osteocalcin was only seen in mature osteoblasts up to 
mineralisation after which expression was lost (Liu et al., 1994, Aubin et al., 
1995). BSP and osteocalcin were evident at day 0 in both DP E11 and DP F2 
for non-osteogenic and osteogenic treatment, which again supported the 
notion of lineage-commitment in these clones. Elsewhere, osteocalcin has 
been reported to be expressed in progenitors following a minimum of 28-35 
days in osteogenic culture (Gronthos et al., 2003), and was not upregulated 
for up to 28 days alongside non-osteogenic (Neumann et al., 2008). Likewise, 
BSP did not upregulate expression between non-osteogenic and osteogenic 
treatment, as previously reported (Janebodin et al., 2011), which may suggest 
osteogenic imprinting and restricted differentiation potential in unstimulated 
cells (Satomura et al., 2000). Indeed, DP F2 formed the densest and deepest 
alizarin red and had decreased BSP and osteocalcin in 23 day osteogenic 
treatment, likely due to completion of mineralisation phase and thus lacked 
need of said gene-expression. All bone marrow clones and DP 2.7 lacked 
osteocalcin and BSP, and was likely due to their lesser matrix maturation and 
earlier-stage mineralisation. Interestingly, osteocalcin was reportedly 
expressed by dental pulp populations and only a subset within bone marrow, 
while BSP was not expressed in dental pulp but is within a subset of bone 
marrow cells (Gronthos et al., 2000), which is opposed to expression seen 
here. As a side note, osteonectin-null mice are osteopenic and display 
decreased bone formation (Delany et al., 2000), but osteonectin is also present 
in many other tissues at sites of turnover, and injury and disease, contributing 
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to matrix organisation (Bradshaw and Sage, 2001). As such, osteonectin is 
critical in bone remodelling (Delany and Hankenson, 2009), but appears to not 
undergo predictive changes in expression during in vitro osteogenesis. 
As mentioned previously, all bone marrow clones and DP 2.7 significantly 
increased osteopontin expression, which was reported first to be expressed 
during osteoblastic differentiation and bind calcium within the matrix, and likely 
accounted for alizarin red staining, albeit binding was to a lesser extent than 
BSP (Chen et al., 1992). Conversely, osteopontin was proposed to inhibit 
hydroxyapatite formation controlling the size of crystals formed (Hunter et al., 
1996). All clones analysed underwent osteogenesis, however, dental pulp 
clones formed the most diffuse and extensive calcified extracellular matrix 
compared to bone marrow clones. The two dental pulp clones that formed the 
most calcified matrix, DP E11 and DP F2, were the only clones to express the 
mature osteogenic genes BSP and osteocalcin in non-differentiation, which 
likely underlined their committed lineage restriction without need for 
osteogenic promoting medium (Kuznetsov et al., 1997), and suggested a 
“default” osteo-differentiation pathway in confluent DPSC cultures (Janebodin 
et al., 2011), unlike the more primitive BMSC progenitor clones that required 
osteogenic-promotion for increased osteopontin gene expression and protein 
level. In addition, absence of mature osteo-markers, BSP and osteocalcin by 
DP 2.7, could be due to its lack of commitment and thus adipogenic capability. 
Thus, it is likely that DPSCs are “primed” for differentiation and gave greater 
mineralisation within the same time-period than BMSCs. This is due to their in 
vivo role whereby BMSCs are constantly remodelling bone, and DPSCs 
require a rapid-response within the tooth following damage/injury, and hence 
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these MSC cell-soucres are at different stages of and have different time-
scales for mineralisation. 
 
A consideration of in vitro studies is their limitations and that in vivo models 
offer genuine predictive tissue regenerative ability (Gronthos et al., 2003), with 
evidence that serum source significantly affected cultured cells (Zheng et al., 
2006) and their differentiation ability (Duggal and Brinchmann, 2011). In vitro 
attempts have failed to characterise and distinguish multi-potent clones based 
on cell morphology and growth rate (Kuznetsov et al., 1997, Kuznetsov et al., 
2001), and cell surface marker expression (Shi et al., 2001, Gronthos et al., 
2003). In support, the data presented within this chapter suggested that 
phenotype is likely not useful in predicting a cells’ differentiation ability, as no 
specific MSC gene marker was highlighted as beneficial to differentiation 
capacity. Others have reported isolation of multipotent DPSC progenitors from 
monopotent clones by differential expression of minimal criteria MSC marker 
CD90, where the multipotent clone expressed CD90 at <5% of the population 
(Lacerda-Pinheiro et al., 2012), which would be opposite to that expected. 
Likewise, a second minimal criteria MSC marker CD105 was shown to be 
inversely correlated with differentiation ability in umbilical cord-MSCs (Jin et 
al., 2009). Ambiguity in MCAM has also been reported, where an MCAM+ 
subpopulation of periodontal ligament MSCs showed higher proliferative 
potential and osteogenic capacity than MCAM- cells (Zhu et al., 2013), while a 
subpopulation of MCAM-/CD31- DPSCs regenerated capillary and neuronal 
networks in amputated pulp in vivo (Iohara et al., 2009). Another adhesion 
molecule VCAM1 displayed tri-lineage capacity in STRO-1+/VCAM1+ cells, but 
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was limited to clones at PDL 20, as clones >25 PDLs displayed differentiation 
inability (Gronthos et al., 2003). Interestingly, VCAM1+ BMSCs were 
preferentially adipogenic (Fukiage et al., 2008), and of the three DPSC clones 
only the VCAM1+ clone, DP 2.7, was adipogenic. Hence, VCAM1- progenitors 
could be preferable for osteogenesis, as DP E11 and DP F2 (see Chapter 3, 
figure 3.19). In addition, Msx2 was reported to prevent osteoblast 
differentiation (Dodig et al., 1999), while elsewhere Msx2 was reported to 
promote osteogenic differentiation of MSCs by enhancing Wnt signalling 
important for osteogenesis (Cheng et al., 2008). Although the most osteogenic 
clones DP E11 and DP F2 expressed the highest MSX2, MSX2 expression 
was not associated with BMSC clone osteogenic capacity. 
The only marker with any apparent relevance to differentiation capacity was 
SOX2. While SOX2 was reported to be expressed by heterogeneous DPSCs 
(Karaoz et al., 2011), single-cell populations weakly expressed (Janebodin et 
al., 2011), and here DPSC clones were negative (see Chapter 3, figure 3.16). 
This supported the notion that DPSC clones are lineage-restricted and -
committed, as DPSCs lost SOX2 upon commitment unlike Nanog (Nozaki and 
Ohura, 2011), which is a non-defining factor for pluripotency in somatic-
induced stem cells (Takahashi and Yamanaka, 2006). Nanog was expressed 
by all BMSC and DPSC clones analysed, and thus SOX2 was suggested a 
better predictor of differentiation capacity (Nozaki and Ohura, 2011). In 
addition, SOX2- DPSC clones only displayed uni- or bi-potent differentiation 
capacities, inclusive of osteogenesis. Hence, the pool of “truly” multipotent 
MSCs in dental pulp may be lower compared with bone marrow, as all BMSC 
clones expressed SOX2 and proved tri-potent differentiation.  
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To summarise, in support of the previous chapter findings, BMSC clones 
formed few and large sized colonies with a high and less varied proliferation 
rate beyond 20 PDLs, which was characteristic of cells higher in the stem cell 
hierarchy and closely related to the mother stem cell. This chapter highlighted 
high frequency and multipotent capacity of BMSC clones as a true indicator of 
their primitive stem cell nature. Whereas, in the previous chapter DPSCs 
formed many small colonies with more variable proliferation rates 
characteristic of lower stem cell hierarchy lineage committed TA cells, and in 
this chapter DPSCs displayed limited differentiation capacity with uni- and bi- 
potent clones. However, dental pulp tissue clones appear preferential for bone 
formation, and are potentially a reliable alternative source to bone marrow, 
advancing tissue engineering in pulpal regeneration and craniofacial bone 
regenerative medicine (Miura et al., 2006). 
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Chapter 5 
Influence of Bone and Tooth Matrix Extracts on Proliferation and 
Osteogenesis of Bone Marrow and Dental Pulp Mesenchymal Stromal 
Cell Clones 
 
5.1 Introduction 
The tissue regenerative capabilities of bone marrow was introduced in the 
early 1970’s, by way of so termed stromal stem cells (Patt and Maloney, 1975), 
although it was not until the early 1990’s that use of MSCs in regenerative 
medicine was conducted. In addition, the recognition of extracted bone matrix 
on osteogenesis was introduced in 1965, via a process proposed as 
“autoinduction”,  due to migration and proliferation of immature host cells into 
decalcified bone matrix implants, which formed new osteoblasts (Urist, 1965). 
This followed a report the same year that suggested organic bone matrix 
determines osteoclasis (Irving and Migliore, 1965). Then, the late 1980’s and 
early 1990’s saw use of implantable scaffolds for tissue engineering (based on 
literature report dates). Followed by use of bone mineralised-tissue protein 
extracts due to contained bioactive components e.g. BMPs (Boden, 1999). 
More recently, is the idea of de-cellularised tissue protein matrices for use in 
re-cellularisation with specific cells, to precisely control and direct 
differentiation (Hoganson et al., 2014). Thus, while several applications exist 
to promote tissue regeneration, they all involve use of cells or proteins or 
biomaterial scaffolds, and it is the view here that an ideal cell-type source 
combined with a protein scaffold, would be optimal for translational 
regenerative medicine. 
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Regarding proteins within the extracellular matrix, research as early as the 
1980’s implicated proteoglycans (PGs) and their glycosaminoglycan (GAG) 
chains in sequestration of growth factors produced within the bone marrow 
microenvironment by e.g. stromal cells, and subsequent presentation in a 
biologically active form to e.g. haematopoietic progenitor cells. The functional 
result of GAG depletion is a 50% decrease in colony-forming unit number, 
which indicates influence of GAGs on cell replication (Gordon et al., 1987). In 
addition, research on the haematopoietic environment, shows the GAG 
hyaluronan regulates cytokine production e.g. IGF-1 (involved in proliferation 
and growth-promotion) via TNFα, and IL-1β (involved in inflammation, 
proliferation, differentiation, and apoptosis) (Noble et al., 1993), which are 
likely important processes in tissue regeneration (Goncharova et al., 2012). 
Other PGs within the extracellular matrix include biglycan and decorin, and 
their GAG chains dermatan and chondroitin sulfate. These PGs are highly 
expressed and display spatially restricted gene expression patterns and 
localisation during bone (Bianco et al., 1990) and tooth development 
(Matsuura et al., 2001). Consequently, extracellular matrix proteins are no 
longer considered as a structural contribution only, but a protein that directly 
and/or indirectly influences cellular behaviour. 
 
Both bone and tooth tissues express proteins involved in mineralisation and 
calcification e.g. BSP, bone-acidic glycoprotein-75 (BAG-75) (Bronckers et al., 
1993), and more tooth-associated dentin sialoprotein/dentin phosphoprotein 
(DSP/DPP) and dentin matrix protein-1 (DMP1) (Hu et al., 2006). While 
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research has uncovered bone associated proteins that are expressed in tooth, 
there are tooth restricted proteins found within the enamel e.g. amelogenins, 
amelobastins, enamelins and tuftelins (Robey, 1996), which are proposed as 
essential in bio-mineralisation and formation of hard tissues (Lyngstadaas et 
al., 2009). 
 
In addition to the potential of an individual MSC clone, it has become evident 
that the extracellular matrix mircro-environment in which they find themselves, 
has a major influence on their behaviour; with biomaterial scaffolds providing 
a template structure and simultaneous cell signals for promotion of proliferation 
and differentiation (O'Brien, 2011). With characterisation and differentiation 
capacity of MSC clones being defined in the previous two chapters, the next 
focus was the influence of whole-protein matrix extracts of the MSC-clone 
niche from rat bone and tooth, on clonal proliferation and differentiation, 
specifically the capacity for osteogenic mineralisation. This research chapter 
aimed to assess the influence of whole-protein matrix extracts on in vitro clone 
viability, morphology, expansion, and osteoinduction, and to visualise protein 
profiles of extracted matrices. 
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5.2 Materials and Methods 
The metabolism assay was used as a measure of cell viability for BMSC and 
DPSC clones over a 7 day period, to choose clones for further analysis (see 
2.13 Metabolism Assay with Thiazolyl Blue Tetrazolium Bromide (MTT)). Cells 
were seeded in 10% culture medium at 2.8x103/cm2, 5.7x103/cm2, 
11.4x103/cm2, 17.1x103/cm2, and 22.8x103/cm2. Whole-proteins from matrices 
were extracted from long bones and tooth incisors, referred to bone matrix 
extract (BME) and tooth matrix extract (TME), respectively (see 2.11 
Mineralised Tissue Whole-Protein Extraction and Dialysis), and were each 
measured for protein concentration by assay (see 2.12 Bicinchoninic Acid 
(BCA) Protein Assay). One clone from each source was taken for further 
analysis without and with protein at 0.1µg/mL, 0.5µg/mL, 1µg/mL, and 2µg/mL, 
using an optimal seeding density of 5.7x103 cells per cm2. Morphological 
effects of BME and TME on cells was visually observed and assessed by cell 
size, appearance and thickness of stress-fibres. Growth expansion was 
assessed in presence of matrix extracts for 0.1µg/mL, 0.5µg/mL, and 1µg/mL 
protein concentrations, by successively passaging cells every 3-4 days up to 
day 30. The optimal protein concentration of 0.5µg/mL was then set for both 
extracts and was exposed to each clone for a period of 23 days, and assessed 
for alizarin red stain (see 2.7.9 Osteogenic Differentiation Alizarin Red 
Staining) and bone-related gene expression using qPCR (table 2.5) (see 2.6 
Quantitative-Polymerase Chain Reaction of Colony Clones). In addition, BME 
and TME whole-protein extracts (10µg) underwent SDS-PAGE to identify 
protein band profiles (see 2.14 Sodium Dodecyl Sulphate – Polyacrylamide 
Gel Electrophoresis), by coomassie blue and silver staining. 
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5.3 Results 
5.3.1 Cell Viability of MSC Clones from Bone Marrow and Dental Pulp 
The number of viable cells of BM 2.6 and BM 3.1 peaked at day three, and BM 
1.4 activity peaked at day five, and all plateaued thereafter (figure 5.1). The 
highest activity rate was that of BM 3.1, which displayed the most distinct 
relationship between seeding density and viability. By day 7, BM 3.1 cells 
seeded at 2.8x103/cm2 had a significantly lower viability compared to cells 
seeded at 11.4x103/cm2, 17.1x103/cm2, and 22.8x103/cm2. Although the 
viability of BM 3.1 was twice that of BM 1.4, by day 7, BM 1.4 also showed 
cells seeded at 2.8x103/cm2 had a significantly lower viability than cells seeded 
at 11.4x103/cm2, 17.1x103/cm2, and 22.8x103/cm2, and additionally viability of 
cells seeded at 5.7x103/cm2 was significantly lower than 17.1x103/cm2. For 
clone BM 2.6, cells seeded at the lowest density 2.8x103/cm2 only had a 
significantly lower viability compared to cells seeded at the highest density 
22.8x103/cm2 (figure 5.1). 
Viability of DPSC clones peaked later than BMSC clones. DP 2.7 and DP E11 
peaked at day five and decreased thereafter, whereas DP F2 increased up to 
day seven and gave the highest number of viable cells, displaying the most 
distinct relationship between viability and seeding density (figure 5.2). By day 
7, DP F2 clone viability at each seeding density was significantly different to 
the other, with exception of no difference between 2.8x103/cm2 and 
5.7x103/cm2, and so viability correlated well with cell seeding density. DP E11 
cells seeded at 2.8x103/cm2 had a significantly lower viability than all higher 
seeding densities, and at 5.7x103/cm2 viability was significantly lower than 
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17.1x103/cm2 and 22.8x103/cm2. DP 2.7 cells seeded at 2.8x103/cm2 only had 
a significantly lower viability than 17.1x103/cm2. 
Consequently, BM 3.1 and DP F2 were taken on for further analysis with 
whole-protein matrix extracts. 
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Figure 5.1: Progenitor clones BM 1.4, BM 2.6, and BM 3.1, viability in 
culture for seven days. BM 1.4 activity peaked at day five, and BM 2.6 and 
BM 3.1 peaked at day three, and all plateaued thereafter. BM 3.1 gave 
highest activity rate and displayed most distinct relationship between 
viability and seeding density, as seen from day 7 statistics (inset). Seeding 
density stated as cell number (x103 per cm2). Mean±SEmean. n=1 (triplicate). 
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Figure 5.2: Progenitor clones DP 2.7, DP E11, and DP F2, viability in culture 
for seven days. DP 2.7 and DP E11 activity peaked at day five and 
decreased thereafter. DP F2 activity increased up to day seven. DP F2 gave 
highest activity rate and displayed most distinct relationship between 
viability and seeding density, as seen from day 7 statistics (inset). Seeding 
density stated as cell number (x103 per cm2). Mean± SEmean. n=1 (triplicate). 
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5.3.2 Viability and Morphology of Selected MSC Clones in Whole-Protein 
Matrix Extracts 
From the cell viability of bone marrow and dental pulp clones, the most highly 
active clone from each source that displayed significant differences between 
seeding densities was chosen for further analysis i.e. BM 3.1 and DP F2. 
These two clones had their viability and cell expansion ability assessed in the 
presence of whole-protein matrix extracts from rat long-bones, termed bone 
matrix extract (BME), and rat incisor tooth, termed tooth matrix extract (TME). 
 
The viability of clone BM 3.1 with 2µg/mL BME was significantly (P<0.01) 
decreased by day three (figure 5.3), which was probably due to a too high 
concentration of protein as no viable cells were visualised in the cell culture 
(figure 5.5). No-extract control and other protein concentrations were not 
significantly decreased, but at 1µg/mL the viability was below that of lower 
protein concentrations (figure 5.3) and the cultured cells appeared larger in 
size with a stressed-like morphology (figure 5.5). 
 
In the presence of TME, BM 3.1 displayed more varied effects in viability by 
day three (figure 5.3). Similarly as BME by day three, 2µg/mL of TME 
significantly (P<0.01) decreased viability, and cells were few in number and 
morphologically appeared with thick aligned stress-fibres (figure 5.6). A second 
group of TME protein concentrations (0.5µg/mL and 1µg/mL) significantly 
(P<0.05) decreased viability compared to no-extract control and 0.1µg/mL 
(figure 5.3). 
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For the majority, both BME and TME proteins displayed no influence on DP F2 
viability, with exception that 2µg/mL TME significantly (P<0.05) decreased 
activity on day three (figure 5.4). Likewise, the morphological appearance of 
DP F2 remained relatively unchanged, with only few enlarged cells with thin 
stress-fibres in 2µg/mL BME and TME (figures 5.7 and 5.8). 
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Figure 5.3: Viability of BM 3.1 in BME and TME proteins for three days. At 
day three, protein concentrations were grouped and encircled (brown) 
having been found statistically different from another concentration. BME 
and TME at 2µg/mL caused a significant (P<0.01) decrease in viability 
compared to no-extract and all other protein concentrations. TME at 
0.5µg/mL and 1µg/mL, had significantly (P<0.05) lower viability than no-
extract and 0.1µg/mL. Seeding density was 5.7x103 cells per cm2. n=2 
(triplicate). Mean± SEmean. ** = P<0.01, * = P<0.05. 
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Figure 5.4: Viability of DP F2 in BME and TME proteins for three days. BME 
activity plateaued following day two, and in TME activity increased up to day 
three. For BME, no differences in viability were seen between protein 
concentrations, and only 2µg/mL TME was found to significantly (P<0.05) 
decrease viability compared to no-extract. Seeding density was 5.7x103 
cells per cm2. n=2 (triplicate). Mean± SEmean. * = P<0.05. 
  
 
Figure 5.5: Progenitor clone BM 3.1 morphology exposed to BME protein over three days. By day three, morphology of cells 
with 0.1µg/mL and 0.5µg/mL protein remained unchanged compared with no-extract. While 1µg/mL had larger cells with 
stressed-like morphology (black arrow), and 2µg/mL had no viable cells (white arrow). Scale bar: 20x objective. 
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Figure 5.6: Progenitor clone BM 3.1 morphology exposed to TME protein over three days. Over three days, morphology of cells 
with 0.1µg/mL and 0.5µg/mL protein remained unchanged compared with no-extract. By day three, 1µg/mL had a larger cell 
morphology with thin stress-fibres (black arrow). On day one, 2µg/mL had some non-viable cells (white arrow), and by day three 
the few cells present had thick aligned stress-fibres (black arrow-head). Scale bar: 20x objective.  
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Figure 5.7: Progenitor clone DP F2 morphology exposed to BME protein over three days. Morphology of cells with 0.1µg/mL, 
0.5µg/mL, and 1µg/mL protein remained relatively unchanged compared to no-extract. By day three, 2µg/mL had a few enlarged 
cells with thin stress-fibres (black arrow). Scale bar: 20x objective. 
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Figure 5.8: Progenitor clone DP F2 morphology exposed to TME protein over three days. Morphology of cells with 0.1µg/mL, 
0.5µg/mL, and 1µg/mL protein remained relatively unchanged compared to no-extract. By day three, 2µg/mL had a few enlarged 
cells with thin stress-fibres (black arrow). Scale bar: 20x objective. 
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5.3.3 Growth Profile of Selected MSC Clones with Whole-Protein Matrix 
Extracts 
From the viability assays, 2µg/mL protein concentration was excluded for 
further analysis due to its deleterious effects on cell-stress and number of 
viable cells, and MSC characteristics. All other protein concentrations were 
further assessed during extended clonal expansion by the population doubling 
level growth profile. 
 
For BM 3.1 during the 32 day culture period, compared to no-extract control at 
13.9 PDLs, all BME concentrations marginally decreased cell expansion and 
achieved PDLs of 13.4 in 0.5µg/mL, 12.8 in 0.1µg/mL and 1µg/mL (figure 5.9). 
While TME decreased cell expansion in a protein concentration-dependent 
manner, and achieved PDLs of 12.1 in 0.1µg/mL, 11.1 in 0.5µg/mL, and 10.4 
in 1µg/mL (figure 5.9). 
 
For DP F2, extended expansion in BME protein was unaffected up to day 16. 
After day 16, compared to no-extract control at 14.3 PDLs, cell expansion in 
BME decreased up to day 32 achieving PDLs of 13.4, 13.2, and 11.6 for 
0.1µg/mL, 0.5µg/mL and 1µg/mL. Unlike BM 3.1, TME proteins decreased cell 
expansion in a protein concentration-independent manner, which achieved 
PDLs of 12.2 in 0.1µg/mL and 0.5µg/mL, and 11.5 in 1µg/mL (figure 15.9). 
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Figure 5.9: Progenitor clones BM 3.1 and DP F2 growth expansion in BME 
and TME proteins for 32 days. BME effects upon BM 3.1 cell expansion was 
minimal, but TME decreased expansion in a concentration-dependent 
manner. For DP F2, BME decreased cell number half way through culture 
time, while all TME concentrations decreased expansion equally over the 
culture period. 
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5.3.4 Mineralising Effects of Whole-Protein Matrix Extracts on Selected 
MSC Clones 
From the previous viability and growth expansion assays on BM 3.1 and DP 
F2 clones, a final protein concentration of 0.5µg/mL was chosen to assess the 
mineralising effects of the whole-protein matrix extracts on the clones over 23 
days (period for normal osteogenic differentiation). The 0.5µg/mL protein 
concentration was decided as the optimal concentration due to the similar 
viability and morphological appearance compared to no-extract control, and 
0.5µg/mL concentration displayed decreased population doubling level, which 
potentially indicated cellular differentiation.  
 
After 23 days in vitro culture, BM 3.1 did not synthesise a mineralised matrix 
when exposed to BME protein as seen from absence of nodule morphology 
and no alizarin red stain for extracellular matrix calcium deposits. On the other 
hand, TME promoted nodule formation that stained red with alizarin for 
extracellular matrix calcium (figure 5.10), similarly as osteogenic promotion 
(see Chapter 4, figure 4.10). No-extract control did not show mineral synthesis 
or alizarin red staining (figures 5.10). At day 23, BM 3.1 osteonectin gene 
expression in BME and TME was significantly decreased compared to no-
extract control (P<0.01), and TME was very significantly decreased compared 
to BME (P<0.01). Gene expression levels of osteopontin, however, did not 
show any significant changes (figure 5.12). In addition, BSP and osteocalcin 
was not expressed in BM 3.1, similarly as in osteo-inductive medium (figure 
4.13). 
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After 23 days in vitro culture, DP F2 synthesised a mineralised matrix in both 
BME and TME, and promoted areas of dense accumulates that stained brown 
with alizarin for calcium deposits within the extracellular matrix. No-extract 
control did not show mineral synthesis or alizarin red staining (figure 5.11). 
Compared to no-extract control at day 23, BSP was significantly higher in TME 
(P<0.05), osteocalcin was significantly higher in BME and TME (P<0.001) and 
BME was significantly higher than TME (P<0.01), and osteopontin was 
significantly higher in BME and TME (P<0.05) (figure 5.12). Osteonectin 
showed no significant changes. 
 
  
Figure 5.10: Progenitor clone BM 3.1 mineral synthesis exposed to BME and TME proteins, at day 23. BME exposure did not 
promote calcium deposits. TME promoted dense spherical nodules (arrows), with alizarin red stained calcium deposits within 
the extracellular matrix (arrow-head). Morphology of no-extract medium remained unchanged and showed no alizarin red stain. 
Scale bars: 4x and 20x objectives. 
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Figure 5.11: Progenitor clone DP F2 mineral synthesis exposed to BME and TME proteins, at day 23. BME and TME promoted 
areas of dense accumulates (arrows), with alizarin red stained calcium deposits within the extracellular matrix (arrow-head). 
Morphology of no-extract medium remained unchanged and showed and showed no alizarin red stain. Scale bars: 4x and 20x 
objectives. 
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Figure 5.12: Progenitor clones BM 3.1 and DP F2 expression levels of 
bone-related genes following in vitro exposure to BME and TME proteins for 
23 days. BM 3.1 osteonectin expression in BME and TME was very 
significantly lower than no-extract, but osteopontin was not significant. For 
DP F2, BSP was significantly higher in TME, and osteocalcin and 
osteopontin were significantly higher in BME and TME. DP F2 osteonectin 
was not significant. Mean±SD. * = P<0.05, ** = P<0.01, *** = P<0.001. 
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5.3.5 Separation of Whole-Protein Matrix Extracts from Bone and Tooth 
SDS-PAGE separation of BME and TME protein extracts showed three 
identical bands with coomassie brilliant blue staining between 38KDa and 
82KDa at apparent 65KDa, 70KDa and 75KDa. On further analysis with a 
protein-sensitive (<100ng) silver stain, additional proteins were uniquely 
observed in BME extract between 114-204KDa, and TME extract between 82-
114KDa (figure 5.13). 
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Figure 5.13: Separation of whole-protein matrix extracts from rat bone 
(BME) and rat tooth (TME) by SDS-PAGE. In coomassie brilliant blue (top), 
three main bands are evident in both protein extracts between 38KDa and 
82KDa, at apparent 65KDa, 70KDa and 75KDa (white arrow heads). Other 
bands (black arrow heads) appear unique to each extract when observed 
by the protein-sensitive silver stain (bottom). 10µg protein each sample. 
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5.4 Discussion 
This chapter highlights two important points often questioned in tissue 
engineering and regenerative medicine i.e. what is the best tissue-sourced 
cells to use? And what is the optimal mircro-environment support needed? E.g. 
protein and/or scaffold. These two points shed light to preferentially use 
DPSCs and tooth protein extract. Due to, the effects of BME and TME on 
DPSCs was protein concentration-independent, as cell viability, growth-
expansion, and cell morphology was maintained, and that TME was successful 
at promoting mineralisation in BMSCs and DPSCs. 
 
Viability of BM 3.1 was significantly effected in a concentration-dependent 
manner so that with increased protein concentration the viability decreased, 
and was concomitant with the appearance of thick cytoskeletal fibres that are 
indicative of stress in rigid and non-motile cells (Tojkander et al., 2012). Such 
thick stress-fibres were seen in BM 3.1 with higher protein matrix-extract 
concentrations, which suggested the MSC clone experienced cytotoxic stress-
induced morphological changes when in presence of too high extracellular 
matrix protein concentration. DP F2 was for the majority unaffected by higher 
protein concentrations and displayed similar viability and morphology, which 
could be accounted for as DPSCs are reported as more resistant to external 
oxidative-stress factors than BMSCs (Alraies, 2013). Concerning growth 
expansion, BME displayed minimal effect, unlike that which as may be 
expected due to the plethora of mineral and calcium promoting extracellular 
matrix proteins present in bone e.g. proteoglycans biglycan and decorin 
(Bianco et al., 1990), and BSP and BAG-75 (Bronckers et al., 1993). Such 
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proteins, however, while having ability to promote mineralisation, also have the 
ability to promote a state of proliferation e.g. biglycan (Chen et al., 2002, 
Waddington et al., 2003a) (see Chapter 1, sections Proteoglycans Regulate 
Cellular Behaviour, and Biglycan Regulates Cellular Proliferation and 
Differentiation). TME decreased proliferation, with BM 3.1 growth expansion 
decreased in a concentration-dependent manner, while DP F2 growth 
expansion marginally decreased in a concentration-independent manner. This 
growth expansion decrease could well be due to the array of additional proteins 
within the tooth that constitute the extracellular matrix and promote 
mineralisation e.g. amelogenin and enamelin (reviewed (Goldberg and Smith, 
2004)), compared to bone. In addition, as to why BME promoted mineralisation 
in DP F2 and not BM 3.1 could well be related to the hierarchical position of 
these MSCs, with BMSCs proposed as a progenitor closely related to the 
mother stem cell higher up the hierarchy, and so may need longer and more 
sustained periods for differentiation promotion. Whereas, DPSCs are 
proposed lineage-restricted transit-amplifying (TA) cells that are partially 
committed and so may require less time for mineralisation within the correct 
micro-environment. This can be related to the in vivo role of DPSCs, which 
requires rapid cell number amplification, followed by immediate odontoblast-
like cell formation for tertiary dentin production, after trauma/injury and death 
to the original odontoblast cell layer (Smith et al., 1995). Reparative tertiary 
dentinogenesis involved recruitment of DPSCs from the pulp (of which several 
niches are proposed) to allow dentin bridge formation at pulp-exposed sites, 
as well as ectopic bone formation (Goldberg and Smith, 2004), due to BMP 
activity (Butler et al., 1977), and as such DPSCs within pulp are likely “primed” 
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for mineralisation roles such as odontogenesis and osteogenesis. 
Interestingly, following extrusion trauma of rat incisor, osteopontin was highly 
expressed in reparative dentine and shared structural characteristics of 
primary bone (Aguiar and Arana-Chavez, 2007). As such, with a supportive 
micro-environment DPSCs were able to acutely form proteins associated with 
osteogenic mineralisation, seen by significant increases in BSP, osteocalcin, 
and osteopontin compared with no-extract. The expression of BSP in DPSCs 
exposed to both BME and TME was evidently higher than osteocalcin. This 
may suggest that DPSCs are in a state associated with the initial phase of 
mineralisation as BSP peaks before osteocalcin, which disappeared following 
completion of mineralisation (Aubin et al., 1995), and possibly why alizarin 
stain was brown and not deep red in colour as within osteo-inductive medium 
(see Chapter 4, figure 4.12). In addition, dense accumulates were evident in 
the extracellular matrix of cell-culture with matrix-extract protein, which were 
not present in the no-extract control medium culture stained with alizarin. 
 
While bone harbours ten-fold BSP and osteopontin than in tooth (Fujisawa et 
al., 1993), only TME promoted mineralised nodules by BM 3.1. Although BM 
3.1 exposed to TME did not see any upregulation in osteopontin (as in 
osteogenic treatment, see 4.3.3 Osteogenic Differentiation of Characterised 
Progenitor Clones), other mineralisation-specific proteins that were not 
analysed here could be responsible for alizarin red stained calcium-binding 
within the extracellular matrix e.g. BAG-75 (Gorski et al., 1996), which was 
enriched at mineralisation-foci within developing bone (Gorski et al., 2004). In 
addition, when in barrier-restricted oral epithlium co-culture, BMSCs are 
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promoted to produce odontogenic genes such as DMP1, Pax9, and DSPP that 
facilitate mineralisation (Li et al., 2007, Mashhadi Abbas et al., 2013), which 
may be comparable in effect to exposing BMSC clone to TME proteins. This is 
supported by evidence that conditioned-medium from tooth-germ cells 
stimulated DMP1 and DPP protein expression, and mineralised nodule 
formation by umbilical-cord MSCs (Li et al., 2013), and by DPSCs, creating a 
potent odontogenic micro-environment (Yu et al., 2006). Interestingly, in an 
approach to secondary dentinogenesis, canine dentin and bone matrix 
extracts were implanted into pulpal sites, and reported that dentin matrix 
promoted dentin histogenesis and odontoblast-like cell differentiation, whereas 
bone matrix promoted  tertiary reparative dentin only (Tziafas and Kolokuris, 
1990). This highlights that TME is potentially more potent than BME due to 
some constituent proteins in TME that are not present in BME. 
 
Many proteins associated with mineralisation and calcification are present in 
both skeletal bone and tooth tissues (reviewed (Staines et al., 2012)), which 
include majorly osteopontin, BSP, BAG-75 (Bronckers et al., 1993), and more 
dentin-primary DSP/DPP and DMP1 (Hu et al., 2006). Proteins specific to tooth 
are those within the enamel e.g. amelogenins, amelobastins, enamelins and 
tuftelins (Robey, 1996), which are suggested to contribute extensively to bio-
mineralisation and formation of hard tissues (Lyngstadaas et al., 2009). The 
main protein bands present in BME and TME may represent full-length 
osteopontin at 65KDa (Kim and Shin, 2007) and BSP at 70 KDa (Wuttke et al., 
2001). These bands were more concentrated in BME than TME and was 
probably due to ten-times concentration of BSP and osteopontin within bone 
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than dentin (Fujisawa et al., 1993) (importance of proteins discussed in 
Chapter 4, section 4.4 Discussion). For example, BSP-null mice displayed 
tooth root and alveolar bone resorption (Foster et al., 2013),  and delayed bone 
growth and mineralisation (Malaval et al., 2008). While ostepontin null-mice 
are reported to display hyper-mineralised bone matrix (Boskey et al., 2002) 
and reduced tooth resorption due to decreased odontoclastic cells following 
orthodontic tooth force (Chung et al., 2008). 
The distinct protein band seen in the TME between 82-114KDa could belong 
to tooth-associated proteins DSP (Bronckers et al., 1993), and DPP and/or full-
length DMP1 that co-elute together, all of which reported a 95KDa protein band 
in SDS-PAGE (Sun et al., 2011). These proteins were vital to tooth 
development and mineralisation, which led to dentinogenesis imperfecta and 
the disease-associated phenotype in mice with DSP/DPP and DMP1 
mutations, respectively (Ye et al., 2004). Other extracellular matrix proteins 
highly expressed in bone and tooth are SLRPs, decorin and biglycan, which 
are becoming increasingly evident as important in mineralisation processes 
(Sugars et al., 2003) (see Chapter 1, section Proteoglycans Regulate Cellular 
Behaviour). These SLRPs were probably within the smear of protein bands 
seen above 38KDa, accounting for the core proteins and in vivo degradation 
of (Waddington et al., 2003b), as these glycosylated proteins are of a larger 
100-350KDa range (see Chapter 1, figure 1.4). Biglycan and decorin were 
differentially and spatially expressed during bone (Bianco et al., 1990) and 
tooth development (Matsuura et al., 2001), and during tooth resorption 
(Benedetto et al., 2013), due to their proposed distinct in vivo roles. Biglycan 
has been reported to initiate apatite formation (Boskey et al., 1997) while 
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decorin inhibited mineralisation and rather contributed to collagen fibril 
assembly (Hoshi et al., 1999). Within the tooth, these functions suggested that 
decorin influenced dentin formation by associating with type I collagen fibrils 
to regulate its mineralisation, and that biglycan was potentially involved in 
differentiation of odontoblasts and ameloblasts, and consequently enamel 
formation (Matsuura et al., 2001). The presence of such specific proteins and 
glycosaminoglycans, however, needs to be further elucidated and confirmed 
via Western blot analyses on SDS-PAGE of separated matrix extracts. 
 
In summary, DPSCs were able to undergo mineral synthesis when exposed to 
BME and TME, likely due to their lineage-commitment related to their position 
within the stem cell hierarchy, and the niche micro-environment in which they 
are maintained in vivo. Whereas the HSC environment of BMSCs is highly 
complex and is able to compartmentalise progenitors of many systemic cell-
types (Morrison and Scadden, 2014) not limited to mineralised tissues, which 
may keep them in a state that is higher up the stem cell hierarchy. Therefore, 
BMSCs probably needed additional time in the presence of BME, but exposure 
to TME-proteins promoted such osteogenic differentiation and maturation. In 
addition, DPSC viability and growth expansion was higher compared to 
BMSCs in the presence whole-protein matrix extracts. Thus, preferential use 
of DPSCs and its tissue-sourced protein-extracts could potentially be an 
advantage to tissue regenerative medicine, by preferential capacity for bio-
mineralisation applications. 
 
 
 174 
Chapter 6 
Proliferation and Differentiation of Bone Marrow and Dental Pulp 
Mesenchymal Stromal Cell Clones on Bone and Tooth Tissue Slabs 
 
6.1 Introduction 
Study of osseointegration and endosseous healing processes in bone grafting 
and dental implants, has led to better understand the biological cascade as 
three distinct phases: 1) osteoconduction, cell recruitment through blood 
clotting, 2) de novo bone formation, mineralised interfacial matrix as observed 
in cementum and primary bone, and 3) bone remodeling, exquisite highly-
organised microarchitecture (Davies, 2003). Thus, investigations on identifying 
the most efficacious source of MSCs and protein matrix extract to mimic an 
optimal microenvironment for mineralisation, is of utmost importance to tissue 
engineering and improvement in regenerative medicine applications. 
 
Human BMSCs and DPSCs were capable of attachment and proliferation on 
lyophilized bovine bone grafts up to 7 days in culture (Weszl et al., 2012). In 
vivo research into use of DPSCs as an alternative cell-source, revealed 
potential of tooth-tissue scaffolds as a suitable microenvironment to support 
cell differentiation for tissue engineering and has been suggested for clinical 
dental therapeutic purposes (Batouli et al., 2003), as the dentin-pulp complex 
does not re-model but supports reparative dentin formation by DPSCs that 
differentiate to odontoblast-like cells following injury to protect the pulp (Smith 
et al., 1995). On the other hand, BMSCs did not form dentinogenic tissue in 
response to tooth-tissue scaffolds and was suggested to be due to distinct 
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regulatory mechanisms controlling mineralisation and consequently different 
organisation of the mineralised tissue (Batouli et al., 2003). Interestingly, 
reparative dentine formed by odotoblast-like cells following DPSC recruitment 
from the pulp, was strongly immunoreactive for osteopontin, similarly to 
primary bone, and these osteopontin-forming odontoblast-like cells resembled 
osteoblasts rather than odontoblasts (Aguiar and Arana-Chavez, 2007). In 
addition, osteopontin was found to initiate bone remodeling via osteocyte 
expression (Terai et al., 1999), and be highly enriched at regions of bone 
resorption, to attract and bind osteoclasts and precursors, and subsequently 
act as an anchor for osteoclasts (Reinholt et al., 1990). Likewise, osteopontin 
was observed along newly formed tooth cementum following applied force, 
and was suggested to play a role in osteogenic differentiation (Kim et al., 
2012). 
 
Following on from in vitro characterisation and differentiation of bone marrow 
and dental pulp MSC clones, the behaviour of MSC clones on both bone and 
tooth tissue-slabs was investigated, in an organotypic culture model, to 
represent an in vivo micro-environment of tissue trauma and injury e.g. fracture 
and caries, respectively. Scanning electron microscopy (SEM) detected cell 
attachment and morphology, and proliferating cell nuclear antigen (PCNA) 
stained the growth expansion of clones on tissue-slabs. 
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6.2 Materials and Methods 
Rat long-bones from femur, tibia, and fibula, and tooth lower and upper incisors 
were dissected and cleaned of all attached soft-tissues. Extracted bones and 
teeth were sectioned longitudinally and cut two or three times to produce 
tissue-slabs of 4-5mm length. BMSC and DPSC clones were seeded onto 
tissue-slabs at 16x103 cells/cm2 in culture medium (see 2.8 Mineralised 
Tissue-Slab Preparation and Culture). Following two days incubation, cell-
seeded tissue-slabs were fixed with glutaraldehyde, and observed for 
morphology by scanning by electron microscopy (SEM), and for a marker of 
proliferation, proliferating cell nuclear antigen (PCNA). Control tissue-slabs 
had no cells seeded with culture medium. PCNA detection used HRP-
conjugated secondary antibody and TMB-substrate development to a blue 
colour (see 2.9 Mineralised Tissue-Slab Antibody Detection). SEM involved 
specimen dehydration in a series of increasing alcohol concentrations and 
drying with HMDS chemical agent overnight. Tissue-slab samples were affixed 
to aluminium stubs with carbon adhesive tape and gold sputter-coated for 
viewing under SEM (see 2.10 Mineralised Tissue-Slab Scanning Electron 
Microscopy). 
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6.3 Results 
6.3.1 Scanning Electron Microscopy of Bone Marrow and Dental Pulp 
MSC Clone Attachment to Bone and Tooth Tissue Slabs 
BM 3.1 attached to bone slab but no cells were visible on tooth slab. On bone, 
BM 3.1 had many extensions that interacted with other attached cells (figure 
6.1, black arrow-head) as well as the tissue environment haversian canals 
(figure 6.1, black arrow). DP F2 attached to both bone and tooth slabs, and 
similar to BM 3.1, had many extensions interacting with other cells and its 
environment. BM 3.1 cells on bone slab and DP F2 cells on tooth slab were 
rather flattened with a large surface area and spread morphology, whereas DP 
F2 on bone slab was more rounded with extensive filopodia (figure 6.1). DP 
F2 cells also appeared to produce their own organic matrix (figure 6.1, white 
arrow). All attached cells appeared to align themselves in a single and parallel 
direction. Bone haversian canals and tooth tubules were evident across tissue 
slabs (figure 6.1, yellow asterisks) and at higher magnification collagen fibrils 
were clearly distinguished (figure 6.1, yellow arrows).
  
 
Figure 6.1: Scanning electron microscopy (SEM) of progenitor clones BM 3.1 and DP F2 following two days in vitro culture on 
bone and tooth slabs, at mid PDL. BM 3.1 attached to bone slab but no cells were visible on tooth slab, while DP F2 attached 
to both bone and tooth slabs. MSCs (white arrow-head) had many extensions interacting with other cells (black arrow-head) and 
its environment (black arrow). MSCs also appeared to produce their own matrix (white arrow). Bone haversian canals and tooth 
tubules (yellow asterisks), and collagen fibrils (yellow arrows). Magnification and scale bar inset. 
1
7
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6.3.2 Proliferation of Bone Marrow and Dental Pulp MSC Clone on 
Bone and Tooth Tissue Slabs 
MSC clones, BM 3.1 and DP F2, seeded on bone slab had visible areas of 
proliferation indicated by the blue staining for PCNA, with DP F2 showing 
larger areas of blue compared to BM 3.1 (figure 6.2). On tooth slabs, 
however, PCNA bound non-cellular elements, as BM 3.1 tooth slab (no 
visibly attached cells with SEM analysis) colour was similar to the control 
tissue slab with no cells (figure 6.2). Despite cross-reactive blue staining, 
DP F2 displayed a deeper blue PCNA stain, potentially indicating active cell 
proliferation. All IgG isotype antibody controls showed no blue staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
Figure 6.2: Proliferation of MSC clones BM 3.1 and DP F2 following two days culture in vitro on bone and tooth slabs, at mid 
PDL. BM 3.1 and DP F2 seeded on bone slab had visible areas of proliferation indicated by blue staining for PCNA (black arrow). 
On tooth slab, BM 3.1 PCNA stained non-specific blue, similarly as control tissue slab with no cells. DP F2, however, stained 
deeper blue for PCNA, potentially indicating active cell proliferation. IgG isotype antibody controls showed no staining. Equal 
light intensity and exposure for tissue samples. Bone haversian canal (black asterix). Magnification x10, scale bar = 100µm. 
1
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6.4 Discussion 
Critical to in vitro primary research investigations on optimal progenitor and 
protein sources for tissue regeneration, is relating and interpreting its findings 
to clinical applications such as bone grafting and dental implants, in order to 
better understand osseointegration and endosseous healing processes. As 
such, use of tissue-slabs can mimic and represent an in vivo micro-
environment of trauma and injury. Here, DPSC clone DP F2 attached to bone 
and tooth tissue-slab surfaces, whereas BMSC clone BM 3.1 only showed 
attachment to bone tissue-slab, and both clones indicated proliferation and 
potential differentiation. 
 
Proliferation of BM 3.1 and DP F2 was evident on bone slab following two days 
culture, and human BMSCs and DPSCs were capable of attachment and 
proliferation on lyophilized bovine bone grafts up to 7 days in culture (Weszl et 
al., 2012). On tooth slab, proliferation was only evident in DP F2, as no BM 3.1 
cells were attached to tooth slab. In addition, control tooth slab with no cells 
showed similar levels of blue TMB-substrate as BM 3.1 tooth slab (no cells 
attached), which indicated that PCNA was cross-reactive to a non-cellular 
structure, possibly to a protein within the pre-dentin layer, and that alternative 
antibodies for proliferation should be tested e.g. Ki-67. From the morphology 
of cells under SEM, it was interesting to hypothesize that rounded cells were 
actively proliferating, as displayed by DP F2 on bone slab, while flattened cells 
were undergoing differentiation, as displayed by BM 3.1 on bone slab and DP 
F2 on tooth slab. As after 2 days culture, human MSCs and fibroblasts are 
reported to have prominent spindle shapes, and that murine osteoblasts 
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exhibit a branched structure with increased focal adhesion points, suggesting 
proliferation and differentiation, respectively (Lavenus et al., 2011). On bone 
tissue-slabs, BM 3.1 morphology displayed flat cells with lower PCNA, while 
DP F2 morphology displayed rounded cyto-types with higher PCNA. 
Oppositely to bone slab, on tooth tissue DP F2 was flattened and similar to BM 
3.1 on bone slab, potentially indicating differentiation. DP F2 PCNA staining 
was not area-specific for tooth slab and was judged on depth of colour alone 
comparative to the no-cells control, with DP F2 displaying increased PCNA 
staining. Morphology of cells can be indicative of their cell-cycle state, whereby 
actively proliferating cells were considered rounded with filopodia and a clearly 
visible cell-border, whilst non-proliferating cells are largely spread flattened 
cells (Gonzalez et al., 2009). Human MSCs are said to exhibit two distinct 
morphologies termed rapidly self-renewing cells (RS), and flat cells (FC) that 
had a very low proliferation rate. Flat cells had a larger surface area and the 
cell-specific flatness could be correlated with higher level of focal adhesions 
(Docheva et al., 2008). In addition, the role of focal adhesion kinase (FAK) in 
osteogenic differentiation was purported important (Mathieu and Loboa, 2012), 
with FAK knock-down reported to diminish osteocalcin secretion (Chen et al., 
2013). As seen during in vitro culture, however, BM 3.1 cells are of a more 
cobble-stone shape compared to DP F2 with a defined dendritic cell-shape 
(see Chapter 3, figures 3.14 and 3.15), and so additional immunocytochemical 
analyses are required to confirm differentiation e.g. anti-FAK, osteopontin, 
BSP, and osteocalcin. Interestingly, DP F2 on bone slab for two days displayed 
a round-like morphology along with apparent organic-matrix production, and it 
was reported that during proliferation phases, bone stromal cells expressed 
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dermatan-sulfated biglycan, which peaked and was highly expressed at two 
days culture (Waddington et al., 2003b). 
 
SEM analysis of calf pulp-derived cells spread and flatten following 7 days 
culture to form cell-cell contact on dentin, similarly as here after 2 days culture, 
and following 14 days cells became multilayered (Schmalz et al., 2001), with 
human pulpal-cells surviving for periods of up to 16 days on dentin surfaces 
(Huang et al., 2006a). Elsewhere, human dental pulp cells are reported to 
proliferate minimally, unlike 3T3 fibroblasts, on a dentin surface compared to 
culture plastic using trypsinized cell-counts (Huang et al., 2006b). As seen 
here with BM 3.1 on tooth slab, no cells were visible and at higher 
magnification only debris could be seen similar to that seen in Huang et al., 
2006b, which was likely due to SEM processing. Absence of dental pulp cells 
on dentin surface would account for the discrepancy of apparent low cell 
numbers when Huang et al., 2006b compared cell number of dental pulp cells 
and fibroblasts during tissue culture plastic expansion and proliferation with 
collagen gel scaffold matrix, which gave similar cell growth profiles. In addition, 
dental pulp cells are reported to interact with open dentin tubules following 2 
days (Shao et al., 2011), 7 days (Schmalz et al., 2001), and 16 days (Huang 
et al., 2006a), which exhibited odontoblast behaviour. Here, however, no 
specific association between MSCs and dentin tubules or bone haversian 
canals was evident. Interestingly, actin filaments of multilayered human 
DPSCs on human dentin discs aligned in a parallel fashion as early as day 2, 
and was highly organised by day 10 culture, which was also characteristic of 
odontoblasts (Shao et al., 2011). Such alignment of cells was displayed in 
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attached bone marrow and dental pulp clones on both bone slab and tooth 
slab, and was indicative of micro-environment influence on cell behaviour and 
that study of in vivo native injury micro-environments can potentially provide 
beneficial in understanding interaction between MSCs and their environment 
for tissue engineering in orthopaedic and dental regenerative medicine. 
Interestingly, human dentin surfaces have provided a scaffold onto which 
seeded DPSCs were able to undergo dentinogenesis and produce a reparative 
dentin-like tissue matrix (Batouli et al., 2003) 
 
BMSCs and DPSCs are suggested to undergo organogenesis and replicate 
their own niche of origin i.e. bone and tooth, respectively, which highlights 
inherent tissue “memory’’ that may be pivotal for cell therapy and tissue 
engineering applications (Janebodin et al., 2011). In support, distinct 
regulation mechanisms between BMSCs and DPSCs have been suggested, 
which may lead to different organisation of mineralised tissues (Batouli et al., 
2003). Within an organotypic model, attachment of DPSCs to both bone and 
tooth tissue slabs, and their proliferation and apparent differentiation within two 
days culture, suggests dental pulp is potentially a better source of MSCs for 
mineralised tissue engineering purposes, which is a therapy lacking in 
craniofacial medicine (Miura et al., 2006). 
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Chapter 7 
General Discussion 
 
The term mesenchymal stem cell was highlighted as being misused in the 
literature, to classify unfractionated and multipotent plastic adherent cells in 
vitro, and until their characterisation such cells should be referred to as 
mesenchymal stromal cells (MSCs) (Horwitz et al., 2005). Here, the MSC 
criteria met were i) uniform population forming colony units (fibronectin-
adherent clones) ii) long-term self-renewal (population doubling level) iii) 
specific surface marker expression (PCR analyses) and iv) multipotent 
differentiation (adipogenic, chondrogenic, and osteogenic), as set out by The 
International Society for Cellular Therapy position statement (Dominici et al., 
2006). 
 
Our results showed that dental pulp stromal cells had a higher colony forming 
efficiency compared to bone marrow stromal cells as found by Gronthos et al., 
2000 in human molars, and Alge et al., 2010 in rat. Gronthos et al., 2000 
suggest this was due to basic composition differences, where dental pulp was 
largely fibrous and bone marrow majorly constituted haematopoietic cells 
(>99.9%). They indicated that when bone marrow is free of haematopoietic 
cells and subjected to collagenase treatment, colony forming efficiency 
increased 10-fold compared to whole aspirates of bone marrow. The authors 
stated that the 10-fold increase were unpublished observations, and that the 
numbers of colony forming units from connective tissue without 
haematopoietic cells were similar to dental pulp. As in our methodology, 
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however, we employed cell separation using histopaque and β1-integrin 
adhesion assay to isolate the representative population of bone marrow 
progenitor stromal cells from haematopoietic stem cells, and showed that even 
without haematopoietic stem cells, the bone marrow progenitors had a lower 
colony forming efficiency. The significant differences between the number of 
colonies formed likely relates to the hierarchical theory that large colonies 
formed by the bone marrow MSC progenitors are closely related to the mother 
stem cell, whereas the small colonies formed by dental pulp MSCs are lineage 
restricted transit-amplifying cells (Chan et al., 2004). This hypothesis is 
supported by SOX2 expression in BMSC clones and lack of expression by 
DPSC clones. As SOX2 is vital for embryonic development and was expressed 
by pluripotent ESCs, and overexpression of which increased proliferation, as 
well as adipogenic and osteogenic differentiation in porcine BMSCs (Fan et 
al., 2013b). Likewise, all BMSC clones proved tri-potent adipo-chondro-osteo 
capacity that represented progenitor stem cells, while DPSC clones only 
proved uni- or bi- potent (osteo-inclusive) capacity that represented lineage-
committed transit-amplifying cells. 
 
The developmental origins of DPSC colony-forming units were reported as 
entirely neural crest derived, and BMSC colony-forming units as 43% neural 
crest derived (Komada et al., 2012). This indicated that DPSCs are not 
contributed to beyond developmental stages into adulthood, whereas 57% of 
BMSCs are contributed to by mesenchyme-derived and other as yet unknown 
cells. BMSCs compose part of the haematopoietic microenvironment that 
supports compartmentalised HSCs, BMSCs, and lymphoid and myeloid 
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progenitor niches (Morrison and Scadden, 2014), providing a vast diversity of 
cells from erythrocytes to specialised lymphocytes, which involves delicate 
transcription and growth factor balance to robustly sustain stem cell hierarchy 
dynamics, and health to the whole body (Maclean et al., 2014). Within this 
haematopoietic environment BMSCs are likely kept in a progenitor-state, until 
needed for bone remodelling that occurs during adulthood (Parfitt, 1984). 
Whereas, the dental pulp microenvironment is much less complex, but still of 
vital importance to maintain in the adult. The sole known in vivo role of DPSCs 
is formation of odontoblast-like cells that produce reparative tertiary dentin 
after trauma/injury and death to original odontoblasts, to limit pulpal destruction 
(Smith et al., 1995). Such replacement with odontoblast-like cells, probably 
requires rapid amplification of cell numbers and immediate differentiation 
following recruitment from the pulp tissue, where there are several niches 
proposed (Sloan and Waddington, 2009), In addition, evidence showed 
genetic lineage tracing (Cre/LacZ) of neural crest-derived DPSCs to the sub-
odontoblastic and perivascular regions (Janebodin et al., 2011). Hence, all 
DPSC clones underwent mineralised osteoblastic differentiation, which likely 
relates to their in vivo role described above and thus their lack of 
multipotentiality. This may indicate that DPSCs are lineage committed due to 
loss of stem cell characteristics and gain of a more differentiated and mature 
progeny (as reviewed (Alison et al., 2002)). In addition, it is interesting to 
propose that due to lineage-restriction of DPSCs that dental pulp is a more 
heterogeneous population when undergoing differentiation stimulation, 
compared to whole bone marrow that proved multipotent at a single-cell clonal 
level. In opposition to lineage-restriction, others reported gain of adipo- and 
 188 
chondro- capacity in erupted murine molars, compared to unerupted molars 
that were not capable of adipo- and chondro- differentiation, and displayed 
significantly reduced osteo-dentinogenic potential (Balic et al., 2010). 
 
Another crux to tissue engineering, in conjunction with the ideal cell source, is 
an appropriate scaffold for the survival of cells and promotion of specified 
differentiation. As described above, BMSCs are within the haematopoietic 
microenvironment sustaining a progenitor-state, with the DPSC niche 
harbouring cells until recruitment from the pulp, which likely involves an 
extracellular matrix that promotes odontoblast-like cell differentiation. Proteins 
within the tooth extracellular matrix included proteoglycans decorin and 
biglycan (Rahemtulla et al., 1984) that are involved in processes of 
mineralisation (Ameye and Young, 2002, Waddington et al., 2003b). While 
these proteoglycans were present in bone, additional proteins unique to tooth 
are likely major factors to potentially contributing towards DPSC lineage-
commitment e.g.  amelogenins, amelobastins, enamelins and tuftelins (Robey, 
1996) that are suggested to contribute extensively to bio-mineralisation and 
formation of hard tissues (Lyngstadaas et al., 2009). Here, only exposure to 
tooth-matrix extract caused BMSC clone mineralisation, whereas both bone- 
and tooth- matrix extracts promoted DPSC clone mineralisation, which again 
highlighted potent influence of tooth proteins on the BMSC progenitor clone 
and thus lineage-commitment of DPSC clone due to mineralisation by bone 
proteins, within the given time-frame. Similarly, a versatile DPSC clone DP F2 
attached, and displayed expansion and potentially differentiation, on bone and 
tooth tissue slabs. Interestingly, enamel matrix protein combined with natural 
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bone mineral are being investigated for their influence, which showed 
enhanced speed of newly formed bone in rodent (Miron et al., 2014), and 
significant primate periodontal regeneration (Cochran et al., 2003), which 
sheds light on their potential clinical application. Currently, treatment of dental-
diseases e.g. periodontitis involves grafting of bone and/or guided tissue 
regeneration (GTR) (Feng and Lengner, 2013). Due to varied and 
unpredictable success of current dental treatments, potential regenerative 
medicine applications such as combined cell with protein scaffold/biomaterial 
is becoming increasingly popular, particularly alternative autologous cell-
sources like dental pulp. Interestingly, as of August 2013, patient recruitment 
started on a clinical trial using deciduous dental pulp MSCs, with collagen and 
hydroxyapatite biomaterial for alveolar bone defect tissue engineering in cleft 
lip/palate patients (Bueno, 2013). 
 
While scientists strive for a “holy grail” marker-phenotye representing an ideal 
and preferential MSC for use in tissue engineering and regenerative medicine, 
still much is yet unknown as to the specific roles of individual markers. For 
example, the minimal MSC triplicate markers (CD73, CD90 and CD105) are 
stated paramount for definition of an MSC, admittedly along with other criteria, 
but the roles of the markers are undefined. CD73 and CD105 are reported as 
unspecific for MSCs, as fibroblasts (human fetal lung) express this phenotypic 
markers but lack colony and differentiation capacity (Alt et al., 2011). In 
addition, SOX2 is an important transcription factor in embryogenesis and adult 
progenitor maintenance, and specifically in mouse during odontogenesis 
(Zhang et al., 2012). Human third molars, however, contain two distinct 
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populations of cells that showed SOX2+ DPSCs lack CD73 and vice versa 
(Atari et al., 2012), as presented here whereby CD73+ DPSC clones did not 
express SOX2. Although each clone analysed by qPCR gave a unique 
expression profile, unfortunately this did not relate to the multipotential 
capacity of MSCs. Likewise, MSX2 was implicated in the maintenance of cell 
proliferation (Dodig et al., 1999, Liu et al., 1999), however, quantitative 
analyses did not relate expression to proliferative ability, here. As such, the 
reliable marker for multipotent differentiation proved to be embryonic 
transcription factor SOX2. 
 
Since discovery over a decade ago, DPSCs hold much potential as an 
alternative and easily accessible source of MSCs for tissue engineering and 
regenerative medicine (Gronthos et al., 2000), still more research and analysis 
is required; with BMSCs having been studied for almost half a decade. The 
focus, here, was how standard-use BMSCs and alternative-sourced DPSCs 
compared in contributing to bone-tissue regeneration, specifically for the 
orofacial region due to congenital abnormality and following trauma or tumor 
resection, which is an unmet clinical need (as reviewed (Mao and Prockop, 
2012)). Due to their lineage-commitment, DPSCs provide a viable alternative 
source of MSCs for mineralised tissue formation, which lends support to cryo-
banking of such tissues for translational-medicine and importantly 
standardisation of cell culture methods, as is becoming more recognised by 
the scientific community (Stacey, 2012). As such, fundamental to stem- and 
progenitor- cell classification is continuous and repeated assessment during in 
vitro culture, and perhaps more cumbersome in vivo studies. Concomitant with 
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such analysis is cell manipulation, which can include cell-
transformation/immortalisation, and so continuous study of stem cell and 
progenitor cell biological-characteristics is important for determining 
therapeutic application of each cell-type (Seaberg and van der Kooy, 2003). In 
addition, long-term cryopreservation of progenitor cells from human bone 
marrow and dental pulp up to three and two years, respectively, was reported 
to maintain osteogenic differentiation capacity, which is an attractive feature 
with possibilities to tailor patient therapy (Kotobuki et al., 2005, Papaccio et al., 
2006). Such differentiation ability following cryopreservation was capable 
along five separate lineages for primary human heterogeneous dental pulp 
progenitors (Zhang et al., 2006). Cryo-injury, however, is a multifaceted issue 
(Gao and Critser, 2000), and karyotyping was suggested to be regularly 
conducted alongside cryo-storage to ensure normal cytogenetics (Breyer et 
al., 2006). 
 
Thus, bone marrow clonal cells can be categorised as primitive stem cells, 
closely related to the mother stem cell, due to their forming of few and large 
colonies, and dental pulp clones referred to as transit-amplifying cells, due to 
formation of many small colonies (Chan et al., 2004). In addition, bone marrow 
cells showed less variable proliferation and would likely be considered a more 
homogeneous tissue source, while dental pulp cells showed more variable 
proliferative potential and could be considered more heterogeneous in nature, 
properties of stem cells and transit-amplifying cells, respectively (Pellegrini et 
al., 1999). Such a classification may be fitting, due to the  multipotent 
differentiation ability of bone marrow, and lineage restricted differentiation of 
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the dental pulp, possibly as a result of loss of stem cell characteristics and 
progressive gain of a more differentiated committed mature progeny (as 
reviewed (Alison et al., 2002)). Hence, DPSCs may be beneficial to use if 
mineralised tissue is required, due to limited proliferation and potent 
differentiation capacity, as opposed to stem cells that may form non-specific 
tissues to the destination, due to rapid self-renewal and spontaneous 
differentiation characteristics (Seong et al., 2010).  
 
In support of this thesis, clonal analysis revealed existence of multipotent 
colonies (Pittenger et al., 1999, Muraglia et al., 2000) and opposes the notion 
of a total cell tissue population harboring several committed progenitor cell-
types that each forms e.g. bone, cartilage, or adipose (Dennis and Caplan, 
1996a). Principal to tissue engineering and regenerative medicine is study of 
clonal cell populations, to best characterise and understand which tissue 
source is most efficacious for mineralised clinical applications such as bone 
repair and tooth caries (Dennis and Caplan, 1996b), which is particularly 
lacking for craniofacial therapy. Thus, preferential use of DPSCs and tissue-
sourced tooth protein-extracts could potentially be advantageous to tissue 
regenerative medicine, due preferential capacity for bio-mineralisation. And 
perhaps more wider in wound-healing therapy (Nuschke, 2013) and pulpal 
treatment (Iohara et al., 2009), as BMSCs produce factors e.g. FGF2 and 
MMP-9 during in vivo osteogenesis that is critical in angiogenesis promotion 
(Batouli et al., 2003). 
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Chapter 8 
Future Work 
 
There is still much debate concerning use of clonal or heterogeneous MSC 
populations, as a heterogeneous BMSC population displayed propensity for 
chondrogenic differentiation in vivo, while clonal populations were only capable 
of adipogenic and osteogenic differentiation in vitro (Dennis and Caplan, 
1996a). As such, “mixed” clonal populations may provide cytokine, trophic 
factor, and/or hormone support that is required for differentiation into e.g. 
cartilage tissue, for which TGFβ superfamily was essential (Wang et al., 2014). 
In addition, would “mixed” clonal populations have a synergistic effect on cell 
proliferation and gain-of differentiation capacity, with only one (DP F2) of three 
DPSC clones, here, capable of chondrogenesis. Likewise, would “mixing” 
clonal populations with different surface marker expressions, e.g. MCAM, have 
gain-of differentiation capacity, as an MCAM+ subpopulation of periodontal 
ligament MSCs showed higher proliferative potential and osteogenic capacity 
than MCAM- cells (Zhu et al., 2013), while a subpopulation of MCAM-/CD31- 
DPSCs regenerated capillary and neuronal networks in canine amputated pulp 
in vivo (Iohara et al., 2009) with angiogenesis and innervation being crucial for 
pulpal regeneration. Issues highlighted by the International Society for Cellular 
Therapy, is in vivo demonstration of self-renewal capacity and multi-lineage 
differentiation as during in vitro culture (Horwitz et al., 2005), and clonal in vivo 
differentiation pattern could be observed against their known in vitro capacity, 
as a “true” measure of potential. 
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The potential clinical use of whole-protein bone- and tooth- matrix extracts for 
tissue engineering needs to be further analysed using immunodepletion 
against unique proteins highlighted in each extract to observe for loss-of 
differentiation capacity, in order to identify those proteins vital in mineralisation 
e.g. against proteoglycans biglycan and decorin. In addition, inhibiting MSC 
cell-surface integrins such as α2β1, which is a major collagen receptor 
(Watson and Gibbins, 1998), by snake venom rhodocytin (Suzuki-Inoue et al., 
2006), can uncover those integrins important for cell migration and attachment 
(Ganguly et al., 2013), and spatial positioning within a stem cell niche that play 
a key role in niche maintenance (Riquelme et al., 2008). Additionally, the 
effects on change in MSC morphology can be observed, as other integrin 
ligands e.g. fibronectin can inhibit terminal differentiation (Watt et al., 1993) 
and potentially promote migration and proliferation at injury sites. 
Lastly, to follow on from the organotypic tissue-slab experiments as a bridge 
from in vivo, the use of a Cre/Lac Z reporter system could label and track the 
destination of MSC clones in an in vivo injury model at sites of damage e.g. 
fracture or caries, and potentially determine MSC proliferative potential and 
differentiation capacity to uncover their role in healing processes. 
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